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Preface
The Research Analysis and Utilization System (RAUS) is designed
to serve four functions:
Collect and systematically classify the findings of all
intramural and extramural research supported by the
National Institute on Drug Abuse (NIDA);
Evaluate the findings in selected areas of particular
interest and formulate a state-of-the-art review by a
panel of scientific peers;
Disseminate findings to researchers in the field and to
administrators, planners, instructors, and other
interested persons;
Provide a feedback mechanism to NIDA staff and planners
so that the administration and monitoring of the NIDA
research program reflect the very latest knowledge
gleaned from research in the field.
Since there is a limit to the number of research findings that
can be intensively reviewed annually, four subject areas are
chosen each year to undergo a thorough examination.
Distinguished scientists in the selected field are provided with
copies of reports from NIDA-funded research and invited to add
any information derived from the literature and from their own
research in order to formulate a comprehensive view of the
field. Each reviewer is charged with writing a state-of-the-art
paper in his or her particular subject area. These papers,
together with a summary of the discussions and recommendations
which take place at the review meeting, make up a RAUS Review
Report in the NIDA Research Monograph Series.
Relapse and recovery are two related areas which are central to
drug abuse treatment and research. This view of drug addiction
and dependence as chronic, relapsing disease is supported by both
v
research and clinical experience. Recent research shows that
many drug abusers have relatively short "addiction careers" and
suggests that with a better understanding of relapse (and its
prevention), we may be able to assist clients more effectively in
reaching a state of recovery.
The meeting on which this monograph is based took place September
19-20, 1985, at the National Institute on Drug Abuse. Its focus
was on: (1) a review of available theoretical perspectives;
(2) reviews of long-term studies of treated samples to assess
patterns of relapse and recovery over protracted time spans;
(3) understanding relapse and recovery through examination of
controlled studies and shorter term followup research; and
(4) implications of research for clinical practice. The meeting
was jointly chaired by Frank M. Tims, Ph.D., and Carl G. Leuke-
feld, D.S.W. Ms. Jacqueline P. Ludford, Chief, Research Analysis
Branch, Office of Science, is coordinator of NIDA's RAUS system.
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Relapse and Recovery
in Drug Abuse: An Introduction
Frank M. Tims and Carl G. Leukefeld
From the treatment perspective, relapse and recovery are key
issues. The high rate of relapse is an especially frustrating
problem, and the notion of a "cure" remains elusive. Substance
abuse careers are episodic, with periods of abstinence, reduction
of use, and relapse the prevailing pattern, often with the course
of events being influenced by external factors such as availability
of drugs and societal pressures. Given the patterns of relapse and
remission, a variety of interpretations of the nature of substance
abuse as a disease condition, how it should be treated, and what
the goals of treatment should be, have evolved.
High relapse rates among substance abusers remain old news.
Numerous studies have documented that high relapse rates prevail
across classes of substances--for example, Marlatt (1979) has found
that the average time from abstinence to relapse varies from 4 to
32 days for tobacco, alcohol, and opiates. But there are a host of
questions which should be addressed in attempts to understand
relapse, as well as recovery. Prominent among these questions is
one of definition. What constitutes relapse in treatment
populations where a variety of post-treatment substance use
patterns may be observed? If treatment is for a particular
substance abuse problem, how are we to consider such issues as
controlled or occasional use, substitution, and continuation of use
of another, perhaps lesser, substance which may constitute abuse?
A common solution to this dilemma of classifying relapse to a
specific substance is to apply a criterion of loss of control or
return to some level of use (For example, see Hall, this volume).
There is also a problem presented by the complexity of substance
use patterns, as seen in the contrast between polydrug abusers and
opiate addicts. As Hubbard and Marsden (this volume) point out,
multiple drug use among clients being admitted to treatment is
common, and use of a given substance in the early posttreatment
period is often continuation of the pattern present at termination
of treatment. It appears that some subgroups maintain positive
treatment outcomes and have lower relapse rates, although these
groups need sharper definition and elaboration. Also, there is a
need to better understand how treatment brings about desired
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behavioral changes, and how these changes can be maintained for
specific client types.
Like relapse, recovery is an area where knowledge is lacking.
While relapse is observable almost immediately, recovery is a
complex, long-term phenomenon. There are criterion problems. At
what point is recovery achieved, or, stated dlfferently, is
recovery a continuing process over a lifetime of high risk?
Research using data from the Drug Abuse Reporting Program (DARP)
has noted that while a large percentage of opiate addicts
eventually cease use after treatment, marijuana use appears to be a
lasting pattern among many clients otherwise drug abstinent
(Simpson and Sells 1982). Duckitt and others (1985) have also
raised the questin regarding relapse after treatment for
alcoholics. Clinicians recognize that "slips" or occasional lapses
may occur without return to regular use, and researchers have noted
that ex-addicts may occasionally use opiates without returning to
regular use (Waldorf 1983). Understanding the recovery process is
not easy since this is an area of incremental knowledge growth, and
the study of long-term careers is essential for this development.
Nevertheless, there are some favorable indications in the area of
opioid addiction. Simpson and others (1982) found that an
increasing percentage of opioid addicts reach and maintain
abstinence over a 6-year period, with more than half this sample
opioid abstinent at 6 years. Moreover, findings from another
sample of opioid addicts in the DARP treatment population revealed
reasonably stable outcomes over a much longer period (Joe et al.
1984). These DARP outcome studies are a sharp contrast to those of
treatment samples from the 1950s.
In attempts to better understand relapse and recovery, numerous
theoretical formulations have been advanced, often with limited
data. Better integration of theory and empirical findings,
organized to build on promising treatment approaches, could make a
major contribution. This would serve to: (1) clarify existing
theory and assess the relative utility of those theories to better
explain relapse and recovery; (2) critically examine recent
long-term studies of substance abuse clients, with a view to
identifying differential outcome patterns and predictors;
(3) review more short-term, controlled studies which have the
potential for increased understanding of relapse and recovery; and
(4) consider the implications of theory and research findings for
clinical practice. Thus, the structure and outline of this
volume. Because a key question has to do with the extent to which
relapse and recovery are generalitable across categories of
substances, a major objective here was to include researchers and
studies focused on varied addictive or dependency-producing
substances--especially opiates, alcohol, and tobacco. In addition,
a variety of disciplinary, theoretical, and clinical perspectives
are represented.
The first chapters deal with theory from differing perspectives.
Dr. Thomas Babor. who led the discussion on theory, presents recent
work on the utility of the drug dependence syndrome construct as an
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organizing principle in clinical research. Dr. Donald Wesson
presents a more general review of existing theory in the substance
abuse field, and Dr. John Grabowski reviews perspectives from the
smoking literature, with particular emphasis on behavioral
approaches to explaining dependency, its treatment, and relapse.
A number of longitudinal studies are then examined for insights
into relapse and recovery. Dr. James F. Maddux led the discussion
in this area, and presents findings from a number of studies across
categories of substances. Longitudinal data presentations are also
given by Colin Taylor, who discusses a cohort of employed male
alcoholics, Dr. D. Dwayne Simpson, who reports long-term findings
for opioid addicts treated in community-based programs, and Dr.
Timothy Baker, who presents a data on clients treated for tobacco
dependency.
The third group of chapters focus on the theme, "understanding
relapse and recovery," and are primarily concerned with controlled
and interpretive studies of short term treatments. Discussion in
this area was led by Dr. Sharon M. Hall, who presents findings on
relapse among opiate, alcohol, and tobacco clients treated in
short-term programs (under 30 days) and followed weekly
thereafter. Dr. William McAuliffe reports findings on relapse
among opioid addicts who were discharged as completing treatment
and abstinent. Dr. Robert Hubbard provides a useful examination of
drug abuse patterns at admission to treatment, and patterns of drug
use after treatment, for a large sample of clients, and raises
interesting questions as to how to view "relapse" when multiple
drug use is the prevailing pattern and when drug substitution
(licit or illicit) occurs after treatment. Dr. George Bigelow
examines relapse to cigarette smoking (and intervention to prevent
relapse) among a sample of patients who suffered myocardial
infarction, further exploring the insights which are available to
the drug abuse field from studies of relapse to tobacco smoking.
Clinical implications of existing research on relapse and recovery
research are addressed in a paper by Dr. Bruce Rounsaville.
Finally, a series of recommendations based on the deliberations of
the above-mentioned authors and other participants was developed,
and is presented in the concluding chapter of this monograph. The
meeting was jointly chaired by the authors of this chapter.
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Theories of Relapse and Recovery
and Their Implications for Drug
Abuse Treatment
Donald R. Wesson, Barbara E. Havassy, and David E. Smith
Psychotherapists, drug abuse counselors, treatment program planners, and
researchers have theories about what relapse is, why it occurs, and how it is
prevented. Such theories are important because they shape the treatments
provided to drug abusers. For example, a therapist who believes that drug abuse
is a chronic, relapsing disease will treat a patient who has relapsed differently
from one who views drug abuse as a secondary symptom of underlying
psychopathology. A clinical researcher who accepts a theory of inherited
endorphin deficiency will design and test treatments for relapse differently from
a researcher who believes that drug abuse is learned behavior.
In this chapter, we review selected theories of relapse and the antithesis of
relapse, recovery. We selected theories that are of current importance: those that
form the foundations of currently used treatment modalities, or those that mold
common notions about the behavior of drug abusers. We will describe the
theory, give examples of research which support the theory, and discuss how the
theory influences treatment.
Relapse can be defined as a discrete event, which occurs at the moment a person
resumes drug use. or as a process which occurs over time. In the latter view, it
may mean resumption of addiction; return to drug use of the game intensity as in
the past; daily drug use for a specified number of sequential days (e.g., daily use
for 1 week); or a consequence of the drug use, such as the return to the hospital
for further drug abuse treatment (e.g., Litman et al. 1983).
The definition of relapse may be shaded by the treatment modality and the goals
of treatment. For example, in a methadone maintenance client for whom the
only realistic treatment goal is reduction in illicit drug use, relapse generally
means resumption of frequent or daily opiate use.
Relapse rates are dependent on: (1) the definition of relapse used, (2) the
method of detecting relapse, and (3) the method used to compute them. Given
the different meanings of relapse previously stated, it is apparent that large
variations in relapse rates could result from the definition of relapse used.
Methods of detecting relapse also vary widely. In drug treatment outcome
research, an interview with the subject combined with urine testing to validate
current drug use is a common method of assessing relapse. The method is not
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precise, however, because urine testing analytic methods vary in sensitivity, in
specificity, and in the drugs that can be detected. For example, EMIT is
extremely sensitive for morphine, marijuana, and benzoylecgonine (a cocaine
metabolite) and can detect them in urine for several days following use. Thin-
layer chromatography, another commonly used screening method, is less sensitive
for these drugs and may miss some drug use which would be detected with
EMIT.
Two time frames are in common use in computing relapse rates. One ascertains
current drug use at specific time intervals following treatment termination (e.g., 1
year after the end of treatment). This does not capture intermittent drug use
unless it is occurring at the time of followup. The other method ascertains
whether there was drug use at any time during the followup period. Since drug
abusers often have periods of abstinence interspersed with use, the second
method will generally produce higher relapse rates (Pickens et al. 1985).
A final variation in computing relapse rates is in the handling of missing data.
Since investigators are unable to contact all subjects in followup studies,
assumptions must be made about subjects lost to followup. They may be
assumed to have relapsed, or they can be “replaced” by subjects who could be
located. The method of handling missing data is often not overtly specified in
reports of relapse rates; yet, it can account for considerable variance.
GENETIC THEORIES AND RELAPSE
The vulnerabilities to drug dependence that are under genetic control are usually
discussed as risk factors in developing drug dependency, but they also have a
relationship to relapse.
Adoption, twin, and animal studies provide evidence of important genetic factors
in alcoholism. The risk of developing alcoholism is closely associated with the
degree of genetic relationship to an alcoholic parent. Offspring of alcoholic
parents have an increased risk of developing alcoholism, a relationship which
holds even when the children are raised separately from each other and from the
biological parents (Schuckit et al. 1985).
The theory postulates a genetically transmitted biochemical abnormality that
predisposes some individuals to abuse of a drug if they use it. The abnormality
has not yet been identified; however, examples of altered metabolism of alcohol
in young men with a family history of alcoholism (who are assumed to be at
higher risk of developing alcoholism should they use alcohol) have been
described (Schuckit and Duby 1982). Their subjects had more facial flushing in
response to alcohol than controls without a family history of alcoholism. The
flushing in response to alcohol ingestion is similar, but less intense, to that which
occurs in some Orientals, North American Indians, and Eskimos. It is the result
of blood acetaldehyde. a metabolite in the breakdown of ethanol. The
relationship between this particular finding and alcoholism is not clear as one
might logically expect that the flushing, generally perceived as unpleasant, would
offer protection from development of alcoholism. The finding of this example of
altered metabolism in subgroups of individuals adds weight to the genetic theory.
The genetic theory explains why not everyone who drinks heavily develops
alcoholism and why people who have the abnormality are more likely to relapse
if they depart from abstinence.
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A genetic theory has also been proposed for opiate dependence. Goldstein (1978)
hypothesized that some individuals might be predisposed to develop narcotic
dependency. He hypothesizes that a person could inherit  an endorphin
deficiency. If people with the deficiency happened to use narcotics, they would
discover a “normalizing” or euphorogenic effect in excess of that experienced by
people without the abnormality. This effect would predispose them to
dependency opiates and make it harder to remain abstinent.
Implications for Treatment
Genetic theory is used to bolster the illness model of drug dependence.
Vulnerability on a genetic basis is used as a “nonjudgmental” way of explaining
to drug abusers why they cannot return to “controlled” drug use.
METABOLIC THEORIES
In the early 1960s, Dole and Nyswander were studying the metabolic kinetics of
morphine when they observed improvement in subjects’ functioning in response
to substituting methadone for morphine. Long before the discovery of narcotic
receptors, endorphins, or enkephalins, Dole and Nyswander postulated that
repeated exposure to narcotic drugs might induce metabolic changes in neurons
(Dole and Nyswander 1967, p. 22). Methadone corrected the metabolic change.
Since methadone was meeting a metabolic need of the patient, replacement
methadone therapy, perhaps lifelong, was rational and the treatment fit a medical
model (i.e., like exogenous insulin for a diabetic).
The hypothesis that exposure to narcotics produces metabolic alterations is
supported by more recent work with opiate receptors, beta-endorphin, and
enkephalins. After the discovery by Goldstein in 1971 that some neurons had
specialized recognition sites on the cell’s membrane for opiates, scientists
searched for an endogenous substance with opioid activity that would bind to the
receptor. Several endogenous substances meeting the criteria were subsequently
found: beta-endorphin, a fragment of beta-lipotropin; and two pentapeptides,
methionine-enkephalin and leucine-enkephalin. Goldstein (1978) speculated that
a relationship existed between beta-endorphin levels and heroin addiction. He
hypothesized that the use of heroin would suppress endorphin production,
analogous to feedback regulation of other hormones. Further, persistent opiate
withdrawal symptoms would result from endorphin deficiency, and protracted
narcotic withdrawal symptoms could help account for the high relapse rate among
opiate addicts.
Ho et al. (1980) provide empirical support for Goldstein’s hypothesis that beta-
endorphin levels are abnormal in opiate addicts. They compared plasma levels of
endorphins in heroin addicts and nondrug-using controls and found that the
mean level of immunoassayable plasma endorphin activity, which reacts with
beta-endorphin and beta-lipotropin, was reduced in the heroin addicts to about
one-third the level of the nonaddict controls.
Implications for Treatment
The metabolic theory of opiate dependence supplies support for opiate
dependency as a disease. Reduced endorphin levels of narcotic addicts provide
plausible medical reason for a relapse. Metabolic theories bolster the medical
disease model of narcotic drug abuse and provide a medical foundation for
narcotic maintenance therapy (e.g., methadone and LAAM). The endorphin
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deficiency model also has an implication about the duration of methadone
treatment. If one supposes that the addict inherited an endorphin deficiency,
analogous to insulin deficiency in diabetics, then “replacement” could be life-
long. Many providers of methadone maintenance do not use this model. They
view the need for methadone maintenance to be temporary and the appropriate
use of methadone to be to provide a time-limited period of psychosocial
stabilization while rehabilitation occurs. Widespread acceptance of this latter
perspective has led to legislation that prohibits maintenance therapy of unlimited
duration. Typically, in the United States, opiate addicts are provided methadone
maintenance for periods of 1 or 2 years.
LEARNING THEORIES
Learning theories have been developed to explain initiation of drug use,
habituation, withdrawal, and relapse. We will restrict our discussion to the
learning theories most relevant to relapse: (a) conditioning theory, and (b) social
learning theories.
CONDITIONING THEORY
Wikler (1961, 1965, 1973) proposed the conditioned withdrawal syndrome to
explain why formerly addicted persons who appear to be “cured” of their
addiction while in treatment or in jail return to opiate use when no longer
physically dependent. According to Wikler, environmental and social stimuli
formerly associated with actual withdrawal and drug-seeking became classically
conditioned stimuli for a conditioned withdrawal syndrome. Wikler and Pescor
(1967) demonstrated a conditioned withdrawal syndrome in rats. Rats that were
no longer morphine dependent showed signs of narcotic withdrawal (e.g., “wet
shakes”) when they were returned to the cage in which they had previously
suffered narcotic withdrawal.
With Ludwig, Wikler extended the conditioned withdrawal model to alcohol
relapse (Ludwig and Wikler 1974). Over time, craving and other alcohol
withdrawal phenomena become conditioned to environmental and emotional
stimuli through temporal continuity. Once conditioned, exposure to the same or
similar stimuli would cause an abstinent alcoholic to experience withdrawal.
Some evidence of conditioned abstinence in intravenous heroin addicts was found
by Sideroff and Jarvik (1980). Eight addicts who were completing a l4-day
detoxification program were shown a 6-minute videotape depicting scenes of
heroin being prepared for injection and being injected. Compared to a control
group of two heroin users who snorted heroin and six patients who were not
drug dependent, the intravenous heroin users, while watching the videotape,
developed greater increases in anxiety, depression, drug cravings, galvanic skin
resistance, and heart rate. These investigators propose that the psychological and
physiological changes they observed demonstrated conditioned withdrawal.
Implications for Treatment
A direct application of classical conditioning is aversion treatment of alcoholism
with emetine. Patients have sessions in which they are given emetine, which
produces severe nausea and sometimes vomiting, while being allowed to smell or
taste their preferred alcoholic beverage. With repeated pairings of alcohol with
nausea, instead of the usual pleasurable feelings, alcohol loses its appeal.
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To prevent relapse to narcotic use, Wikler (1980) proposed active extinction of
the classically conditioned abstinence syndrome and the operantly conditioned
drug-seeking behavior by eliciting the abstinence syndrome while preventing the
reinforcing effects of opiates. He predicted that repeated elicitation of the
conditioned withdrawal syndrome while the reinforcer (i.e., the relief obtained
from the narcotic) is blocked with an orally effective, long-acting narcotic
antagonist (such as naltrexone) should eventually extinguish the conditioned
withdrawal syndrome, and the drive for self-administration of narcotics should
cease.
SOCIAL LEARNING THEORIES
Social learning models of addiction and relapse acknowledge the role of classical
and operant conditioning; however, they focus on cognitive-mediated processes in
the acquisition, maintenance, and modification of behavior. The various social
learning theories complement conditioning theory by focusing on the cognitive
processes occurring between stimulus and behavior.
A general  model  of  relapse in a  social  learning framework has three
components: first, the patient encounters a high-risk situation during abstinence;
second, the patient has expectations about whether the situation can be handled
without use of drugs; and third, the patient has a limited repertoire of behaviors
and skills to cope with the high-risk situation.
What follows the high-risk situation depends on whether the situation resulted in
drug use. The model holds that avoiding use leads to heightened expectations
about personal control, mastery, and continued abstinence. Using a drug in
response to the high-risk situation can lead to feelings of failure and guilt, which
can precipitate further use.
Consequences of relapse have been discussed by Bandura (1978) and Marlatt and
Gordon (1980). “Catastrophizing” (Bandura 1978) is an exaggerated or extreme
response to an occasion of use. Persons who doubt their ability to control their
use, e.g., those with low efficacy expectations, are likely to overreact or
“catastrophize” the consequences of a single lapse and view the lapse as a global
failure. The Marlatt and Gordon (1980) abstinence violation effect (AVE) is a
similar construct. It has two components: cognitive dissonance (having a self-
image as a nonuser which conflicts with the actual drug-using behavior) and
personal attribution of the transgression as a sign of weakness and failure.
Although the AVE varies in intensity, its occurrence will increase the probability
of repeating the drug use since the dissonance and the attribution of weakness
will drive behavior to reduce the dissonance.
Implications for Treatment
The work of social learning theorists contains specific formulations regarding
relapse prevention. Treatment derived from social learning theories attempts to
prevent relapse by intervening at different points in the chain of behaviors,
beginning with antecedents to the high-risk situation and extending through
actual relapse. The interventions are tailored to the particular stage in the
sequence and to the particular person.
Social learning theorists agree that a critical point of intervention is at the time
of experiencing a situation of risk. Treatment goals include fostering recognition
of the situation as one of risk, maximizing expectations of efficacy in handling
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the situation, and enhancing the behavioral repertoire to cope with the situation.
The person is taught to recognize his or her high-risk situation and to practice
coping skills needed to avoid drug use should the situation be encountered.
Following a slip or a relapse, interventions include teaching clients how to limit
or contain an episode of drug use and how to apply cognitive restructuring.
Cognitive restructuring involves conceptualizing the episode of use as a limited
slip rather than a major disaster; analyzing the high-risk situation; and learning
new coping skills.
PSYCHOPATHOLOGY AS A CAUSE OF RELAPSE
Many psychodynamically trained practitioners view addiction as a symptom of
underlying psychopathology. Their view is based on observations that many
drug-dependent persons display a broad range of symptoms and behaviors that
match one or more DSM III diagnostic categories (e.g., personality disorders,
major affective disorders). Divergent opinions often revolve around whether the
psychiatric symptoms are the result or the cause of drug abuse. Many alcoholics,
for example, show certain personality characteristics (high extroversion and
anxiety) on the Minnesota Multiphasic Personality Inventory (MMPI). The
methodological difficulty is to determine whether the personality traits predated,
and perhaps contributed to, the development of alcoholism, or whether the
personality traits are a product of being alcoholic. The latter interpretation is
supported by prospective studies of men who later became alcoholics. The
studies found no evidence of childhood psychiatric problems or “neuroticism”
when compared to adequate control populations (Schuckit et al. 1985).
Some chemically dependent patients do, however, have severe psychopathology
which predates their drug use; and the psychopathology will persist, or become
more overt, after sustained abstinence from drugs. Referred to as dual diagnosis
(a major psychiatric disorder not caused by drug abuse combined with a
substance abuse disorder), such patients are difficult to treat in traditional
substance abuse treatment programs and often do not do well with psychotherapy
or other modes of psychiatric treatment. Many bounce back and forth between
drug treatment programs and mental health clinics or hospitals, generally creating
havoc in both.
Implications for Treatment
The theory that all substance abusers have underlying psychopathology has
practical ramifications in treatment: many therapists view the drug dependency
as a secondary symptom that will disappear when the underlying psychopathology
is adequately treated. As a consequence, they choose not to address the drug use.
A related posi t ion is  that  the pat ient  is  using drugs to self-medicate
psychopathology; therefore. the treatment intervention is directed at the
underlying pathology. With both of these approaches, abstinence is viewed as
evidence that the psychopathology is resolving; relapse means that the
psychopathology is not resolved.
An approach that is gaining favor is to treat the addiction as the primary
problem and to delay treatment of the overt psychopathology until a period of
abstinence has been achieved. Depression or other psychopathology may be
secondary to the drug use and may therefore resolve without specific intervention
apart from treatment of the chemical dependency, e.g., the acute depression
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following cocaine use (Gawin and Kleber 1985, Smith and Wesson 1985).
Treatment of relapse would directly address the drug use.
THE ROLE OF STRESS AND SOCIAL SUPPORT IN RELAPSE
The notion that stress and social support are related to relapse is embedded in
many different relapse theories; therefore, we discuss stress and social support
separate from any specific theory of relapse.
STRESS
Reference to the role of stress in contributing to relapse is ubiquitous in the drug
abuse literature. Stress, operationalized as negative life events, is implicated in
treatment failure (Benfari et al. 1982) or as a cause of relapse (Shiffman 1982;
Marlatt and Gordon 1980; Mermelstein et al. 1983a, 1983b; Ogbru 1976). Despite
the frequent references to stress as a cause of relapse, mechanisms of this implied
relationship are not clear.
The role of stress as one of several contributors to relapse following treatment
has been well-articulated by a group of investigators associated with the Social
Ecology Laboratory (e.g., Cronkite and Moos 1980; Finney et al. 1980; Moos et
al. 1979). Finney et al. (1980) found that a large number of posttreatment
negative life events were associated with poorer posttreatment outcome in
alcoholics. Moos and Finney (1983) report negative life events more prevalent
among relapsed alcoholics than among recovering alcoholics or a matched
nonalcoholic community sample (Moos et al. 1981). The number of negative life
events at 6 months posttreatment predicted complaints of physical symptoms and
depression at 2 years posttreatment even after socioeconomic variables and level
of functioning at treatment intake were controlled (Finney et al. 1980).
Cronkite and Moos (1980) found that posttreatment stress affects alcohol
treatment outcome, especially level of depression. Among the three
posttreatment factors in their path-analysis model, stressors and coping responses
were more strongly related to outcome than family environment. More stressors
are associated with poorer outcomes. The way in which the data were collected,
however, does not make it possible to separate the stressors produced by the
relapse (e.g., separation from spouse due to return to drinking) from stressors
leading to a relapse (e.g., drinking in response to a separation).
SOCIAL SUPPORT
A dominant hypothesis in the literature is that social support functions as a
buffer to stressful life experiences--i.e., the negative consequences of stressful
life events--are mitigated by social support. There has been, however. a growing
accumulation of challenges to the buffer hypothesis (e.g., Gore 1978; Thoits 1982;
Mitchell 1984).
Another hypothesis is that social support has a generally beneficial effect,
independent of whether persons have stressful events in their lives, and that
those who receive social support. have greater well-being. In a recent review,
Cohen and Wills (1985) concluded that there is evidence consistent with both
models. According to Cohen and Wills, evidence for a buffering effect is found
when social support is measured as a resource available in response to particular
stressful events. Evidence is found for the generally salubrious effects of
support when it is assessed as the extent of a person’s integration in a social
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network. Each represents a different conceptualization and measurement of
processes by which social support affects well-being.
Of relevance to drug abuse treatment is how social support functions in relation
to relapse. Both of the above models of support may have value in this regard.
Other important aspects of the role of support in relapse, though not necessarily
mutually exclusive, include the possible negative consequences of social support,
the issue of drug-specific versus general social support, and the role of support
from family and significant others.
Negative Aspects of Social Support
A common, though not explicit, assumption is that social support is always of
positive value. Only a few investigators (e.g., Lehman et al. 1983; Mitchell 1984;
Schaefer et al. 1981; Shinn et al. 1983) have examined the quality of social
support or acknowledge negative aspects of various forms of social support, i.e.,
there are sometimes negative consequences to having support. Negative aspects
of being involved in supportive relationships include the demands made by
others, the constraints they exert over one’s choices, the efforts required to
sustain the contact, and the disappointment often inherent in relationships when
help is needed and expected, but not forthcoming.
The potentially negative aspects of social support are acknowledged in the
addictions literature (Tucker 1979; Reed 1985). Social support can either assist in
the maintenance of abstinence or foster relapse. Some family interactions that
appear to be supportive may, in fact, promote relapse (e.g., Coleman 1980;
Stanton et al. 1982; Todd 1984). For example, smoking treatment clients who
have spouses who also smoke and who are not in treatment have a lower
probability of successfully stopping (Lichtenstein 1982).
Peer groups can also provide social support that can promote relapse. Certainly,
friends who are still using drugs are more likely to support relapse than recovery.
Empirical evidence that peer pressure can promote relapse is found in the work
of Marlatt and Gordon (1980). They report situations in which patients describe
that being offered a drug or being around others who are using, even if the drug
is not offered, were relapse precipitants for 18% of smokers (n = 35), 25% of
alcoholics (n = 70), and 34% of opiate users (n = 32).
Drug-Specific Versus General Social Support
Drug users may receive general social support, but it may not include support for
achieving and maintaining abstinence. If network members are unaware of, or
not sensitive to, the users’ problem. the support they provide may not be a
resource to cope with issues concerning maintaining abstinence. Or, if network
members also have problems with the drug, the support offered may be in the
service of relapse. This consideration of social support, general versus drug-
specific, in relation to drug use and relapse is relatively new and has not received
sufficient attention.
Mermeistein et al. (1983b) explored partner support specific to smoking cessation
treatment. In the last week of treatment, after the target quit date, subjects
rated their spouses on the frequency of supportive behaviors related to smoking
cessation and how helpful these behaviors were for maintaining abstinence.
Subjects were divided into three groups at each followup point: those who never
quit, those who quit and relapsed, and those who were abstinent. At all three
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f o l l o w u p  p o i n t s ,  t h e r e  w a s  s i g n i f i c a n t  g r o u p  e f f e c t  o n  h e l p f u l n e s s
scores: subjects who never quit rated their spouses’ behavior significantly less
helpful than the subjects who were abstinent or who relapsed. Differences
between relapsers and abstainers did not reach significance.
In research concerning commonaiities of relapse in three drug groups (smokers,
alcoholics, and opiate abusers) (see Hall and Havassy, this volume), the
relationship of both general and abstinence-specific social  support  to
posttreatment relapse was assessed (Havassy et al., in press). Subjects provided
information about the support from network members for treatment and
abstinence. They also completed measures concerning helpfulness of abstinence-
specific support from a significant partner (adapted from Mermelstein et al.
1983b), general social support and negative social support. Preliminary findings
on the first 77 subjects of a sample of 230 indicate that greater general social
support predicted longer periods of abstinence following treatment for all three
drug groups. Greater experienced helpfulness of abstinence-specific support
from a partner predicted a longer time before relapse, but did not attain a .05
level  of  s ignif icance;  greater  drug use of  network members and their
encouragement of drug use predicted shorter periods of abstinence.
In related work, Janis and Hoffman (1970, 1982) experimentally manipulated
abstinence-specific support from a treatment partner to maintain abstinence from
smoking. In long-term followup interviews conducted 1 and 10 years
posttreatment, they found that clients treated in pairs who were in the high-
partner contact condition (daily calls for 5 weeks) were more successful in
maintaining abstinence than were clients in the low-contact or the control
condition. According to Janis (1983), high-contact partnerships meet the
following criteria of effective helping relationships: high disclosure of personal
information relevant to the problem, e.g., smoking cessation; disclosures
accompanied by mutual acceptance; reference to the antismoking norm in the
contact; and contact beyond the duration of the formal treatment.
Spouse/Partner and Family Support and Relapse
The support available from spouses, significant others, and families in relapse
prevention treatment has been explored with mixed results, i.e., support can have
both positive and negative consequences. Studies in which levels of spousal or
familial support are investigated occur most notably in the weight-loss treatment
(e.g., Brownell et al. 1978; Stuart and Davis 1972; Mahoney and Mahoney 1976)
and in the smoking-cessation literature (e.g., Mermeistein et al. 1983b). Mahoney
and Mahoney (1976) found family support to be positive; Stuart and Davis (1972)
found it detrimental to weight loss. Although there were no differences among
the groups in mean weight reduction at the end of treatment in the Brownell et
al. (1978) study, at 3 and 6 months posttreatment, subjects whose spouses had
been trained with them in behavioral weight-loss techniques lost significantly
more weight than subjects whose spouses had not been trained.
Naturally occurring marital and family support and their correlation with
posttreatment outcome have been studied by Moos and his colleagues and, more
recently, by Havassy et al. Moos and Finney (1983) report results of alcohol
treatment studies indicating that marital and familial cohesion correlated with
better outcome in several areas, including posttreatment alcohol consumption.
Havassy et al. (in press) found subjects (in three drug treatment groups: alcohol,
tobacco, and opiates) with partners had significantly longer periods before relapse
than those with no partners:
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Implications for Treatment
As numerous studies point to the contribution of stress to relapse, therapists
should recognize that patients are vulnerable to relapse during times of stress.
Teaching techniques for coping with stress is one example of how therapists
counter the relapse potential of stressful life events.
Examples of deliberate manipulation of social support to prevent relapse may be
seen in such programs as Alcoholics Anonymous (AA), Synanon, Weight
Watchers, or drug treatment aftercare programs that emphasize or create a “buddy
system” (or sponsor). Treatment programs, especially those for obesity and
cigarette smoking, frequently establish overt support conditions to assist clients in
withstanding and overcoming stressful situations without relapse.
THEORIES OF RECOVERY
In the context of addictive behavior, the term “recovery” can mean “cure” of
addiction, “abstinence” from drug use, or “remission” of the drug-dependent state.
Theories about recovery usually describe a process of achieving and maintaining
abstinence that is not necessarily related to any specific type of treatment. These
theories reflect notions about influences of major life changes in producing and
sustaining abstinence.
MATURATION THEORY OF WINICK
Using 1955-60 data from the Federal Bureau of Narcotics registry, Winick (1962)
noted that most opiate addicts began use in their late teens and early twenties
and disappeared from the narcotics registry after age 35. From this observation,
Winick hypothesized that, by age 35, most opiate addicts “mature out” of the
problems that originally led to heroin use. After 35 years of age, they find the
drive to continue drug use not sufficiently compelling for them to continue the
life-style necessary for opiate use.
Subsequent longitudinal studies do not support the maturation hypothesis. For
example, Harrington and Cox (1979), in a 20-year followup of 51 heroin addicts,
found that only 1 was drug-free after age 40. Likewise, Vaillant (1973), in a 20-
year longitudinal study of addicts admitted to the U.S. Public Health Service
Hospital in Lexington in 1952, found that only 35% of addicts could be classified
as “matured out” by age 40.
NATURAL RECOVERY FROM OPIATE ADDICTION
Waldorf (1983) studied 201 ex-opiate addicts (half were treated, and the other
half had quit without treatment). He concluded that the concept of “maturing
out,” preconditions such as “hitting bottom,” and existential crises were not
adequate to explain the variety of recovery experiences. The ability to quit was
not necessarily related to treatment. Addicts used a variety of methods to obtain
and maintain abstinence. Those who were successful generally broke ail ties with
opiates users and created new interests, new social networks, and new social
identities.
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TWELVE-STEP RECOVERY MODEL
Members of AA or other 12-step recovery groups use the term recovery to mean
more than abstinence from drug and alcohol: being “in recovery” implies that the
person has accepted that addiction as a lifelong, incurable disease; that the person
is participating in 12-step recovery groups; and that the person is learning to live
a comfortable and responsible life without the use of psychoactive drugs.
Additionally, a model of recovery evolving from 12-step “recovery” groups views
cessation of drug use as an active, continuing process.
Recovery groups accept that once alcohol or drug dependence has developed, the
illness will persist throughout the remainder of a person’s life. Therefore,
maintenance of sobriety requires strict abstinence, aided by continued
participation in recovery groups. When 12-step recovery group members speak
of the quality of someone’s recovery, they mean the number of meetings he is
attending, his giving the maintenance of his sobriety the highest priority in his
life, his level of comfort in living without drugs or alcohol, and the step he is
currently “working.” An important method of maintaining sobriety and
reinforcing a person’s long-term recovery is called “twelve-stepping” or helping
others with the problem.
The recovery model stresses abstinence from all mood-altering substances
(generally excluding nicotine and caffeine), and any use of drugs or alcohol is
called a relapse. Behavior may be labeled as relapse even before return to drug
use. In the recovery model, it is stressed that relapse does not happen as a
single, isolated event, but is proceeded by a period of altered attitudes and
cognitive style. Members of AA refer to this pattern of thinking as “stinking
thinking.” First, the person begins to view himself or herself as “cured” and no
longer in need of attending meetings and being constantly vigilant to prevent
relapse. The person reduces or stops attending AA or other 12-step meetings.
Next, the person questions the need to maintain abstinence from all psychotropic
drugs and eventually tries a drug, not necessarily the primary drug of abuse, “to
see” if this leads to a compulsive use of the primary drug of abuse. If it does
not, the notion that strict avoidance of all psychoactive drugs is not necessary is
confirmed. Lastly, the person “tests” his or her ability to control use of the
previously abused drug. If loss of control is not immediate, the notion of the
“cure” is reinforced, and the person is further estranged from recovery support
peers. Since the recovery model assumes that drug dependency is a lifelong
illness, the drug use is viewed as a return of the illness.
Implications for Treatment
Although many forms of treatment include or encourage their patients to
participate in AA or other forms of 12-step recovery, the participation is viewed
as a treatment adjunct. Twelve-step recovery incorporates many of the change
forces described by Waldorf in natural recovery: new social networks, new social
identity, and new interests. Many addicts, however, reject If-step involvement
because of the religious overtones. The challenge to substance abuse treatment is
finding ways to engage more patients in 12-step recovery and in creating
alternatives to harness the potent change forces active within 12-step recovery.
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CONCLUSION
There is a great diversity of theory about relapse and recovery. This diversity
can be considered from both a treatment and a scientific perspective. From the
treatment perspective, the diversity has an important practical consequence:
different theoretical positions translate to different treatments and interventions.
What happens to someone who relapses depends on the treatment provider’s
response, and that depends on the theoretical model that influences the provider.
In some formulations, most notably social learning theory, a relapse can facilitate
learning about high-risk situations. In other models, a relapse may convince
people that they are unable to maintain “controlled” drug use. Thus, relapse need
not be synonymous with treatment failure.
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The Drug Dependence Syndrome
Concept as an Organizing Principle
in the Explanation and Prediction
of Relapse
Thomas F. Babor, Ned L. Cooney, and Richard J. Lauerman
Common sense suggests that addictive behaviors are at once
biologically based illnesses, personality-related psychological
disorders and socially learned "bad habits." All of these common
sense notions have provided a basis for theories of addiction,
typically described in the academic literature as the medical,
psychological, and social models of substance use, respectively.
Depending on the relative emphasis given to disease processes,
self-contol, psychological vulnerability, or social learning,
common sense theory reflects the implicit assumptions ordinary
laymen have about the "problem" of psychoactive substance use.
In this chapter we will consider a theory of dependence that
contains elements of all of these common sense notions of
addiction; namely, that dependence is a socially learned,
biologically based, psychologically mediated condition that impairs
an individual's ability to exercise voluntary control over such
substances as alcohol, nicotine, and other drugs. In the process
of describing and evaluating this drug dependence syndrome (DOS)
concept, we will give special emphasis to its implications for the
understanding of both relapse to, and recovery from, a variety of
addictive disorders.
The term relapse refers to the return to substance use, following a
period of voluntary or enforced abstinence, at a level of intensity
comparible to that attained before abstinence. Recovery means
either the stabilization of abstinence, or the regular consumption
of a substance without the negative consequences previously
associated with drug use.
THE DRUG DEPENDENCE SYNDROME CONCEPT
The drug dependence syndrome concept was developed (Edwards et al.
1981) within the context of the World Health Organization's ongoing
program on nomenclature and classification of alcohol- and
drug-related problems. Previous work by a WHO Expert Committee
(1964) had recommended abandonment of the concepts of addiction and
habituation in favor of drug dependence, which was differentiated
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into psychic and physical manifestations. Subsequent developments
in the classification of alcoholism within International
Classification of Disease-9th Edition led to the substitution of
the words "alcohol dependence syndrome" for such terms as
alcoholism and alcohol addiction. The more generic drug dependence
syndrome concept grew out of earlier formulations of alcohol
dependence (Edwards et al. 1976; Edwards et al. 1977).
The essential postulates of the syndrome concept of dependence
include: 1) the clustering of certain cognitive, behavioral, and
physiological elements which are all related to a common
psychobiological process; 2) the distribution of these elements
along a continuum of severity; 3) recognition of individual
differences in the patterning of elements according to such
influences as culture and personality; and 4) conceptual as well as
statistical independence of dependence and syndrome-related
disabilities. Although no assumptions are made with respect to the
progressiveness of the syndrome or its irreversibility, there has
been some suggestion (Edwards and Gross 1976) that very severe
alcohol dependence is not reversible. Tolerance and withdrawal can
exist in the absence of the behavioral and cognitive elements.
When this occurs, the term "neuroadaptation" is employed to suggest
that tolerance and withdrawal are not identical to the broader
phenomenon of a psychobiological dependence syndrome. Beyond the
biological changes associated with both physical withdrawal and
tolerance is the behavioral manifestation of the syndrome "in which
the use of a given psychoactive drug, or class of drugs, is given
much higher priority than other behaviors that once had higher
value" (Edwards et al. 1981).
The drug dependence syndrome (DDS) as a construct is the organizing
principle for a general theory of dependence. The core syndrome
elements include the cognitive, behavioral, and physiological
symptoms summarized in table 1. The broader dependence model,
described in detail by Edwards et al. (1981), postulates that the
initiation and maintenance of drug-taking behavior is a function of
both distal and immediate antecedent variables ranging from genetic
to social influences. The general DDS theory maintains that a
complete explanation of an individual's substance use must include
statements concerning the frequency and severity of dependence, the
kinds and degrees of disability, and the personal and environmental
influences on substance use. What ties together the elements of
the syndrome and helps to account for their interrelationships is
an often unstated set of assumptions about the learning processes
behind the acquisition and maintenance of drug dependence. These
processes include classical conditioning, operant conditioning, and
cognitive mediation.
As a theory of relapse, the DDS postulates that readdiction
liability is a direct function of the severity of the syndrome
before abstinence was begun. Relapse is portrayed as the
re-emergence of previously conditioned responses that had been
associated with substance use. Recovery, on the other hand, is
described in terms of the extinction of conditioned responses that
takes place during or after treatment. Because the theory behind
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the drug dependence syndrome construct is a synthesis of both
general learning theory and more specific conditioning models of
dependence (Wikler 1965), it may be instructive to review related
theories of alcohol and drug abuse whose assumptions complement or
resemble those of DDS. This will provide a context for reviewing
empirical evidence supporting or refuting hypotheses derived from
DOS theory or related models.
TABLE 1
Constituent Elements of the Alcohol and Drug
Dependence Syndrome
Elements
Narrowing of the repertoire
Salience of substance-taking
behavior
Increased tolerance
Repeated withdrawal symptoms
Use to avoid withdrawal
Compulsion to use substance
Readdiction liability
Interpretation/Examples
A tendency for the drinking
or drug use to become
stereotyped around a
regular schedule of almost
continuous daily consumption
Substance use given higher
priority than other
activities, in spite of its
negative consequences
More and more of substance
required to produce
behavioral, subjective and
metabolic changes; large
amounts of substance can be
tolerated
Tremulousness, sweatiness,
nausea, etc. after short
periods of abstinence
Relief or avoidance of
withdrawal symptoms by
further substance use,
especially in morning
Subjective awareness of
craving for substance, as
well as impaired control
over quantity and frequency
of intake
A tendency for the syndrome
to be rapidly reinstated
when substance use is
recommenced after a period
of abstinence
Based on Edwards et al., 1976; 1981.
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RELAPSE THEORIES
Behavioral psychology has provided theories linking different
elements of the drug dependence syndrome to relapse after
treatment. Wikler (1965) proposed a model of opiate relapse based
on respondent conditioning principles. In Pavlov's conditioning
paradigm, a neutral stimulus is repeatedly paired with an
unconditioned stimulus that naturally elicits an unconditioned
response. With repeated trials, the neutral stimulus takes on the
properties of a conditioned stimulus and elicits a conditioned
response. In a regular drug user, certain environmental stimuli
are repeatedly paired with pharmacologic withdrawal symptoms
arising from episodes of acute abstinence between drug doses.
These previously neutral stimuli become capable of producing
conditioned withdrawal reactions long after cessation of drug use.
These conditioned withdrawal reactions may be labeled "craving" by
the addict or alcoholic, and prompt the individual to seek relief
through substance use.
Siegel (1979) proposed a dif
conditioned craving. In his
erent mode of acquisition of
model, the environmental stimuli that
reliably predict drug effects enable the addict to make adaptive,
compensatory, physiological responses in anticipation of these
effects. These conditioned responses are opposite to the acute
drug effects and thus maintain homeostatic balance. This process
can explain the development of tolerance. Furthermore, when these
conditioned physiological responses are not followed by drug
consumption, they may be experienced as conditioned withdrawal or
craving. Thus, Wikler and Siegel used respondent conditioning to
link drug craving, tolerance, and withdrawal. Impaired control can
also be explained by this theory. The most reliable cue for drug
effects are drug self-administration procedures. The process of
"cooking up" heroin, gulping a first drink, or puffing on a
cigarette in a previously dependent individual provides a complex
of strong conditioned stimuli producing conditioned craving or
withdrawal responses. Such responses may dramatically increase
motivation for substance use and lead to a perception of loss of
control. Ludwig and Wikler (1974) suggest a slightly different
process underlying loss of control in alcoholics. They hypothesize
that loss of control represents an inability to accurately utilize
information from interoceptive cues (e.g., perceived intoxication)
necessary to regulate the rate or quantity of alcohol consumed.
Although Wikler (1965) and Siegel (1979) developed their classical
conditioning models based on opiate dependence, these conditioning
concepts have been adapted to explain alcohol dependence (e.g.,
Ludwig and Wikler 1974) and nicotine dependence (Pomerleau 1981).
An alternative behavioral conceptualization of relapse has been
proposed by cognitive social learning theorists. Bandura (1977),
writing about processes underlying all coping behavior, suggested
that coping is partially determined by expectations that one is
capable of performing a coping response. It has been suggested
that the strength of an individual's expectation regarding coping,
his or her perceived self-efficacy, influences the probability of
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relapse after first use of a drug following a period of
abstinence. If individuals who are severely alcohol dependent also
believe that they are unable to cope with temptation after a first
drink, then rapid relapse in dependent individuals may be mediated
by their low perceived self-efficacy (Rollnick and Heather 1982;
Wilson 1978). In this view, the belief that one will lose control
after a single drink becomes a self-fulfilling prophecy.
Some theories of drug abuse derived or borrowed from traditional
reinforcement theory also incorporate a wide variety of other
explanatory constructs. Thus, while Frederick (1980) views drug
abuse as a learned behavior, personality and motivation are seen as
particularly important in bringing about relapse. In McAuliffe and
Gordon's (1980) combination of effects theory, it is the potential
for enjoying opiate euphoria, in combination with the relative
permanence of acquired reinforcers, that plays a crucial role in
relapse. In this model, long-term abstinence by addicts is
hypothesized to be facilitated by successful reintegration into
society, which provides an alternative system of rewards. Zinberg
(1980) has emphasized the influence of social settings that,
operating through such mechanisms as social sanctions and rituals,
play an active role in controlling use, even by those who at one
time have been severely dependent.
The drug dependence syndrome model may also be seen as related to
biologically-based theories which stress the ability of drugs and
alcohol to alter body biochemistry and metabolism. Dole and
Nyswander (1980) attribute relapse and the persistence of physical
dependence to residual tolerance and metabolic deficiencies induced
by opiate-type drugs. Schuckit (1980) believes that genetic
factors play a role in the physiological drive to return to drugs,
as mediated by a protracted abstinence syndrome, or through
inherited psychological vulnerabilities.
This review of theories of alcohol and drug relapse suggests that
relapse is a complex phenomenon with multiple determinants.
Although many of the theories have been developed in terms of a
single drug of abuse (e.g., alcohol, opiates), the following
learning theory principles may be applicable to relapse with any
substance: 1) classical conditioning of drug/alcohol related cues;
2) operant reinforcement of drug/alcohol seeking behavior;
3) cognitive mediation of conditioned responses; and 4) social
reinforcement of recovery-related behaviors.
EMPIRICAL EVIDENCE
Having reviewed the DDS concept, the theoretical model that it is
embedded in, and a number of related theories, we will now focus on
some of the empirical research conducted to test hypotheses
concerning the relationship between dependence concepts and relapse.
Alcohol Dependence
Several alcohol administration studies have examined the
relationship between dependence and reaction to a priming dose of
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alcohol. Hodgson et al. (1979) found that severely dependent
alcoholics significantly increased, while moderately dependent
alcoholics decreased, the speed with which they consumed a standard
alcoholic drink 3 hours after consuming a priming dose. A
subsequent study (Stockwell et al. 1982) independently manipulated
the expected and actual alcohol content of a priming dose and found
that severely dependent alcoholics increased their drinking speed
after actual alcohol consumption, regardless of whether they were
told the priming drink contained alcohol. This suggests the
importance of internal, physiological drinking cues as triggers for
craving in severely dependent drinkers. In another priming dose
study, Kaplan et al. (1983) found that severely dependent
alcoholics were more likely than moderately dependent alcoholics to
choose an additional drink instead of a lottery ticket after a
priming dose.
Marlatt and Gordon (1980) emphasize the importance of coping skills
as mediators of relapse. Such skills may also mediate between
dependence and relapse. Litman et al. (1977) found a relationship
between the self-rated degree of alcohol dependence and the use of
specific skills for coping with potential relapse situations. More
dependent individuals tended to utilize thinking of the negative
consequences and guilt associated with drinking. They also engaged
in active behavioral avoidance of drinking-related situations more
than less dependent drinkers. However, only avoidance was judged
by them to be an effective coping strategy.
An important test of the validity and utility of the dependence
syndrome concept is how well dependence predicts treatment
outcome. Seven alcoholism treatment followup studies have assessed
individual differences in severity of dependence. In the first
such study, Orford et al. (1976) randomly assigned 100 married
males to brief advice or more intensive treatment. Both treatments
were abstinence-oriented. Sixty-five subjects and their wives were
contacted 2 years after entering treatment. Among the 26 subjects
with "good" outcomes, controlled drinkers were more likely than
abstainers to obtain low scores on a seven-item dependence symptom
scale.
The Rand study (Polich et al. 1981) followed a national sample of
treated alcoholic males for 4 years. In an analysis of 200
subjects, alcoholics aged 40 or over who had high scores on a
6-item dependence scale were less likely to be drinking with
dependence symptoms at 4 years posttreatment if they were abstinent
at an 18-month followup. On the other hand, alcoholics under age
40 with low dependence scores on admission who engaged in moderate
drinking at 18 months were less likely to be drinking with
dependence symptoms at 4 years than those who were abstinent at 18
months. For the other two groups, older men with low dependence
symptoms and younger men with high dependence symptoms, the
interaction was more complex, with marital status playing an
important role.
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In the first analysis of alcohol dependence in female subjects
(Hesselbrock et al. 1983), 67 male and 47 female treated alcoholics
were followed after abstinence-oriented inpatient treatment. A
dependence symptom scale was significantly correlated with drinking
status at a 6 month posttreatment followup for male subjects but
not for female subjects.
Heather et al. (1983) administered the Severity of Alcohol
Dependence Questionnaire (SADQ; Stockwell et al. 1979) to 35 male
and 15 female inpatient alcoholics. Six months after
abstinence-oriented treatment, 67 percent of the subjects were
contacted. The SADQ did not significantly predict abstinence
versus drinking, and, among the drinkers, the SADQ did not predict
regular nonproblem drinking. In addition to assessing severity of
dependence at intake, subjects completed a scale assessing beliefs
about their control over drinking. This "Subjective Dependence
Scale" significantly predicted regular nonproblem drinkers among
those reporting any drinking at the posttreatment followup. These
results support the contention that a relationship between
dependence and relapse is mediated by beliefs about control over
drinking (Wilson 1978).
Litman et al. (1984) followed a sample of 194 men and 64 women
treated in an abstinence-oriented inpatient program. A 6-item
dependence questionnaire did not discriminate light/moderate
drinkers from abstainers and relapsers at a 6- to 12-month
posttreatment followup.
Foy et al. (1984) randomly assigned 62 male veterans to behavioral
inpatient alcoholism treatment with or without training in
controlled drinking skills. A five-item dependence scale was
administered at admission to treatment. All but three subjects
were followed up 12 months post-discharge. Pretreatment dependence
was significantly correlated (r=-.22) with a variable reflecting
the percentage of drinking days in which alcohol consumption was
moderate. Although this correlation was statistically significant,
the clinical significance of the prediction is questionable.
Finally, an unpublished study by Kivlahan et al. (in press)
followed a sample of 268 male veterans in inpatient alcoholism
treatment. Pretreatment dependence was assessed using the Alcohol
Dependence Scale (ADS) (Skinner and Allen 1982). Nine-month
followup interviews were completed on 78 percent of the sample.
Although the ADS did not predict amount of drinking, there was a
weak but reliable association with drinking relapse status (t=.16),
with relapsing patients obtaining higher ADS scores at admission.
In summary, at least seven studies have examined the relationship
between pretreatment alcohol dependence and posttreatment outcome.
One study found a strong relationship between dependence and
controlled drinking, but in an analysis of only 26 subjects (Orford
et al. 1976). Two other studies found that predictions based on
dependence were moderated by age, marital status (Polich et al.
1981). or gender (Hesselbrock et al. 1983). Two studies found that
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predictions were statistically but not clinically significant (Foy
et al. 1984; Kivlahan et al., in press). Finally, two studies
found no reliable predictions could be made from dependence
measures.
There are several possible reasons for equivocal or conflicting
findings in the above studies. Perhaps there are major differences
between the various dependence scales employed. However, Cooney et
al. (1986) found that four different dependence scales were highly
correlated with one another and thus were functionally equivalent.
Various outcome measures were employed in the studies, including
relapse status, light or moderate drinking, and drinking without
dependence symptoms. Only the latter provides a true test of the
reinstatement hypothesis (Polich et al. 1981) and no study measured
rapidity of reinstatement. Finally, widely varying statistical
methods were employed in these studies. It may be necessary to
control for age, marital status (Pollch et al. 1981). gender
(Hesselbrock et al. 1983), and beliefs about control (Heather
et al. 1983) to examine the predictive validity of dependence
measures.
Nicotine Dependence
Nicotine dependence has been thought to underlie tobacco smoking.
Russell (1974) stated that there is "little doubt that if it were
not for the nicotine in tobacco smoke, people would be little more
inclined to smoke than they are to blow bubbles or to light
sparklers" (p. 793). Evidence for the role of nicotine in tobacco
smoking comes from studies of nicotine regulation, tobacco
tolerance, and tobacco withdrawal phenomena.
Jarvik (1979) asserted that tolerance to tobacco products has been
clearly demonstrated in both humans and in animals. A tobacco
withdrawal syndrome has been identified (Shiffman 1979) with much
individual variability but some consistent patterns. Objective
indicators of the withdrawal syndrome include changes in EEG and
cardiovascular function, decrements in psychomotor performance, and
weight gain. Subjective symptoms include irritability, anxiety,
inability to concentrate, insomnia, and craving for cigarettes.
Although Shiffman (1984) has more recently questioned the
importance of withdrawal symptoms in promoting relapse after
smoking cessation, others have suggested that managing these
symptoms may be crucial to the maintenance of nonsmoking (Jarvik
1979).
Investigators have attempted to measure individual differences in
smokers' degrees of nicotine dependence. The most widely used
measure of smoking dependence is dosage, measured by self-reported
smoking rate, serum nicotine, or its metabolite cotinine. Studies
that used biochemical measures of dosage reported more consistent
relationships between dosage and tolerance, withdrawal, and
cessation success (Hughes 1984). For example, Hall et al. (1984)
followed 114 smokers in a behavioral smoking cessation clinic.
Although self-reported pretreatment smoking rate, self-reported
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nicotine dose per day, and cotinine level predicted abstinence
status up to 1 year after treatment, cotinine level was found to
account for more variance in outcome than the other measures.
Since the half-life of cotinine is approximately 20 hours, blood
levels of cotinine may provide an accurate index of daily nicotine
intake.
Several questionnaires have been used to assess dependence
phenomena related to smoking. Fagerstrom's (1978) "Tolerance
Questionnaire" has been validated against physiological measures of
withdrawal (temperature change) and tolerance (heart rate response
to smoking). Other studies have failed to replicate the
relationship of the questionnaire to withdrawal and tolerance
(Hughes and Hatsukami 1983). Shiffman and Jarvik (1976) developed
a questionnaire to measure withdrawal reactions. Pomerleau et al.
(1983) found that heavy smokers reported more withdrawal symptoms
on this questionnaire than light smokers after overnight cigarette
deprivation.
A crucial test of the clinical value of the dependence construct is
to demonstrate that dependent smokers are especially likely to
benefit from dependence-based treatment. Two treatment procedures
have recently been developed that take nicotine dependence into
account. Monitored nicotine fading is a behavioral procedure
wherein subjects switch to cigarette brands with progressively
lower nicotine content (e.g., Foxx and Brown 1979). Nicotine
chewing gum is a pharmacological approach. We are not aware of any
research showing that dependent smokers are especially responsive
to nicotine fading procedures. But at least seven studies have
examined the relationship between dependence and response to
nicotine chewing gum. Two studies using dosage (Brantmark et al.
1973; Hall et al. 1985b) and five studies using the Fagerstrom
questionnaire (Christen et al. 1984; Fagerstrom 1982; Hall et al.
1985a; Hughes and Hatsukami 1983; Jarvik and Schneider 1984) found
that dependent smokers had higher quit rates on nicotine gum than
without the gum, while nondependent smokers had similar quit rates
with or without nicotine gum.
Opiate Dependence
Although no specific research has been conducted to test the
predictive validity of the DDS concept in samples of opiate
addicts, there is considerable evidence for the existence of
syndrome elements in the cycle of addiction and relapse observed In
chronic opiate users. Donegan et al. (1983) and McAuliffe and
Cordon (1980) have reviewed the literature and concluded that:
1) opiates have a high potential to serve as reinforcers;
2) repeated administration of opiates typically results in the
development of pronounced tolerance and physiological dependence;
3) stimuli associated with habitual administration can elicit a
variety of compensatory or withdrawal effects; and 4) former heroin
addicts are especially vulnerable to relapse when in stressful
situations. However. in one of the most extensive tests of
Wikler's notion of conditioned abstinence, Meyer and Mirin (1979)
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did not confirm the hypothesis that opiate craving is internally
signaled by the unpleasant effects of withdrawal. Rather, craving
was most likely when subjects had cognitive expectancies about the
availability of heroin. Furthermore, Chaney et al. (1982) reported
that only 16% of 38 opiate relapse episodes could be attributed to
conditioned withdrawal defined as negative physiological states not
associated with prior substance abuse.
In summary, the empirical evidence suggests that severity of
dependence may be an important determinant of relapse to use of
alcohol, opiates and tobacco, but further research is needed to
confirm this hypothesis. The severely dependent person is likely
to have a narrow range of effective coping strategies. He or she
may experience conditioned craving or withdrawal symptoms,
especially after a priming drug dose. Such a person is also likely
to have little belief in his or her ability to control consumption
once it is started.
EVALUATION AND CRITIQUE
Before attempting to evaluate the adequacy of the DDS construct as
an organizing principle for a theory of relapse behavior, it will
be important to consider briefly the more general issue of minimal
standards for establishing a theory of relapse. Modern behavioral
science derives many of its methods and assumptions from the
principles of natural science. These include the requirements
that: 1) the theory leads to empirical predictions which can
determine its validity by their confirmation; 2) the terms in the
predictions be operationally defined and the conditions clearly
specified; and 3) the possibility exists to disprove the theory.
These minimal criteria, accurate prediction, public verifiability,
and scientific falsifiability, are complemented by such
characteristics as breadth, depth, uniqueness, elegance, and
clinical utility. For example, theories whose derivations permit
causal control over important aspects of behavior are more useful
than those that do not. Also desirable are theories that encompass
many empirical phenomena and derive predictions from a relatively
parsimonious set of assumptions. First, it should be noted that
the DDS model is fairly representative of other theories in the
general field of alcoholism and drug dependence (Lettieri et al.
1980). In its broader outlines, it is rather loosely constructed
and incorporates a wide variety of antecedent and explanatory
variables. Where it differs from other theories is in its attempt
to tie together biological, psychological, and social variables in
a network of reciprocal causation using concepts borrowed from
learning theory. The syndrome elements are the building blocks of
the theory. The syndrome concept, borrowed from clinical medicine,
is the basis for defining the shape and boundaries of dependence.
Learning theory is the glue that holds the model together and
provides the derivation of postulates and hypotheses.
With regard to the criterion of accurate prediction, DDS theory and
related learning theory models do suggest rather clear hypotheses
about mechanisms of relapse. They are less clear about the
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implications of high dependence for recovery, except to suggest
that with increasing time, the conditioned responses evoked by
environmental and interoceptive stimuli should be extinguished,
thereby making abstinence more likely and easy to maintain.
A major problem with the criterion of public verifiability is the
operational definition of syndrome elements and related
constructs. The. Alcohol Dependence Syndrome was postulated as a
provisional formulation, and was based on a combination of clinical
experience and theoretical speculation (Edwards et al. 1976,
1977). The Drug Dependence Syndrome model was formulated in the
context of a discussion of nomenclature and classification of
alcohol- and drug-related problems (Edwards et al. 1981). This
should be kept in mind when considering the model as a formal
theory of dependence.
The definition of several syndrome elements presents difficulties.
Research attempting to establish operational measures of the
elements that are reliable and valid is needed. "Narrowing of the
drug-taking repertoire" suggests that the individual's drug use is
stereotyped and functionally autonomous. The element "salience of
drink- (drug-) seeking behavior" contends that priority in
maintaining drug intake supplants the individual's attention to
personal, interpersonal, and social obligations. Both of these
elements describe gross, macro-level behavioral phenomena that
represent much more complicated levels of analysis than the
elements of withdrawal and tolerance. "Subjective awareness of
compulsion to drink (take drugs)" is another element that is
somewhat unclear. For example, it is uncertain whether the
individual ingests the drug and loses control, or decides not to
exercise control over the amount of the drug that is taken into the
system. The inclusion of a cognitive element in the dependence
syndrome raises questions about the role of private experience in a
scientific theory of behavior. Given the general acceptance of
subjective feelings and thoughts in contemporary behavioral
science, their inclusion in this model is no more problematic than
other cognitive behavioral theories that emphasize the importance
of cognitive mediation. The final element, reinstatement of the
syndrome, is a characteristic rather than an element of the
syndrome, and can only be operationalized by a synthetic
combination of the syndrome elements. When considered in this way,
reinstatement becomes an hypothesis to be tested under specific
conditions, such as when a "slip" occurs for an abstinent
alcoholic.
The operationalization of elements (i.e., establishing loose
parameters) of the DDS construct has just begun to occur and has
already been subject to a variety of disciplinary interpretations.
Whether these elements do in fact cluster, and are interrelated
aspects of the same syndrome can only be borne out by further
research.
Critics of the dependence syndrome concept have contended that
owing to its phenomenologlcal ambiguity, it is but another
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restatement of the traditional disease concept (Shaw 1979). The
argument that the syndrome is a restatement of the disease concept
stems from the tendency to interpret the syndrome primarily in
psychobiological terms. Syndrome proponents have provided a less
than complete explanation of both behavioral and subjective
mechanisms underlying the syndrome. Edwards and Gross (1976) do
state that should a clinician opt to use the syndrome for
diagnostic purposes, a "conservative approach is generally the most
responsible, and that abstinence is normally the safest choice of
goal" for treatment. Critics have seized this position as
reflective of syndrome proponents' orientation toward abstinence
and the traditional disease concept. Syndrome proponents, however,
dismiss the disease concept since it is too confused for empirical
inquiry. In summary, the strength of the DDS is also its weakness,
in that ambiguity prompts attempts to establish operational
definitions of the elements, and also fosters idiosyncratic and
unidiscipllned efforts to define syndrome elements and the syndrome
itself. Attempts to examine and study the syndrome have opened a
heretofore dichotomously labelled (i.e., alcoholic versus not
alcoholic, dependent versus not dependent) area of clinical
inquiry. Regardless of Edwards' and Gross' formulation, interest
in drug dependence has been engendered and has suggested avenues
for research into biological, behavioral, and situational
determinants of relapse.
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Acquisition, Maintenance,
Cessation, and Reacquisition: An
Overview and Behavioral Perspec-
tive of Relapse to Tobacco Use
John Grabowski
Tobacco use is a prototypic case of drug dependence and an appetitive habitual
behavior. It encompasses many of the phenomena studied in the behavioral
pharmacology laboratory and related clinical settings. It also has been studied by
scientists and clinicians representing a wide range of other theoretical and
disciplinary orientations. Acquisition, maintenance, and treatment of tobacco use
have obvious elements of, and commonalities with, drug self-administration
models, schedule induction models, coping models, social learning models. and
others. More important, it represents a spectrum of biobehavioral disorders
which ultimately and unfortunately produce patients for practitioners of
behavioral or medical disciplines. Therefore, a precise and systematic analysis of
tobacco use presents a unique opportunity to contribute to both the treatment of
drug abuse disorders and the broader area of behavioral medicine disorders.
Despite the extensive literature and considerable interest in the area, the apparent
success in the treatment of tobacco use has not been notable. This chapter will
include consideration of various theoretical perspectives, a basic behavioral
analysis, and a view toward future research and treatment strategies.
THEORIES OF ACQUISITION, MAINTENANCE, CESSATION, AND RELAPSE
Wesson et al. (this volume) have argued that “having a theoretical framework is
important in providing drug abuse treatment because treatment guided by
theoretical constructs results in clear decisive interventions.” It is not at all clear
that this has been the case in drug abuse treatment, despite the fact that theories
are myriad and proliferating. For example, a volume titled Theories on Drug
Abuse (Lettieri et al. 1980) presented 43 alternative theories. These theories were
grouped into four areas, including “relationship to self,” “relationship to others,”
“relationship to society,” and “relationship to nature.” Nevertheless, none of these
theories can be viewed as amply descriptive or predictive to greatly enhance
treatment and, thus, they do not achieve the goal proposed by Wesson et al.
Instead, a sound set of practical therapeutic recipes with parallel tracks and
options based on the best available data, may be what is needed to guide
treatment of drug abuse in many of the settings in which it is practiced.
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Thompson, citing Claude Bernard, has noted vis a vis theories, that
these men start, in fact, from an idea which is based more or less
on observation, and which they regard as an absolute truth. They
then reason logically and without experimenting, from deduction
to deduction they succeed in building a system which is logical
but which has no sort of scientific reality . . . the mind becomes
bound and cramped by the results of its own reasoning; it no
longer has freedom of action and so lacks the power to break
away from that blind faith in theories which is only scientific
superstition. (Thompson 1984, p. 213)
It can readily be argued that “theory” in its least intrusive form might be useful.
Unfortunately, theory builders in the drug abuse arena have not sought to be
unobtrusive, as even the casual reader of Lettieri et al. (1980) would discern.
And, in the area of etiology and treatment of tobacco use, Leventhal and Cleary
(1980) as well as Cummings et al. (1980) have argued that there is a need for
theory. Ironically, Leventhal and Cleary decry the schism between various
research perspectives and the failure of integration without noting that this is a
common result of building theoretical edifices.
Generally accepted is the view that the benefit and merit of theories resides in
the generation of studies which, in turn, will support or refute their premises.
One might question whether our techniques are so poor, and our science so weak,
that we can only do battle in the arena of the straw men (people?) concocted
from current theoretical models. Rather, at this point, a robust description
derived from sound research may be of the greatest utility. In turn, there is a
need to recognize conditions, well beyond the scope of any therapeutic
intervention, which contribute substantially to the problems of tobacco use.
Lichtenstein (1982) observed that the tobacco literature is so vast that inclusive
surveys are untenable. It is now also the case that theoretical analyses become
unduly encumbered in attempts to account for the manifold results with many
disparities. Since theories can generate research far beyond the need, they may,
at this point, hinder rather than breed success in the therapeutic domain. More
data in the realm of basic research may well be of value since it has been from
this source that much of the current precision in therapeutics has arisen. In
summary, what is needed more than a “good theory,” as proposed by some
authors, is a good description of the behavior as provided by Lichtenstein (1982),
Lichtenstein and Brown (1982), and others, and in turn, an integrated therapeutic
strategy based on the data.
A PARSIMONIOUS DESCRIPTION OF ACQUISITION,
MAINTENANCE, AND ELIMINATION OF TOBACCO USE
A question has emerged, particularly recently, as to why the study of tobacco use
is relevant to the issue of drug abuse. There are several often-stated reasons.
First, tobacco use in its several forms is a clear public health problem and thus,
for direct clinical-scientific reasons, it is worthy of study. Second, as previously
noted, the study of tobacco use is in many respects a prototypic, health-
impairing, appetitive, habitual behavior which has commonalities with a wide
range of other biobehavioral (as well as social-behavioral) disorders (Pomerleau
1979, Levinson et al. 1983). And third, tobacco use generally, and smoking in
particular, has all of the characteristic elements of other forms of drug abuse.
That is, the rate and pattern of the behavior itself, the paraphernalia associated
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with use, and the pharmacological agent, give rise to the view that this is a
prototype which will likely give considerable insight into drug abuse and other
disorders (see Henningfield 1984).
ACQUISITION
The theoretical literature (e.g., Lettieri et al. 1980) provides a broad range of
options in specification of the generative conditions for acquisition of drug
abuse. Distilled, these have several essential elements (rarely clearly stated), for
example, physiological, behavioral (including “cognitive” components), social,
environmental, and pharmacological factors, and their interactions.
The conditions antecedent to sustained drug use include social factors, commonly
in the form of friends and family; environmental factors, including drug
availability; and biological factors, including the possible predisposition to the
reinforcing properties of the pharmacological agent itself. However, the relative
contribution of these factors to an individual’s first use of tobacco varies.
Clearly, the event of initial use is multiply determined, and results from the
interaction of diverse factors to which most people in Western culture are
exposed from a very young age. Perhaps a major environmental difference for
young people is the frequency of tobacco use in their immediate environment by
parents and siblings. The importance of the presence of tobacco-using parents in
the home may be twofold: first, there exists a basis for learning through
modeling; and second, in view of recent data on passive smoking, it is likely that
there could be gradual evolution of tolerance to the aversive properties of
cigarette smoke through chronic low-grade exposure.
While acknowledging that offspring of those who do not use tobacco do initiate
use, and that the converse is true as well, most learning models would predict
“imitation” or “modeling” to be a major antecedent to initial use. In the absence
of this major risk factor (Surgeon General’s Report, 1979), there exist the range
of early exposures serving as sufficient alternative stimulus arrays which are
setting conditions for the initiation of smoking. They exist in the media, in the
behavior of peers, and the general evidence of acceptability of tobacco use in
public settings. (In this regard, the development of isolated smoking salons in
public environments might have benefits well beyond those typically suggested.)
As Lichtenstein has noted (1979, 1982), there are more than adequate numbers of
descriptions of this acquisition process, and an abundant supply of speculative
accounts. However, it is patently clear that the complex and intricate theories in
this domain have contributed little more to the development of an understanding
of the acquisition process.
Perhaps the most parsimonious description of tobacco and nicotine use derives
from animal and clinical laboratory studies. These data can be succinctly
summarized. When nicotine is made available on a response-contingent basis and
delivered via an indwelling intravenous catheter, persistent drug self-
administration evolves. As often described in the behavioral pharmacology
literature, this simple demonstration indicates the lawfulness of the process of
drug self-administration. The appropriate direct parallel of inhalation has also
been studied in both the animal and human laboratories and clinical settings (e.g.,
Jarvik 1967; Griffiths et al. 1982; Gust and Pickens 1982). To paraphrase and
extrapolate to the natural environment: when tobacco is made available and
when the conditions for use are established through diverse stimulus conditions--
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including advertising, parents, peers, and others--the teenager engages in self-
administration.
A particularly interesting relationship illustrating the parallels between nicotine
self-administration in the laboratory and tobacco use in the natural environment
is the finding by Salber and Abelin (1967) indicating that 85% to 90% of those
who smoke four cigarettes become chronic smokers. In the laboratory setting,
following initial exposure (at times provided by an investigator-initiated priming
dose--peer pressure?), the probability of acquisition of self-administration is
similarly high,
The self-administration model and the extensive database on the importance of
specific reinforcement schedules and stimulus conditions as determinants of drug
use promulgated by behavioral pharmacologists, is not widely accepted by those
who theorize on drug abuse, its treatment, or relapse. Nevertheless, these data
point to the essential ingredients of a powerful, manageable, and perhaps most
important, useful model of acquisition of tobacco use (Henningfield 1984).
Further microanalysis of environmental determinants of initiation of tobacco use
for the individual is not necessary here, and there are ample sources on which
the scientist or clinician can draw. There is clearly a substantive database
indicating the power of a range of environmental factors as contributors to the
initiation of use.
MAINTENANCE
Maintenance of tobacco use has also been the focus of complex theoretical
machinations. Oral gratification and other descriptions readily succumbing to
Occam’s razor are numerous. Lichtenstein (1979, 1982) has described the general
factors associated with maintained use of tobacco. Frederiksen (1979) has
similarly listed factors in the context of controlled smoking, and Pomerleau
(1979) has provided an overview of factors within the context of reviewing
commonalities of what he terms self-management disorders. More recently,
Pomerleau and Pomerleau (1984) have specified a series of neurotransmitter
alterations and physiological effects of nicotine administration and abstinence
which are correlated with well-documented behavioral manifestations.
Henningfield (1984) has provided an excellent comprehensive review directed at
summarizing the behavioral pharmacology of cigarette smoking. Viewed in
combination, the preponderance of evidence points to orderly and systematic
patterns of sustained tobacco use modulated by an array of environmental and
pharmacological factors. And, this evidence stands without recourse to elaborate
hypothetical constructs.
Clinical and animal laboratory studies have provided clear data on the role of
both operant and classical conditioning in the maintenance of drug use generally
(e.g., see Grabowski and O’Brien 1981) and tobacco specifically (Pomerleau 1979;
Pomerleau and Pomerleau 1984). I t  is  c lear  that  the dominant  act ive
pharmacological agent in tobacco, nicotine, can serve to strengthen and maintain
behavior, which leads to its administration for nonhuman and human subjects
alike (Goldberg et al. 1981; Henningfield and Goldberg 1983a and 1983b). Use
of nicotine via smoking or smokeless tobacco is more complex for humans in
their natural environment, not so much for the character and pattern of self-
administration which closely resembles the behavior engendered in the laboratory,
but for the manifold interactions between smoking, other behaviors (including
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concurrent use of drugs such as caffeine or ethanol), and other, abundant
environmental conditions and events, i.e., the context.
Fortunately, laboratory research with both humans and animals has provided a
means for systematically examining both behavioral and environmental factors.
The relative power of environmental stimuli as determinants of drug-taking has
been amply demonstrated (e.g., Goldberg and Shuster 1967, 1970; Schuster and
Woods 1968; Davis and Smith 1974; Thompson et al. 1971; Carnathan 1977;
Goldberg 1973), and these factors have been repeatedly referred to as
contributing to relapse (Wikler 1965, 1974, 1977; O’Brien et al. 1974, 1975, 1977,
1980; O’Brien and Ternes 1977; Childress et al. 1985). Only a few of the
relevant studies have been cited, but the potential contribution of these factors in
sustained drug use is clear. There can be little question of their importance and
influence in the natural environment.
While characteris t ics  and pat terns of  self-administrat ion evidenced in
experimental settings parallel those under natural conditions, the cumulative
frequency of dosing by inhalation through cigarette smoking may be far beyond
that studied for any agent in laboratory settings. As Pomerleau has noted, the
average one-pack-per-day smoker emits puffing behavior 70,000 times per year.
Few other behaviors are so regularly emitted and reinforced. In turn, few other
reinforcers and the antecedent behaviors are so regularly associated with a
plethora of environmental stimuli which then further contribute to maintained
drug-taking. These relationships have been summarized by Lichtenstein (1982),
Henningfield (1984), and others. Thus, there are both laboratory-based accounts
(e.g., Nevins 1979) and clinical data that predict the strength of maintained
tobacco use without reference to elaborate theoretical constructs.
It must be emphasized that the strength and persistence of a behavior determines
the ease or difficulty with which it will be changed. A satisfactory case can be
made that a range of simple appetitive behaviors occurring in diverse
environments with great frequency are particularly impervious to modification.
This has been evidenced by the seeming lack of success of the techniques used to
alter these behaviors, including tobacco use.
TREATMENT AND CESSATION
Tobacco use cessation efforts are numerous and diverse. Grabowski and Hall
(1985) defined five interdependent levels and modalities of cessation efforts,
including public intervention or information campaigns, self-help programs,
group support programs, individualized behavioral intervention programs, and
pharmacological interventions. Pechacek (1979) outlined the categories somewhat
differently, but the parallels are clear. The origins of the programs vary. Some
have evolved from the standard strategies of publicly addressing health problems,
while others have been derived from rather elaborate theoretical schema (e.g.,
Marlatt 1982, 1985) and still others have derived from precise clinical science
(e.g., Hall et al. 1984, Hall and Miller 1985).
Historically, the success of drug abuse cessation efforts generally, and tobacco
use cessation in particular, have not been notable. Furthermore, in the area of
smoking the results appear to many to be less impressive since tobacco use is
traditionally viewed, even by some clinicians, as a trivial habit. Like all “habits,”
it is considered subject to modification through a modest infusion of “essence of
will power.” In any case, the lack of successful interventions was best
summarized, and perhaps “justified,” by the data of Hunt et al. (1971) as depicted
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in the widely published figure comparing reacquisition of heroin, alcohol, and
tobacco use after treatment (“relapse”). Treatment success, as defined by
continued abstinence at 3 to 12 months, has hovered between 20% to 30%.
Lichtenstein (1982), Pechacek (1979), Pomerleau (1979), Marlatt (1985), and
others have suggested that behaviorally based techniques--(variously labelled
behavioral intervention, behavior modification, behavior therapy, and the like)--
have reached inherent  l imits .  As Marlat t  (1985) indicated (fol lowing
Lichtenstein’s 1982 observation), one consequence of limited success was an
increase in the use of multimodal strategies which proved to be no more
successful than the simpler strategies. However, it should be noted that Marlatt
enunciates this view in the context of the presentation of an elaborate model of
“Relapse Prevention” not dissimilar from many of the multimodal programs. In
addition, it should be noted that Leventhal and Cleary (1980). in their thorough
review, indicated that increments were evidenced in some, but not all,
multimodal programs. It is interesting that despite elaboration and reiteration of
essentially the same basic techniques, smoking cessation program success rates
remain inexplicably low given the energy invested therein, although there are a
few notable exceptions. For example, in two separate programs, Hall and Killen
(1985) have described results with combinations of “skills training” and nicotine
gum which approach the 50% success rate at 12 months. The focus of the
programs appears to be a few essential elements derived from the extensive
repertoire of clinical behavioral scientists with special attention given to the
behavioral and pharmacological consequences as well as correlates of tobacco use
and cessation.
While multimodal treatments have been generally criticized, some of the
criticisms are specific. For example, Lichtenstein (1982) noted that at times, the
combined treatments were made up of components which had not been
demonstrated to be effective. Combined treatments may well be effective, as
demonstrated by Hall and Killen (1985) and Hall et al. (1984). The combined
treatments may be additive or synergistic; however, these greater changes will not
occur because of their combination per se but because of the inherent
effectiveness of the combined treatments themselves. Several other points
concerning treatment are worth noting. As cited above, there has been extensive
research concerning the role of stimulus factors established through operant and
classical conditioning and there has been extensive comment in the literature on
this issue. However, no program has adequately dealt with the role of these
stimuli in intervention. Indeed, there has been greater attention to these events
in treatment for alcohol and opiate abuse (e.g., Marlatt 1985, Childress et al.
1985), and yet the role of such stimulus factors in tobacco use may be greater
given their ubiquitous character.
A second major concern in treatment is linked to the duration and strength of
the behavior in question, as discussed earlier. It is impressive that treatment
programs are effective to the extent that they are, given their brevity and lack of
intensity compared to the usual tobacco use history.
A third point of interest is that the effectiveness of treatment programs might be
greatly enhanced if implementation were in conjunction with naturally occurring
and related environmental events (e.g., see Bigelow, this volume). In the main,
interventions are established in special settings under conditions which make
compliance and attendance at treatment sessions difficult. Alternatively, they
take the form of “self-help” programs of uncertain utility.
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Initiating treatment at moments of other health-related interventions (Bigelow,
this volume) or in relation to work or other environments might well convey
greater strength to many therapeutic strategies. There are both behavioral
markers and environmental conditions providing more suitable points for
interventions. The potential for altering critical features for tobacco use
cessation goes well beyond other drug abuse treatment, in part because of the
general social tolerance of the behavior. While one cannot, for example, publicly
announce and implement a cocaine treatment program at 12:30 p.m. each day on
company premises and expect high levels of voluntary attendance, tobacco use
cessation programs have been established in this fashion. In brief, treatment
programs have not consistently attended to major obvious behavioral and
environmental features which might enhance success.
REINITIATION, REACQUISITION, OR RELAPSE
The focus of this volume is relapse (to drug use). There are two terminological
issues which cloud the discussion in both philosophical and practical terms. The
application of the word to the behavioral phenomena falling under the rubric of
“relapse” is unfortunate, as noted by Marlatt (1985). It connotes, coincident with
its origins in a medical model, a dichotomous state. One “has” the “disease” of
drug abuse or one does not. The conceptual error is evident in the phrasing.
One “has” the disease or condition of diabetes, cholera, trisomy 21, or hepatitis,
but one engages in the behavior of drug abuse. Behavioral factors of drug abuse
generate ‘physiological consequences that a patient “has,” and they must be
medically treated. However, it is well documented that these treatments do not
ameliorate the original behavioral disorders. Thus, one can relapse to illness, but
relapse to drug abuse is an inept articulation of the problem. Marlatt (1985)
redeems “relapse” through the use of a corollary definition, although it would be
most appropriate to place it in the same pasture with the word addiction, which
has also grown ungainly with age (Grabowski and O’Brien 1981).
It appears that behavior and debilitating consequences of drug abuse are best
described by the previously considered behavioral-pharmacological model and
terminology. The individual acquires the behavior of drug use (in this case
tobacco use) as previously noted. This behavior is strengthened and maintained
by interacting behavioral pharmacological and environmental factors. It is
eliminated as a consequence of one or more levels and models of intervention
(Grabowski and Hall 1985, Pechacek 1979).
Interestingly, laboratory models for the study of drug abuse acquisition and
maintenance parallel closely the human case in the natural environment. In
addition to the studies already cited, there has been explicit attention devoted to
analysis of naturally occurring behavioral sequences such as those represented by
concurrent administration of ethanol, opiates, amphetamines, caffeine, and other
agents with tobacco use (Griffiths et al. 1976; Kozlowski 1976; Schuster et al.
1979; Henningfield and Griffiths 1981; Mel1 et al. 1980a, 1980b; Mintz et al.
1981).
Ostensibly, it is in the area of elimination and reacquisition of the behavior that
the behavioral pharmacological analysis derived from the laboratory appears not
to be applicable because of the conditions under which treatment is usually
implemented. However, there are numerous studies in which cessation of drug
self-administration has been examined inadvertently or otherwise, and this
literature has been concisely and articulately reviewed (Poling and Appel 1979).
Occlusion of an infusion catheter results in cessation of responding for drug.
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The explicit experimental manipulation of making an infusion pump inoperative
likewise leads to cessation of responding. Administration of an opiate antagonist
or mecamylamine to the subject (human or nonhuman), self-administering
morphine or nicotine, respectively, leads to cessat ion of  drug-taking.
“Preloading” reduces drug-maintained responding. In brief, nonavailability of a
previously self-administered drug or the functionally similar manipulation of
blocking or reducing its effect leads to abstinence.
Reestablishing conditions for self-administration by unclogging the catheter,
reactivating the infusion pump, or discontinuing antagonist (or agonist)
administration leads to reinitiation of self-administration (“relapse”). Over
successive nonavailability conditions, cessation (i.e., extinction, failure to
respond) occurs more rapidly. Similarly, reinitiation of the behavior also occurs
more rapidly within the constraints of pharmacological effects (i.e., gradual
reemergence of opiate tolerance is related to gradual reacquisition of previous
levels of self-administration). There are similarities between some of these
conditions and the elimination of human drug-taking (Poling and Appel 1979).
The discrepancies and divergence between these laboratory cases and the human
case are clear and the fundamental antecedents to reacquisition are similarly
evident. Furthermore, the problems are more evident in the case of tobacco use
than for other forms of drug use. The elaborate methodologies, models, and
theories currently evolving reside in an anomalous social and therapeutic
condition which should be considered.
Clear ly,  a l l  therapeut ic  s t rategies  contend with the fact  that  the drug
nonavailability condition exists to some degree for some drugs and is nonexistent
for tobacco use. Attending to this issue, Wikler (1965) suggested there is a need
to remove the drug user from the environment during treatment, thereby
modifying the risk of relapse. Grabowski et al. (1984) have noted that the
advantage of this strategy is obviated by the fact that when reintroduced to the
natural environment, the individual remains susceptible to the diverse stimuli
previously associated with drug use. Concurrently, it is evident, as proposed by
Childress et al. (1984), and others, that presentation and extinction of the
discriminative and conditioned stimuli during the period of removal from the
drug use environment may reduce the strength of these stimuli. This might
reduce the probability of reacquisition of drug-taking when the individual
returns to the natural environment. This strategy has not, however, been
effectively implemented. In the case of tobacco use, it may be practical to
implement, in addition to other behavioral strategies, discrete regular sessions in
the natural environment to reduce the probability of reacquisition.
It has been noted that many of the basic elements of tobacco use are common to
drug abuse as well as other biobehavioral disorders. The drug self-administration
model applies admirably to conditions of acquisition and maintenance. It appears
to apply less well to cessation and maintenance of cessation. or its inverse,
reacquisition, not because of a failure in the description but because of the
anomalous conditions under which cessation strategies are initiated and abstinence
must be maintained. Walker and Lidz (1983) have discussed this issue and
summarized it in terms of normative and control ambiguity. That is, there are
social and contextual factors which concurrently and emphatically direct use and
vigorously oppose use. In the laboratory, parallel stimulus conditions can be
established. The formal study directed at analysis of this issue has not been
undertaken. However, there are ample parallels. The prediction is readily made
that, when presented with (a) stimuli associated with the null condition (no drug
43
availability) and (b) stimuli associated with the powerful drug effects and drug
availability itself, drug-taking is highly probable. It is clear that appropriate
steps must be taken to reduce the strength of stimulus factors precipitating
reinitiation of use.
Provided with the conditions described concerning the context of precluding
reacquisition, or “relapse prevention,” several facts are evident. First, one can
delineate, as has been done with great precision and care, the conditions under
which cessation is likely to be maintained, and these discriminations can be made
along the dimension of stimulus variables, coping strategies, individual
characteristics, or social environs (e.g., Lichtenstein and Brown 1982, Marlatt
1985, Shiffman 1982, Havassy et al., in preparation). Second, based on the data
derived from these studies as well as the refinements made to date in relatively
simple but effective strategies (e.g., Hall and Killen 1985; Hall et al. 1984,
Lichtenstein and Rodrigues 1977), improved success rates are probable. In turn,
these efforts, combined with the gradual shift in perceptions concerning smoking,
if not smokeless, tobacco effects, may further enhance success rates. In brief,
the focus, albeit sometimes distorted, on the multiple factors contributing to
reacquisition can be predicted to provide gradual improvements in outcome.
Most important is that it appears that the behavioral strategies considered here
aptly describe the situation and, when judiciously and systematically applied,
they are likely to be effective.
CONCLUSIONS
The primary point of this chapter is that there has been extensive laboratory and
clinical research devoted to the analysis of behavioral mechanisms of acquisition,
maintenance and elimination of drug-taking. The results have been translated,
with varying but increasing success, to the clinic. Unfortunately, there has also
been increasing and perhaps disproportionate attention to theory development
rather than refinement of the simplest effective treatment strategy. This is not to
ignore the utility of theory in some situations. Instead, it is suggested that, at
least in the area of smoking cessation, and quite possibly in other areas of drug
abuse and biobehavioral disorder treatment, effective implementation based on
current data rather than further theory development, is needed.
Finally, the above considerations not withstanding, the major problem
confronting therapists and scientist-clinicians is the previously noted anomalous
environment in which the therapeutic strategies are devised; that is, an
environment in which tobacco use is not only legal but substantially encouraged
on one hand and deemed hazardous and unacceptable on the other hand. This
issue is not resolvable through better theory. The greatest increments in
enhancement of the diverse interventions will come less from future refinements
in the techniques (which are already quite striking in their effectiveness), and
more through changes in the social environment via legislation and public policy.
In particular, attention must be given to all of those steps which would reduce
the availability and complexity of the conditions under which the interventions
must be implemented. In the interim, those engaged in the development of more
effective interventions can perhaps take solace in the fact that the elegance and
overbuilt character of the resulting interventions will likely be extremely useful
in resolution of other diverse biobehavioral disorders.
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Relapse and Recovery in
Substance Abuse Careers
James F. Maddux and David P. Desmond
During the 1950s it was often asserted that few individuals ever
recovered from addiction. Then, in the 196Os, Winick (1962, 1964)
produced data suggesting that approximately two-thirds of narcotic
addicts mature out of their addiction in their thirties. Subse-
quent long-term followup studies have pointed to a truth somewhere
between these two extremes of pessimism and optimism. With alco-
holism, the concept of the incurable skid row derelict has given
way to recognition in the latter half of the 20th century that
many alcoholics achieve long periods of abstinence, sometimes en-
during for a lifetime. In this report, we shall attempt to iden-
tify the major features of substance abuse careers, with emphasis
on relapse and recovery. We shall concentrate on the use of alco-
hol and opioids because use and abuse of these two psychoactive
substances have been studied intensively. Less information is
available about the long-term careers of persons who use tobacco,
marijuana, cocaine, and other commonly abused substances. While
we shall mainly describe patterns of behavior, we shall also com-
ment on theory, for data without theory have restricted meaning.
We draw on three theoretical aproaches which have served to inte-
grate and explain observations about substance abuse: 1) pharma-
cological theory--concepts about the interaction of exogenous
substances with body tissues and organs, especially with the
central nervous system; 2) learning theory--especially the para-
digms of classical conditioning and operant conditioning; and 3)
psychodynamic theory--concepts developed from exploration of
subjective mental experience. In psychodynamic theory, it is
assumed that past experience shapes current behavior--that is,
antecedent experience has persisting consequences. This etiolog-
ical assumption probably pervades most contemporary psychosocial
science. Psychodynamic clinicians and psychosocial scientists
also seem to assume that current circumstances affect behavior.
Some clinicians and scientists also find etiology in the antic-
ipated future. Personal goals and plans seem to affect current
behavior. Thus, in a broadly conceived psychodyanmic theory,
stored representations of past experience, perceptions of current
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circumstances, and anticipated future experience contain potential
etiological factors.
DEFINITIONS
The absence of generally accepted criteria for different levels of
substance use--for abuse, for dependence, for relapse, and for
recovery--have required that investigators develop definitions and
criteria based primarily on their own research questions and
methods. These varied criteria, plus variations in methodology,
have contributed to wide variations in reported recovery and
relapse rates, and have handicapped comparison of the findings of
different studies.
While the advent of the third edition of the Diagnostic and Sta-
tistical Manual of Mental Disorders, DSM-III (American Psychatric
Association 1980), has provided standard criteria for diagnosis of
substance use disorders, the rubrics include wide variation in
severity of the disorders. The Manual does not provide criteria
for recovery.
In this chapter we use the term "opioid" to refer to any substance
of natural or synthetic origin which has morphinelike effects.
Occasionally, when citing the work of others, we use the older
term "narcotic" in a sense approximately synonymous with
"opioids."
The term "dependence" unfortunately has some ambiguity, for two
meanings are ascribed to it. The term is used to refer to an
altered physiological state due to continued use of a substance,
and it is also used to refer to behavior--that is, to regular
compulsive use. When we refer to the altered physiological state,
we use the expression, "physical dependence." We use substance
"dependence" in accordance with DSM-III criteria, and consider it
approximately synonymous with the older term, "addiction." We use
the term "addiction" occasionally in citing the work of others who
use this term.
We use the term "alcoholism" in a broad sense to include not only
alcohol abuse and alcohol dependence, but also problem drinking
which may not meet the DSM-III criteria for abuse or dependence.
The term "abstinence" also has two meanings. It is used to refer
to the abstinence syndrome, a disorder which follows cessation of
use when physical dependence on a substance exists, and also to
refer to a continuing state of abstaining from substance use. We
use "withdrawal" (the DSM-III term) to refer to the abstinence
syndrome, reserving abstinence to refer to the continuing drug-
free state.
ANTECEDENTS OF SUBSTANCE ABUSE
Because conditions preceding and contributing to the onset of
substance abuse may also have a role in relapse, we note here
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several factors thought to have etiological importance in the
onset of substance abuse.
An antecedent personal vulnerability seems an important etiolog-
ical condition for alcohol dependence and opioid dependence. Only
a small proportion of persons who use these substances become
compulsive users. Accumulating evidence points to a genetic
factor in alcoholism (Goodwin 1979), and there is somewhat less
evidence in opioid dependence. Rats have been selectively bred
for susceptibility to morphine addiction (Nichols and Hsiao 1967).
Evidence of a heritable influence in tobacco use has also been
offered (McClearn 1983). In our study (Maddux and Desmond 1981)
of opioid use careers we found a high prevalence of substance
abuse among relatives of our subjects. Twenty-eight percent of
the fathers were considered alcoholic, and 37% of the subjects had
one or more opioid-using siblings; we do not know whether genetic
inheritance or social learning accounts for these high rates of
substance abuse in the families of our subjects.
Adverse childhood experience has been implicated as a contributor
to alcoholism vulnerability in both retrospective and prospective
studies (Vaillant 1983), but in Vaillant's own prospective stud-
ies, adverse childhood experience did not predict alcoholism, with
the exception that having one or two alcoholic parents predicted
alcoholism. In this latter case, the effect of genetic inheri-
tance becomes confounded with that of environment. Vaillant also
found that origin in an ethnic group that tolerated adult alco-
holism but discouraged children from learning safe drinking
practices also predicted alcoholism.
Clinical and other retrospective studies (Chein et al. 1964; Craig
and Brown 1975; Seldin 1972) have implicated adverse childhood
experience in the etiology of opioid dependence. Prospective
studies starting with children before the onset of opioid depen-
dence have not been reported. In retrospective study of the
childhood experience of our subjects, we found ample evidence of
adverse experience, but when we compared the parental family
experience of 50 addicts with their nonaddict brothers, we did not
find noteworthy difference (Maddux and Desmond 1984). We should
note, however, that almost 50% of the nonaddict brothers had
histories of alcohol abuse.
Retrospective studies have indicated that alcoholics began their
drinking to decrease tension, anxiety, or depression (Jellinek
1960). Relief of chronic emotional distress may serve as the
consequence which reinforces alcohol use. Vaillant (1983) did not
find evidence of more emotional distress existing premorbidly
among alcoholics than among nonalcoholics. However, he did find
that alcoholics were more likely to be premorbidly antisocial than
nonalcoholics. Since antisocial behavior often conceals anxiety
or depression (Vaillant 1975), hidden emotional distress may have
existed abundantly in his pre-alcoholic subjects.
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Clinical studies have also indicated that opioid users began their
repeated opioid use to relieve chronic emotional distress (Wikler
and Rasor 1953; Khantzian et al. 1974; Wurmser 1974; Khantzian
1985). While few of our subjects gave histories of chronic
emotional distress, the majority showed evidence of antisocial
behavior preceding opioid use, On several measures of early
deviant behavior, 50 of our subjects were significantly more
deviant than their nonaddicted brothers (Maddux and Desmond 1984).
Our opioid users as well as Vaillant's alcoholics may have con-
cealed their emotional distress in their antisocial behavior
before the onset of the substance use disorder.
CHRONICITY AND RELAPSE
Although chronicity of alcohol abuse has probably been observed
for centuries, biblical and other ancient reports seem to comment
more on the excesses and failures of the drunkard rather than on
the chronicity of the condition. Austin (1979) cited a law
enacted in 1672 in Plymouth, Massachusetts, which stated that
alcohol misuse was a chronic condition among certain drunkards.
Jellinek (1960, p. 220) noted a 19th century report on the danger
of relapse after cure. While Jellinek was primarily concerned
with the concept of alcoholism as a "disease," his descriptions of
the types of alcoholism note both its chronicity and periodicity.
While opium has been known and used for many centuries, the prob-
lems of chronic compulsive use and relapse after a period of
abstinence did not become identified until the 19th century. In
his "Confessions of an English Opium Eater," initially written in
1821, De Quincey (1966) first described the seemingly uncontrol-
lable compulsion to continue using opium. He had multiple periods
of abstinence followed by relapse. When he revised the Confes-
sions for the last time at age 71, he had struggled unsuccessfully
with his laudanum habit for 52 years.
Jones (1953) chronicled a similar lifelong struggle with tobacco
dependence in his biography of Sigmund Freud. Recognition of
compulsive smoking as an addiction or chronic disease was slow to
develop (Jaffe 1977). Tobacco dependence did not enter the offi-
cial diagnostic nomenclature of the American Psychiatric Associa-
tion until 1980. In the DSM-III the course of the disorder was
described as "variable" with some individuals repeatedly
attempting to give up tobacco without success, and others able to
achieve total cessation after a relatively brief episode. Relapse
was alleged to be unlikely among persons who achieved a year or
more of abstinence. Russell, in a review of mostly British
studies (1971), reached a more pessimistic conclusion, asserting
that "as many as three out of four smokers wish to or have tried
to stop their smoking, but less than one in four ever succeeds in
becoming a permanent ex-smoker" (Russell 1971, p. 3).
VARIABILITY IN SUBSTANCE ABUSE CAREERS
Psychoactive substance use seems to vary in adult populations not
only by the substance used and by the number of substances used,
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sequentially or concurrently, but also as a continuum of severity.
This continuum ranges from no use, to nonproblem personal or
social use, to episodic or continuous problem use, to dependence
with inability to abstain, and finally to death as a direct or
indirect consequence of the substance use. The substances used
and the severity vary not only from person to person, but over
time in a given person.
Jellinek (1960) described different levels of severity of
alcoholism and labeled these alpha, beta, gamma, delta, and
epsilon. Delta alcoholism was the most severe level; it included
both physical dependence and inability to abstain. Jellinek
considered alcoholism a progressive disease, but he did not
describe the long-term alcoholic career. Vaillant (1983) has
offered the major contemporary contribution in this area. His
book not only presents the findings from three prospective
longitudinal studies conducted by Vaillant and his colleagues; it
also summarizes the major preceding longitudinal studies and
followup studies. Alcoholism becomes a progressive disease in
only a minority of alcohol abusers. Some heavy drinkers on
occasions will develop problems which meet the DSM-III criteria
for alcohol abuse but will progress no further; some of these
return to social drinking. Among those whose drinking comes to
meet the diagnostic criteria for alcohol dependence, the course
also becomes variable: they have successive periods of absti-
nence, of social drinking, and of relapse to alcohol dependence.
The periods of abstinence are often introduced by treatment or by
participation in Alcoholics Anonymous. Alcohol dependence common-
ly leads either to prolonged abstinence or to social incapacity or
death.
Like the course of alcohol dependence, the course of opioid depen-
dence also varies greatly. In addition to irregular periods of
abstinence, occasional use, daily use, and treatment, the modern
opioid user often has long periods of incarceration. Since 1966,
my colleagues and I have been engaged in a prospective followup
study of 248 opioid users who resided in San Antonio. The findings
in this study illustrate the variable nature of opioid use
careers. The subjects, all men, were hospitalized at the former
Public Health Service Hospital in Fort Worth, Texas. Their mean
age in 1966 was 28, and, if all were alive, it would have been 47
in 1985. Fifty-three (21%) have died. The methods and prelimi-
nary findings of the study have been published (Maddux and Desmond
1981).
Figure 1 shows the marked variations in the 20-year opioid use
careers of ten subjects. Subject 071 used heroin daily for
approximately two years, then served 18 months of a five-year
prison sentence as a patient at the Public Health Service Hos-
pital. Aged 29 when paroled, he remained abstinent from opioids
for 10 years, through age 39 at the time of our last interview.
Subject 067, in marked contrast, remained dependent on heroin or
methadone during most of his adult life, although he did have
several periods of voluntary abstinence lasting three to 14
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FIGURE 1
Substance use careers of ten San Antonio opioid users.
(Maddux and Desmond 1981.) Copyright 2982, Praeger
Publishers.
months. The longest period of abstinence occurred while he was
working for a defense contractor overseas, away from his usual
source of drugs. He died in a hospital at age 41 following
surgery for peptic ulcer.
Similar variability probably exists in the long-term tobacco use
career, but studies of tobacco use patterns over two years or
longer are uncommon (Schwartz 1977; Krasnegor 1979), and mention
of the concept of career in the context of tobacco use disorder is
rare. Our review of the literature turned up only one reference
to a "tobacco use career" (Kozlowski 1979).
RELAPSE AFTER TREATMENT
The majority of treated alcoholics relapse to alcohol abuse or
dependence. Vaillant (1983, p. 284) pooled the results of four
studies in which a total of 685 treated alcoholics were followed
for two years. At the end of two years 63% were abusing alcohol;
21% were abstinent or drinking socially. In Vaillant's own sample
at the end of two years, 67% were abusing alcohol; 20% were
abstinent or drinking socially. By the end of the eight-year
followup period, 95% had resumed drinking at some time, but not
all had relapsed to alcohol abuse or dependence.
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Relapse not only occurs frequently after treatment, it also occurs
rapidly after treatment. Gottheil and associates (1982) reported
that only 19% of 20 treated alcoholics remained abstinent during
six months after treatment; 48% became relapsed drinkers during
that time. The authors cited two other studies, having a combined
total of 499 treated alcoholics, in which only 18% remained absti-
nent during six months after treatment.
Frequent and rapid relapse after treatment also occurs in opioid
dependence. Duvall et al. (1963) found that 97% of 43 opioid
users became readdicted at some time during five years of followup
after treatment. An estimated 67% became readdicted during the
first six months after discharge. In our study (Maddux and
Desmond 1981) of careers of opioid users, we found that 70% of
1,653 treatment and correctional interactions over a mean period
of 20 years were followed by less than one month of abstinence.
Eighty-seven percent were followed by abstinence of less than six
months. In their followup of 2,099 opioid addicts in the Drug
Abuse Reporting Program, Simpson and Sells (1982) reported that
56% to 77% of opioid addicts in different treatment groups resumed
opioid use within one year after completion of treatment.
Frequent and rapid relapse has also been reported following treat-
ment of tobacco dependence. Hunt et al. (1971) plotted relapse
curves of treated alcoholics, heroin addicts, and smokers and
found the three to be essentially the same. In their reviews of
smoking treatment outcomes, Hunt and Bespalec (1974) and Krasnegor
(1979) concluded that most smokers, 70% to 80%, resumed tobacco
use within one year. Hall and associates (1984) more recently
reported a lower relapse rate following treatment with a relapse
prevention component.
Vaillant (1983, p. 180) identified five factors which he consid-
ered important in relapse to alcoholism. Two of these were
factors which also made the person vulnerable before the onset of
alcoholism. The five factors included: 1) a genetic predisposi-
tion; 2) a psychological predisposition; 3) physical dependence,
which may persist for months after abstinence; 4) operant and
Pavlovian conditioning; and 5) absence of protective conditions,
such as a stable social network.
Nearly 50 years ago Kolb (1927) identified three factors which he
considered important in relapse to opioid dependence: 1) a
primary psychic factors, which made the person vulnerable to the
original opioid dependence and to relapse after abstinence; 2)
physical dependence--Kolb felt that his factor became more impor-
tant with increasing years of opioid use; some of his subjects who
were addicted 10 or more years reported feelings of lassitude and
undue fatigue which lasted six to nine months after cure; 3)
memory associations and habit. The repeated relief of discomfort
by taking morphine or heroin formed a strong association between
physical and mental distress and the taking of the drug.
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While Kolb reported environmental adversities which seemed to pre-
cipitate relapse, he attributed more importance to the person's
inability to cope, i.e., the primary psychic factor.
Since Kolb's report, protracted withdrawal existing for six months
following opioid dependence has been measured and described, and
its possible role in relapse has been assessed (Martin 1972).
Thus, in both alcohol and opioid dependence, protracted withdrawal
seems a likely etiological factor in rapid relapse. Withdrawal
may also be a factor in relapse to tobacco dependence (Pomerleau
1979; Shiffman 1979).
The "memory associations and habit" conceived by Kolb have been
reformulated into classical and operant conditioning hypotheses.
Both tpyes of conditioning have been demonstrated (mainly in rats)
to have roles in relapse (Wikler 1980).
In our study of careers of opioid users, we attributed relapse in
part to protacted withdrawal, to conditioning, and to stress, such
as the onset of marital conflict. Additionally, we inferred a
subjective motivational state revealed more in action than in
words. Our subjects came to most treatment interactions under
external coercion, and they rarely seemed to have a desire per-
sistent enough to overcome their opioid dependence.
Many factors associated with relapse to tobacco dependence have
been identified. Prominent ones include the "overlearned" nature
of the habit (Hunt and Matarazzo 1970); withdrawal discomfort
(Schachter 1970; Jarvik 1970); use of other substances, particu-
larly alcohol (Shiffman 1982); social pressures (Marlatt and
George 1984); negative affect (anxiety, tension, and depression)
(Kozlowski 1979; Shiffman 1982); and deficient coping skills (Hall
et al. 1984; Marlatt and George 1984).
LONG-TERM OUTCOMES
The studies which have followed substance abusers for five years
or longer seem almost entirely limited to studies of alcohol and
opioid users. We found only one five-year followup study of
smokers (West et al. 1977). All studies found that small per-
centages of subjects were abstinent at varying followup periods.
Kendell and Staton (1966) followed a group of 62 British alcohol
addicts for an average of 6.7 years after they rejected or were
denied admission to treatment. At followup, 18% had died, 8% had
returned to "normal social drinking," and 15% had been abstinent
at least one year (mean duration was approximately four years) at
followup. Only one of the nine abstinent subjects received no
treatment during the followup.
Hyman (1976) studied a group of 54 New Jersey alcoholics, aged 30
to 54 at admission to treatment, for a period of 15 years from
termination of treatment. At followup, 33% had died, 17% were
"unimproved problem drinkers," 20 were moderate drinkers, and 11%
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were total abstainers for a period of a least three years before
followup. Nineteen percent could not be located or refused to
participate.
Edwards et al. (1983) studied 99 married alcoholic men for an
average period of 11 years. Eighteen had died, 13 were lost to
followup, and 68 were personally interviwed. We recomputed the
published outcome status statistics by using the starting sample
of 99 as the denominator. At followup, 27% were "doing well," 32%
were drinking in an "uncontrolled fashion," 9% were in a category
labeled "equivocal outcome," 18% were dead, and 13% were unknown.
In their summary, Edwards and associates noted that "Pathways to
recovery are individual and complex," and that an important final
path may be ". . . certain psychological shifts." Data from the
Edwards study were reanalyzed by Taylor and associates (1985).
Approximately 25% of the subjects alive throughout the ten-year
study period were continuous drinkers, and 15% were continuously
abstinent. The remaining 60% exhibited a patchwork of abstinence
and troubled drinking; in other words, most experienced multiple
periods of remission followed by relapse.
Vaillant and Milofsky (1982) reported that among 110 alcohol
abusers followed from age 20 to age 47, 21 (19%) became "securely
abstinent," i.e., had achieved three years or more of continuous
abstinence--actually, a mean of 10 years. Some of the most symp-
tomatic drinkers were among those who achieved secure abstinence.
Although alcoholism occurs with demonstrated severity and fre-
quency among Native Americans, a 10-year followup by Westermeyer
and Peake (1983) suggested long-term outcomes similar to those
cited above. At the time of followup, the 45 subjects were found
in the following statuses: abstinent for two years or more, 16%;
problem drinking, 58%; dead, 20%; and unknown, 7%.
The long-term followup studies of opioid addicts have also found
small percentages abstinent at different periods of followup. In
their followup of 453 opioid addicts, Duvall et al. (1963) found
that, at five years after followup, 46% of living subjects were
addicted, 2% were voluntarily abstinent, and 24% were
involuntarily abstinent.
In his study of Kentucky opioid addicts, O'Donnell (1969) de-
scribed the careers of 266 subjects during an average period of 12
years after their first admission to the Public Health Service
Hospital in Lexington. He found that 13% of the subjects
displayed "much abstinence" (more than 50% of noninstitutional
time), and 10% displayed "complete abstinence" after treatment.
Thirty percent were addicted throughout their posthospital
careers. O'Donnell emphasized the general lack of clear-cut
longitudinal patterns, noting that 60% of the subjects were "seen
to shift from one status to another, with periods of narcotic
addiction broken by shifts to other drugs, and frequently by
periods of complete abstinence, sometimes quite long."
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Valliant's followup studies of New York City heroin addicts are
perhaps the most widely cited addiction career studies. In both
his 12-year followup (1966a, 1966b) and his 20-year followup
(1973), Vaillant emphasized a three-year abstinence criterion:
". . . urban heroin addicts who achieve more than three years of
abstinence can usually maintain this abstinence indefinitely." Of
100 addicts admitted to treatment in 1952, 23% had died by 1970,
35% had achieved what he called stable abstinence, and 25% were
still using opioid drugs.
Vaillant's 20-year followup depended primarily on institutional
records. Most of the followup studies of British opioid addicts
(Gordon 1983; Cottrell et al. 1985; Willis and Osbourne 1978)
suffer from the same methodological problem. Other followup
studies have relied primarily on self-reports from subjects, with
variable confirming data from other sources. The validity of data
obtained in followup studies represents a continuing problem.
In our study of 248 opioid users from San Antonio, we learned that
a three-year abstinence does not portend a lifetime abstinence.
In 1981 we reported that 33% of our subjects who achieved three or
more years of abstinence eventually resumed opioid use (Maddux and
Desmond 1981, p. 101). By the end of 1983, 31 subjects had
achieved five years or more of opioid abstinence during their
careers but had later resumed daily use. Of these 31, 12 subjects
(39%) resumed opioid use after periods of abstinence ranging from
five to nine years, and one subject resumed opioid use after 13
years of abstinence.
Ninety-three of our 248 addicts began opioid use in 1954 or before
and were followed either until death or through calendar year
1984. In figure 2 are shown the percentages of subjects in dif-
ferent drug use statuses during July of each year from the year of
first use through the 30th year after first use. The percentage
of subjects in each status is represented by the width of the hor-
izontal bands. Individual subjects shifted among these statuses
over time. For more than 20 years, the percentage of subjects
using illicit opioids daily remained approximately 40%. The per-
centage abstinent during the first two decades ranged from 7% in
year 1 to 24% in year 4. The main changes during these two
decades were the decrease in occasional use, which was most marked
in the first three years, and the large increase in percentage
institutionalized, which peaked in year 12. After the 20-year
mark a steady decline in daily illicit opioid use began, along
with a noticeable decrease in institutionalization. By July of
year 30, only two subjects were using heroin daily and 11 were
maintained on methadone. Twenty (22%) died by the 30th year.
In the 30th year after initial use, 14 (15%) of the 93 subjects
had three years or more of continuous voluntary abstinence from
opioids, no evidence of alcohol or nonopioid drug abuse or depen-
dence, full-time employment of three years duration, and no
arrests for at least three years. The mean duration of abstinence
in this recovered group was eight years as of the 30th career
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FIGURE 2.
Drug use status of 93 San Antonio subjects during July of years 1-30 after onset of
opioid use.
year. We have continued to follow the subjects beyond that point,
however; and at the time of our most recent interview, these men
had accrued an average of four additional years of abstinence,
making a mean of 12 years of continuous abstinence. Four of the
14 subjects experienced episodes of alcohol abuse or dependence
after the 30th career year, however, and one subject received a
lengthy prison term for a drug law violation.
The trend of increasing abstinence with passage of time has also
been reported by Duvall and associates (1963), O'Donnell (1969),
and Vaillant (1973). Kolb (1924) also reported excessive use of
alcohol among his subjects following opioid withdrawal. Vaillant
(1983) also found a trend of increasing abstinence among his
alcholics.
Death occurs as a longterm outcome with notable frequency. The
death rates for alcohol and opioid abusers are reported to be ap-
proximately three times higher than the expected rates (O'Donnell
1969; Maddux and Desmond 1981; Vaillant 1983). The death rates of
cigarette smokers are approximately 1.7 times those of nonsmokers
(Public Health Service 1979).
RECOVERY
The study of recovery from substance dependence has been impeded
by a lack of agreement as to the meaning of the term. Diverse
labels have been applied to the phenomenon, including "cure,"
"maturing out," remission, "de-addiction," cessation, stable
abstinence, and "quitting." Some of the terms imply a permanent
status (cure), while others include possibly temporary or fluc-
tuating conditions (remission, cessation).
Treatment evaluators have used varied concepts of recovery, and
they have used multiple criteria for recovery, including indica-
tors of social adjustment. Duration of abstinence suggestive of
recovery varies, with most followup studies specifying one to
three years of abstinence. Alcohol studies frequently use a
duration of less than three years, and most smoking studies use a
duration of one year or less. Many investigators ignore infre-
quent lapses, "slips," or occasional "chipping." Debate over the
issue of reduced or controlled substance use versus abstinence
continues. A committee of the American Medical Association (1970)
developed criteria for recovery from drug dependence which includ-
ed three years of abstinence from the primary drug and no abuse of
other substance. Bejerot (1975) recommended five years of absti-
nence as a criterion for recovery.
The term recovery conventionally means "the act of regaining or
returning toward a normal or usual state" (Webster 1971). It
refers to a process rather than a state. Members of Alcoholics
Anonymous refer to themselves as "recovering alcoholics," thus
emphasizing the process rather than a state. If recovery is
viewed as a process, then it becomes possible to identify and
describe, more or less arbitrarily, levels in the process. Levels
such as the following could be defined:
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Level 0. Continued daily use of primary substance for one
month or longer, or incarcerated, for one month or longer.
Level 1. Daily substitute medication (e.g. methadone) for
primary substance for one month or longer.
Level 2. Abstinent from primary substance with no substitu-
tion for one month or longer. Recovered from acute with-
drawal.
Level 3a. Only occasional nonproblem use of primary or other
substance for one year or longer. Possible tobacco depen-
dence. Full-time employment for one year or longer unless
physically disabled.
Level 3b. Same, with less employment.
Level 4a. Continuous voluntary abstinence from primary
substance with only occasional use of other substances.
Possible tobacco dependence. Full-time employment for one
year or more unless physically disabled.
Level 4b. Same, with less employment.
Level 5a. Continuous voluntary abstinence from all sub-
stances, except possibly tobacco, for one year or more.
Full-time employment for one year or more unless physically
disabled.
Level 5b. Same, with less employment.
The levels could be extended for two years, three years, or
longer. The use of levels of recovery avoids the difficulty of
attempting to determine whether the person has regained a "normal
or usual state." The person who has had a substance use disorder
may never completely return to his "usual" state which preceded
the disorder. Some remnants of the disorder, such as the loss of
liver cells or the memories of substance effects, probably endure
for a lifetime.
Several studies have identified pretreatment variables which
predicted recovery. Among alcoholics, these include social
stability--especially with respect to employment and family;
absence of arrests, and late onset of alcoholism (Vaillant 1983,
p. 168). Among opioid addicts, the criminal history predicted
posttreatment outcomes with respect to opioid use, employment, and
criminality (Simpson and Sells 1982). Pretreatment criminality,
employment, and alcohol use also predicted, respectively, post-
treatment criminality, employment, and alcohol use. Duration of
treatment was a better predictor of outcome than type of treat-
ment. Several predictors of recovery after smoking treatment have
been identified. Among older studies, gender was one of the most
powerful; women consistently had more difficulty quitting
(Kozlowski 1970). Among men, high extraversion and low neuroti-
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cism predicted good outcome. Other predictors included lower
pretreatment cigarette consumption, low use of other substances--
particularly alcohol and caffeine, having fewer relatives and
friends who smoke, lower levels of chronic illness, and absence of
"negative affect" smoking (Schwartz 1977; Kozlowski 1979).
In our study of opioid use careers, we found several background
variables that were weak but statistically significant predictors
of years of abstinence during the first 10 years after first
opioid use. These included intact parental family, no opioid-
using relative, no convictions before first opioid use, number of
months from first use to daily use, and age at first daily use.
These findings suggest that a better family background leads to
better coping skills and less alienation, and these in turn lead
to less deviant behavior and later onset of daily use; the combi-
nation then leads to a somewhat less severe opioid use career.
These predictor variables account for only 18% of the variance in
years abstinent.
Other studies which have focused on the relationship of both
pretreatment and treatment variables to long-term outcome have
typically found that the predictor variables explained only a
small fraction of the outcome variance (Zahn and Ball 1972;
Whitman et al. 1982; Judson and Goldstine 1982; Simpson et al.
1982). These findings, together with the recognition that formal
treatment only initiates the recovery process (Edwards 1984;
Pechanek 1979; Wille 1980), have prompted some investigators to
look more closely at posttreatment variables. Many substance-
dependent persons begin recovery without treatment (Drew 1968;
Robins et al. 1980; Schacter 1982); study of spontaneous recovery
is frequently advocated (Vaillant 1983; Smart 1976; Waldorf and
Biernacki 1979).
Substance substitution occurs with noteworthy frequency, espe-
cially between alcohol and opioids. Thirty-nine percent of Kolb's
(1924) opioid users were alcoholic before they began opioid use.
This pattern seems less common in the latter half of the 20th
century, yet a substantial minority (25% to 30%) of opioid users
continue to report alcohol abuse or dependence pre-dating onset of
opioid dependence (Green et al. 1978) or prior to treatment (Barr
and Cohen 1980). O'Donnell (1969) observed substitution of alco-
hol and barbiturates among his Kentucky addicts who had ceased
opioid use. Vaillant (1966b) found a substitute substance depen-
dence, usually alcohol, among some of his abstinent former heroin
addicts. Among his abstinent alcoholics, he also found substance
substitution (Vaillant 1983). The substituted substances included
benzodiazepines, marijuana, and tobacco. Waldorf (1983) reported
"heavy drinking" among 41% of 201 recovered addicts, but suggested
that this phenomenon occurred early in the recovery process and
abated within a year. In our career study, we found that 43% of
54 subjects who achieved three years or longer of opioid absti-
nence had substituted alcohol for the opioid drug. Most exhibited
evidence of alcohol abuse or dependence for more than one year.
62
A large minority of patients maintained on methadone drink exces-
sively (Joseph and Appel 1985). Apparently, many opioid users
cannot endure a steady pharmacological state, neither abstinence
nor smooth maintenance. Furthermore, from our clinical observa-
tion, it seems that most opioid addicts in treatment smoke one or
two packs of cigarettes every day. The alcohol and tobacco use by
methadone patients seems to be substance supplementation rather
than a substitution.
Several investigators have identified and described a number of
posttreatment conditions which were thought to facilitate pro-
longed abstinence or recovery. O'Donnell (1969) found that
abstinence from opioids was weakly associated with several varia-
bles: gender (women were more frequently abstinent than men),
less involvement in the drug subculture, and being employed
regularly. The associations were statistically significant, but
were not strong enough to be considered practical predictors of
abstinence. One environmental factor was of such overriding
importance that the other variables had little chance to show an
effect. That major factor was decreased availability of opioid
drugs. O'Donnell's subjects lived in a locale and an era in which
marked changes in medical prescribing practices, enforcement of
narcotics laws, and other social factors acted together to dras-
tically reduce the amount of opioid drugs available.
Vaillant (1966b) reported the following factors associated with
opioid abstinence: compulsory supervision, a stable nonparental
personal relationship, and a change in residence away from the
drug-use area. He reported different but overlaping factors
associated with abstinence after alcoholism (Vaillant 1983):
behavior modification (broadly conceived to include compulsory
supervision), enhanced hope and self-esteem (often from religion
or AA), and social rehabilitation (including a new love relation-
ship). He commented (p. 314) that "Staying sober is not a process
of simply becoming detoxified, but often becomes a work of several
years or . . . a lifetime."
Brill (1972) conceived a transition to addiction and the transi-
tion to abstinence as processes that evolved slowly with much
learning and adaptation. He called factors associated with
recovery "pushes" and "pulls." The pushes included: the bad
life, including arrests, prison, and hospitalization; negative
self-image; overdose; stress from constantly avoiding withdrawal;
and exhaustion of resources. The pulls included: legitimate
aspirations; treatment; personal relationships; and opportunity to
think while in jail or hospital.
Waldorf (1983) identified five processes (excluding development of
alcoholism or other psychiatric disorders) leading to recovery in
samples of 100 treated and 101 untreated ex-addicts: 1) develop-
mental change; 2) conversion to religious, spiritual, or ideolog-
ical groups; 3) change in behavior following environmental change;
4) "retirement" from drug use; and 5) "drift" from deviant into
conventional behavior.
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Among our 54 former addicts who achieved three or more years of
abstinence, we identified the following factors (excluding alcohol
substitution) which probably facilitated the abstinence: treat-
ment or correctional interaction during year before onset of
abstinence (present in 89% of the cases); relocation of residence
away from usual source of drugs; evangelical religious participa-
tion; employment with a drug abuse treatment agency; and probation
or parole for one year or longer (Maddux and Desmond 1981, pp.
99-105). Our later, more extensive analysis of residence reloca-
tion demonstrated this factor to be significantly associated with
abstinence (Maddux and Desmond 1982).
The following three vignettes illustrate factors associated with
recovery among our San Antonio subjects. The careers of the
three men are depicted in figure 1.
Subject 071. After approximately two years of heroin use, he
spent 18 months in involuntary treatment. After release from
treatment, he planned to resume heroin use, but, as he was pre-
paring the heroin for injection, he realized that he had life
goals which were incompatible with heroin use. He wanted to take
care of his family and set a good example for his children, and he
wanted to accomplish something in life. He refused the injection
and remained abstinent for 15 years, through the age of 44 at last
interview.
Subject 111. After four years of occasional use of heroin he
ceased use because he married and his wife promptly threatened to
leave if he used heroin. Nine years later he resumed use in
response to marital conflict, used daily for two years, and then
voluntarily entered a hospital for treatment. After treatment he
became intensely involved in church work. Aged 47 when last
interviewed, he was no longer involved in his church work but had
been abstinent and steadily employed for 18 years.
Subject 162. From age 16, he used heroin daily for 20 years,
except for short periods in hospital or jail, Then, at age 37,
while participating in a prison therapeutic community, he felt a
change in himself. He decided to stop "playing games." After
discharge (not shown in figure 1), he remained abstinent under
compulsory supervision and obtained employment in a drug abuse
treatment program. When last interviewed, at age 52, he had been
abstinent for 14 years.
The following factors were cited in two or more of the studies
reviewed above: compulsory supervision, residence relocation, a
supportive social environment, religious activity, and treatment.
THE MAJOR THEMES
Similar findings by different investigators on several general
features of substance abuse careers in the United States,
especially those of alcohol and opioid users, have emerged in our
review of the literature. These can be summarized as major
themes, as follows:
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1. Personal vulnerability. Only a small proportion of persons
who use psychoactive substances become substance abusers. Some
persons use alcohol throughout a lifetime without disability. A
special vulnerability, genetic or acquired, seems important in the
etiology of alcohol and opioids abuse and in relapse. The evi-
dence for personal vulnerability seems less clear for tobacco
dependence.
2. High risk environment. Increased accessibility of substances
seems to be another important etiological factor. The much
greater prevalence of alcohol abuse over opioid abuse may be a
consequence of increased availability, the difference due to the
greater legal control of opioids. Furthermore, considerable
evidence points to factors in the family and social environment,
especially those promoting social learning of substance abuse.
3. Wide variation. Substance abuse careers vary widely in
duration and severity. Most alcohol and opioid abusers show
irregular periods of abuse, abstinence, ocasional use, daily
non-abusive use, hospitalization and outpatient treatment, and,
especially with opioid uses, incarceration. Less is known about
the tobacco user's career.
4. Substance substitution. Substitution of alcohol abuse for
opioid abuse and the reverse occurs with noteworthy frequency.
Concurrent, supplementary use of one while abusing the other also
occurs. Tobacco dependence is seen with high frequency among both
alcohol and opioid abusers.
5. High mortality. Death rates for alcohol and opioid abusers
are approximately three times higher than expected rates. Death
rates of smokers are 1.7 times higher than those of nonsmokers.
6. Frequent and rapid relapse. Alcohol dependence, opioid
dependence, and tobacco dependence often seem refractory to
treatment. Most treated persons relapse within one year after
treatment.
7. Increasing abstinence. With passage of years, increasing
abstinence is found in alcohol dependence and opioid dependence.
This also probably occurs in tobacco dependence, but long-term
career studies of this disorder have not yet been reported.
8. Maintaining recovery. The minority of alcohol and opioid
abusers who maintain a recovery process for three years or longer
seem to experience personal change with less emotional distress.
Environmental conditions such as treatment to initiate and
maintain the recovery, external coercion, and supportive social
relationships seem useful in maintaining the recovery.
ISSUES
Although general themes of agreement seem to exist about the
characteristics of relapse and recovery in substance abuse,
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several problems handicap understanding of these phenomena. The
problems include:
1. Definitions and criteria. The absence of generally accepted
criteria for relapse and recovery handicap comparison of results
of outcome studies.
2. Clarification and measurement of etiological factors. While
a number of individual and environmental factors have been iden-
tified which seem to affect relapse and recovery, the conceptions
of these conditions vary among investigators. More research is
needed to clarify and measure these variables and to estimate
their effects.
3. Motivation for recovery. Most alcohol and opioid abusers
enter treatment under external coercion. Alcohol abusers often
deny that they have an alcohol problem. Motivation for recovery,
a subjective changing condition, seems a prominent determinant of
the recovery process. More precise analysis and measurement of
this condition is needed.
4. Social drinking. Return to "social" or "controlled" drinking
or drug use as a level of recovery needs further study and
evaluation.
5. Treatment effects. While treatment seems to have beneficial
short-term effects, especially partial or complete recovery from
acute withdrawal, its effects on the long-term career seem less
clear. More study is needed.
6. Validity of data. Most of the data of followup and career
studies consist of self-reports from subjects. While urine
analyses and reports from other sources generally tend to confirm
the self-reports, continued study on the validity of self-reported
recovery from substance abuse subjects is needed.
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Multivariate Description
of Alcoholism Careers:
A 10-Year Followup
Colin Taylor, David Brown, Anni Duckitt, Griffith Edwards,
Edna Oppenheimer, and Margaret Sheehan
INTRODUCTION
This chapter presents data collected by a team of workers at the Addiction
Research Unit in one of its longest standing studies. By 1971, this team had
inducted 99 male, married alcoholics attending the Maudsley Out-Patient Clinic
into a treatment trial in which the standard treatment program was compared
with the efficacy of just giving simple advice (Edwards et al. 1977). Recently,
these alcoholics were contacted again, 10 years or more later, and it is this set of
data with which this chapter is concerned. A number of reports on this project
have already been published (Edwards et al. 1983, 1986; Duckitt et al. 1985;
Taylor et al. 1985.)
The data obtained for these patients does not detail their relapses and recoveries
throughout the period of the followup. It is intended to give an overview of the
processes of change that occurred over those 10 years and show the background
against which the careers of these alcoholics have unfolded. In so doing, the aim
of this primarily descriptive study is to supply the context within which the
individual movements between relapse and abstinence might be understood.
Caution must be taken on interpreting too much and generalizing too far from
these data, because of their inherent limitations: data limited in number to only
99 individuals; limited in time and place to London at the end of the 1960s; and
limited to self-selected subjects, all of them married men, predominantly in their
forties, seeking treatment as out-patients at the Maudsley Hospital clinic.
Nonetheless, we believe these data are important for what they can tell us: not
just for the factual information they provide about these 99 alcoholics, but also
because they raise issues of interest, both methodological and conceptual, that
have a more general application. The larger questions the analysis raises about
career and natural history of alcoholism are:
What is the multidimensional structure of the phenomena which are
subsumed under the simple term “outcome”?
Does a maturation process exist and, if so, how should we characterise
it?
Should career be viewed as following distinct and different pathways, or
is there a continuum of such patterns?
72
These questions are raised--but not answered--by this study. What has been
attempted is (i) to chart periods of time spent in heavy drinking; (ii) to explore
the relationship between the different dimensions of change; and (iii) to relate
these to the severity of the alcohol problem at intake into the study 10 years
previously.
THE BASIC SAMPLE DETAILS
The sample consists of 99 individuals who vary considerably in terms of career,
natural history, and maturation, and are linked only in that the period for which
we observed them began with an alcoholism clinic attendance at the beginning of
the 1970s. They are not a birth cohort, their ages ranging at intake from 20 to
60. Neither are they a cohort at a particular stage of the development of their
alcoholism: some had been previously treated for drinking problems but about 50
percent had not; and the extent of their drinking and dependence varied from
moderately dependent drinking, with an intake of perhaps 5 pints of beer
equivalent a day to more severely dependent individuals whose drinking was in
excess of 20 pints a day.
TABLE I
Selected Sample Characteristics at
Intake into the Study
Age at Intake
20-29 30-39 40-49 50-60 All
16 28 35 20 99
Mean years of problem drinking(1):
1.7 3.5 4.5 8.1 4.4
Mean daily alcohol consumption(2):
286 291 248 217 259
(1) Years since “drinking became problem”
(2) On “typical drinking day” (in ml.)
Some of this background information is shown in table 1. Of these 99 men, 68
were interviewed at followup: 18 had died during the followup period, and 13
were lost to followup (including 1 refusal), Numbers in the subsequent analysis
are reduced somewhat further by occasional missing items of data.
Table 2 shows in the broadest possible terms what happened to this group of
alcoholics in respect to their drinking over the 10-year followup period. It gives
year by year the average number of months the group as a whole spent in each
of three modes of behaviour. Again, a previous publication (Taylor et al. 1985)
displays these “life chart” data and reports more detailed information; but for our
present purposes it will be sufficient to note that there is the gentlest of trends
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towards slightly more abstinence over time. This table, of course, pertains only
to the 68 individuals for whom a followup interview was obtained.
TABLE 2
Drinking Status Data (in Months) During 10 Years
of Followup of Interviewed Sample Members
'72 '73 '74 '75 '76 '77 '78 ' 7 9 '80 '81
Abstinent
4.0 4.1 4.0 4.4 4.2 4.7 4.9 5.4 5.3 5.1
Social
.2 .1 .4 .4 .5 .7 .7 .5 .8 1.1
Troubled
7.8 7.8 7.6 1.2 7.3 6.6 6.4 6.1 5.9 5.8
NOTE: Years are nominal and begin with first full calendar year of followup.
This report goes on to explore the separate patterns of behaviour and experiences
which are contained within this summary presentation of the entire group. Our
central theme is that the course of alcoholism requires a multivariate description.
It cannot be confined to a simple record of drinking and abstinence: mental and
social well-being are likely to vary from individual to individual, even when
their drinking is similar; and apparently successful abstainers may well substitute
for their drinking habits which are as bad or worse. Before proceeding,
therefore, it is necessary to describe the data that have been collected for these
individuals.
DERIVED MEASURES
The 68 individuals were interviewed using a semi-structured questionnaire with
probing, and the interviews were tape-recorded. The interviewees were asked to
give an account of their drinking history over the preceding 10 years. Only
three categories of types of drinking were operationally defined, and the one
with which we shall primarily be concerned here is that of “troubled drinking”--
drinking more than five pints of beer in any day during the month or
experiencing any dependence symptoms or  experiencing other  adverse
consequences. (For full details of the definitions, see Duckitt et al. 1985.)
Apart from the tape-recorded accounts mentioned above, the principal item of
information in this study which is coded on a year-by-year basis throughout the
followup period is that of the drinking histories; this is the information from
which the “life chart” data in table 2 was calculated. The remainder of the
information is in the form of variables which in some sense summarise the entire
10 years of life of each individual. For example, the analyses presented here
concern the total amount of time an individual spent in heavy drinking
throughout the followup period and is a simple total across the years for the
time-based drinking histories.
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In addition to summarizing this 10-year interval, the study paid particular
attention to behaviour during the 12 months immediately prior to followup. The
information collected for this l-year slice is not usually identical in form to the
type of information collected for the entire followup. For example, the l-year
data on drinking is recorded as the total (estimated) consumption of alcohol over
the past 12 months; this is in contrast to the followup data, which concern the
amount of time spent in troubled drinking.
The data were collected in five designated areas of interest within which key
questions were asked covering the entire follow-up, the l-year period, or both,
and for which summary scores were constructed:
(1) TOTAL 10-YEAR FOLLOWUP DRINKING & LAST YEAR
CONSUMPTION
(2) TREATMENT - 10-YEAR FOLLOWUP & LAST YEAR
- Inpatient, Hostels, G.P.
- AA attendance
(3) PHYSICAL HEALTH - 10-YEAR FOLLOWUP
- Cirrhosis, Peptic ulcer,
AlC. brain damage, Chronic illness
(4) MENTAL HEALTH - 10-YEAR FOLLOWUP & LAST YEAR
- Depression, Suicide, Drug problems
(5) SOCIAL ADJUSTMENT - LAST YEAR
- Employment, Stable home
- Legal encounters, Marriage
Ideally, each area would have been covered by a large number of questions in
order to elicit detailed information for the whole field, but practical constraints
determined that only a few key items could be elicited. The information under
each heading is only outlined in this list; to give it in more detail here would be
impossible and a discussion of the difficulties and advantages of constructing
such scores would require a separate paper. (For some further details, see
Duckitt et al. 1985.)
A further set of measures were taken at the followup point which consisted of a
group of standard scales, usually in the form of self-completion questionnaires:
(1) The Eysenck Personality Inventory (“EPI”. Eysenck and Eysenck 1964) is
well known.
(2) The Severity of Alcohol Dependence Questionnaire (SADQ) (Stockwell et al.
1979) is a well-known measure of alcohol dependence. In this particular instance
the subject was asked to recall the most severe period of drinking that he had
ever experienced and to answer the SADQ as for that time. Thus, we have the
worst ever dependence for the subject.
(3) The Purpose in Life inventory (PIL) (Crumbaugh 1968) measures attitudes
such as “I believe man is absolutely free to make all choices / completely bound
by limitations of environment,” and “In achieving life’s goals I have made no
progress whatever / progressed to complete fulfillment.”
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Two final scales, which are not particularly standard, are:
(4) The Troubles scale, which measures physically and socially troublesome
consequences of drinking, is inherited from the intake stage of the study, where
it was developed by Dr. J. Orford (Edwards et al. 1977). It covers basically the
areas of physical withdrawal (e.g., body shakes, blackouts) and social difficulties
such as debt and homelessness.
(5) The Attributions inventory is a 70-item questionnaire developed for this
particular followup to elicit from the alcoholic what influences and impacts have
had the most effect on his drinking problem, for better or for worse. This scale
will not be examined in this presentation, but is the subject of another paper
(Edwards et al., forthcoming).
At this point, it is worth noting that any sort of summary measures over a time
period are likely to weaken the measured relationship between the phenomena
concerned. Thus, a summary measure of depression and another of drinking will
probably not correlate as highly as they would if we had observed the year-by-
year variation in each, assuming that they do indeed relate on a parallel basis
year by year. This attenuation phenomenon would be observed in the case of all
except the most slowly varying measures.
AIMS OF THE ANALYSIS
This long-term study was designed basically as a descriptive study and, although
there were a few key issues around which it was organized, there are few
specific hypotheses. The analysis should aim at presenting the wealth of
information in a parsimonious manner. The original intent of the study, the
comparison of a treatment with an advice group, is not a factor in the present
analysis. The difference between these two groups in followups conducted after
1 and 2 years were minimal and now, 8 years further on there is little possibility
that the groups differ in any significant respect. Rather than making simple
comparisons of pre- and post-treatment states, looking for the often puny effects
of treatment, the aim is instead to chart the larger, natural effects of 10 years of
life. The current analysis, therefore, treats the data as though they were a simple
10-year follow-up of a single cohort of alcoholics.
Although referred to as a cohort, it is important to remember that these men
were taken into the study simply by virtue of being consecutive attendees at the
Maudsley clinic. Viewed as a long-term followup, therefore, what we have is a
10-year slice taken out of each of their lives in a random fashion. Furthermore,
we must dispense with any idea of a “final outcome point” for the study since, in
any important sense of the word, “outcome” was well under way when the
individual entered the study. It is the whole 10-year slice that we wish to
describe.
Ten years out of an individual’s life provide a vast amount of detail, reflecting a
complex interplay of forces. The first object, therefore, of our analysis of these
data is to marshal the information from a particular viewpoint or around a
specific framework so as to provide some order to the description. Even the
crude information presented in the life chart showing the group’s drinking
history provides a challenge to the researcher in terms of its simple description.
A cursory glance through that information shows that although there are some
cases (4%) who were abstinent throughout the followup period and some (20%)
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who remained in troubled drinking, over half the individuals displayed a
patchwork of drinking and abstinence in which no clear organizing principle is
easily discerned.
Part of the initial formulation of this study was the recognition of the obvious
fact that this sort of information cannot be contained in simply the coded
variables listed above. It is with this point in mind that we intend to analyse the
recorded accounts of our study members given at interview.
CHOICE OF ANALYSIS
Our overall aim, then, is to provide a framework upon which we may hang our
descriptions, particularly the descriptions of the drinking histories, partly with a
view to the future analysis of the free response material in the tape-recordings.
One approach we could have adopted, but did not, would have been to embrace
some particular theory of development or career and to see how far our
information allowed us to fit the individuals to this model. As an alternative, we
have tried to use the summary scores and scales to generate by means of
multivariate analysis some organising principle from the data themselves.
The most immediately appealing and the simplest way of doing this is to sort the
individuals in the study into groups or clusters with similar characteristics. These
characteristics would be those represented by the summary scores and scales,
which cover both the full followup period and also give further information on
the current l-year period. In looking for these clusters, we are not so much
seeking to form some typology of alcoholism, but rather to separate out distinct
life courses and pathways through these 10 years.
Such an approach uses no theoretical input, except implicitly in the selecting and
partitioning of the information to be used in the analysis. An alternative
method, which imposes a rather more abstract dimensional structure upon the
data. is principal component analysis. This method of characterising the changes
during the followup period is the subject of a further paper (Taylor et al.,
forthcoming), but it is the cluster analysis which is now to be described. Some
comparisons with the principal components analysis will be drawn later.
Cluster analysis is a notoriously unstable procedure, but there are techniques for
improving its performance. These include using stabilising “secondary”
transformations, selecting representative variables, and replicating analyses by
alternative cluster methods. All of these techniques have been employed in this
particular analysis.
DETAILS OF THE CLUSTER ANALYSIS
In order to maximize the chance of finding a clustering of the individuals, an
initial selection of key variables was made to construct a grouping. In this way,
“noise” or irrelevant differences between people on such a large number of
variables would be kept low. The choice was made from a priori considerations
of the eight most likely variables to show some clustering effect and of further
variables added to this set if they seemed to strengthen the separation between
groups in any way. Variables were deleted from the set if they failed to separate
the groups.
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The method used was an average linkage hierarchical analysis (Lance and
Williams 1966). made on the Euclidean distances between individuals after a
secondary transformation (Sibson 1972). A second analysis of the data was
carried out by Ward’s method of clustering (Ward 1963) to check for sensitivity
to the particular analysis. The two methods agreed very closely in distinguishing
five groups of individuals, although in one analysis the two closest groups
probably would not have been deemed two clearly separate clusters. This point
is taken up briefly below.
IDENTIFYING THE SEPARATE GROUPS
The following hierarchical diagram (figure 1) shows the cluster structuring.
Beginning at the top of the tree, a very small group of six individuals form the
most clearly distinct grouping. This and the next most prominent group are both
comprised of individuals with high dependence levels--one fares very badly and
the other somewhat better. The remaining three groups are less clearly defined
and form a spectrum running from those faring very badly to those generally
doing very well. It is these last three groupings on the right-hand side of the
diagram that were shown as the least separate groups in the clustering. It will be
seen that the analysis suggests that these three might be fruitfully regarded as a
single continuum, which has been arbitrarily divided at numerically convenient
points.
Hi-dep/B Hi-dep/G Lo-dep/B Lo-dep/M Lo-dep/G
(6) (11) (15) (12) (12)
FIGURE  1
Cluster Structure of the Multivariate Data
(as described in the text)
We can look at these five groupings in detail by looking at their profiles across
all the data that we have for the men. The following table 3 shows this
information and gives the mean score for each of the groups on the variables
used in the cluster analysis.
First, before looking at the drinking behaviour of the groups, it shows the SADQ
scale means, to justify our calling the first two groups “high dependence”--
bearing this labeling in mind will help make the table a little clearer. Note that
the cutoff point on the SADQ suggested by Stockwell et al. (op. cit.) for labeling
“severe” as opposed to “moderate” dependence was a score of 30. In figure 1 and
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table 3 the terms “Lo” versus “Hi” are intended only as a labeling and might more
properly be termed low-to-moderate versus severe. The first two groups’ means
are too close for us to be able to claim that one is any higher than the other, but
they both appear greater than the other three groups’ means. Within these right-
hand three groups, there is a gradient from moderately high to low dependence.
(It is not possible to test differences between these groups for statistical
significance, since they result from a cluster analysis of these data and are not
predetermined groupings.)
TABLE 3
Cluster Profiles on the Multivariate Data Set
SADQ 45 50 33 32 15
Alcohol 10yr 64 30 95 56 42
Alcohol 12m 75 7 133 53 48
Troubles 10yr 7.2 1.0 5.0 1.3 0.4
Social Adj. 12m 1.2 2.6 2.1 2.9 3.3
M.Health Adj. 12m 2.3 4.0 3.2 3.9 5.0
Purpose-in-Life 66 111 68 92 116
EPI - N 17 14 16 10 6
Arrests 10yr .83 .33 .45 .27 .08
Treatment 10yr 1.8 1.5 0.8 0.6 0.3
Treatment 12m .50 .08 .oo .oo .oo
AA 12m 1.3 3.1 0.1 .oo 0.0
AA 10yr 1.5 1.9 1.5 1.3 1.2
M.Health 10yr 1.7 1.7 1.8 2.0 2.5
Ph.Health 10yr
Prison 12m
Marriage Brk. 10yr
EPI - E
2.4 2.5 2.5 2.3 2.8
.33 .oo .oo .07 .oo
.50 .42 .45 .47 .33
12 13 11 11 12
H i / B  H i / G  L o / B  L o / M  L o / G
The second section of table 3 shows the amount of drinking over the whole
followup period and over the current year in particular. The gradient across the
low dependence groups is clearly visible in both periods. Note that for the two
high dependence groups the levels of drinking are contained within this range,
except that the “Good” high dependence group has been almost abstinent over the
current year, though not in the past. Note too that the labels “Good” and “Bad”
are used in a relative sense only within each half of the table, in that the “Bad”
high dependence group has mean levels of drinking which are roughly the same
as the “Moderate” low dependence group.
The third section of the table lists some of the other l-year information. The
Troubles scale, which covers predominantly physical withdrawal symptoms in the
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current year, as might be expected follows the same pattern as current drinking.
Note though that the means are much higher in the high dependence groups than
in the low dependence groups with the same level of drinking. In fact, the small
group of dependent people who have continued drinking show the most extreme
scores of all the groups. The remaining figures follow this same pattern, showing
that in current social adjustment and mental health these groupings are
consistent. The levels displayed in all these measures by even the better high
dependence group--that is, those who are currently nearly abstinent--do not
achieve the levels of the good low dependence individuals.
The fourth section of table 3 shows the continuation of the group profiles. The
first item in the top section shows that the general level of confrontation with
the law throughout the followup period has followed a pattern similar to the
social adjustment score. We can see that treatment experience has been more
intense in the high dependence groups, following the pattern of troubles and
drinking. Treatment in a shorter period of time--the last 12 months--however,
does not relate within the low dependence groups to this pattern; indeed it has
been generally nonexistent for the individuals in these three groups.
Involvement with Alcoholics Anonymous (AA) is interesting, in that we can see
it is predominantly confined to the two high dependence groups and it shows
that the current abstainers are currently heavily involved. In the past, all groups
have been involved with AA to some extent, again rather more amongst the
highly dependent people. General levels of mental health throughout the
followup show the same tendencies as the majority of other measures, but less
strongly.
The final section of the table lists the remaining variables, which did not appear
to relate to the clustering. It is worth recording that followup physical health in
general--as we have measured it--does not correlate at all with the other
variables. Our measure was limited to chronic or life-threatening disorders,
which were in fact rather rare.
The overall patterns here suggest a division between high and low dependence
individuals. The highly dependent people themselves are clearly divided into
those who are now more or less abstinent, and a handful who have continued
drinking. Within the low dependence groupings there is a gradient from bad to
good in almost all the measures we have used.
Whether these groups form distinctly separate processes through the 10 years of
observation or whether they merely divide a continuum of experience is not
central to our analysis here. These divisions, even if they only segregate one
extreme from another, serve to show the relationships between the variables; and
it is these relationships that form the multidimensional structure of the overall
phenomenon. A principal components analysis of these same data yields broadly
similar concepts: that is, the centrality of dependence, drinking, and treatment in
differentiating the overall patterns in the general indicators of well-being. It
would require a larger study to determine which of these two descriptive
methods is the more useful or the more accurate.
THE LIFE CHART DRINKING STATUS DATA
The drinking status data of the original “life chart” for the whole group (in table
2) can now be divided into five separate charts, one for each of these subgroups.
Table 4 shows the amount of time spent, year by year, in troubled drinking. The
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extent of light, social drinking is not shown--since so little took place, it has
been included for the present with the time spent in abstinence.
TABLE 4
Life Chart Drinking Status Data for Each Cluster
'72 '73 '74 '75 '76 '77 '78 '79 '80 '81
Hi/B 8.3 9.3 9.3 8.5 9.0 8.5 6.5 6.8 5.5 7.0
Hi/G 7.1 5.0 3.8 3.1 5.0 3.9 4.3 1.9 1.9 0.1
Lo/B 10.4 9.8 11.3 11.9 10.8 11.6 11.5 11.7 11.9 10.1
Lo/M 6.7 7.5 6.6 7.1 6.6 6.2 5.7 5.9 5.9 6.1
Lo/G 5.8 6.3 6.8 5.3 5.0 4.5 4.3 4.1 4.0 4.4
Looking first at the three lower dependence groups, we can see that the general
levels of drinking not only differ between them, but that these different levels
have been maintained throughout the followup period, at least for the two worst
groups. The third group, the one that fared best overall, is possibly an exception
showing a very slight drift out of drinking. The worst group of the three has
consistently drunk for almost all of the 12 months in every year.
In the two high dependence groupings, we see a stronger differential. The better
of the two groups shows a marked drift out of drinking. The very small group
of currently drinking, highly dependent people has maintained a steady level of
drinking throughout the followup, and at a level approximately the same as the
middle group of lower dependence drinkers. This last point may seem to reflect
the earlier finding that, for the same amount of drinking, highly dependent
individuals show more serious troubles. Here, however, it should be remembered
that it is the percentage of time spent drinking that is being discussed.
What of the pattern of relapse and recovery within these groups? By examining
separately each individual history it becomes apparent that the improvements in
the high dependence group are made by individuals moving one by one into
abstinence and remaining there, except for one or two scattered slips. The small
group of currently drinking highly dependent men, by contrast, displays the most
variable patterns in and out of drinking, whereas there is only one such
individual amongst the better of the two (high dependence) groups.
Among the groups at the lower end of the dependence spectrum, the worst is
comprised of men who have consistently drunk throughout the period. A few
such individuals find their way into both of the better groups, presumably
because these few do not score so badly on dependence or on the other measures
of health. Why this is so, and whether they will in time move into worse
conditions, are open questions. The best group commonly shows a pattern of
complete abstinence soon after the beginning of the study. The middle grouping
displays a range which includes some highly variable drinking patterns, but also a
81
few individuals from each extreme of the drinking spectrum. This is in keeping
with its being the midrange of a continuum of behaviours.
It is difficult to quantify this information, but a crude index of year-by-year
consistency of behaviour--the average difference between percent of time spent
in one category and percent of time spent in the other--supports these statements
(55%. 88%, and 91%, 77%, 87%. respectively, for the five clusters).
PREDICTIVE FACTORS
The clusters obtained from these followup data can be related to information
from the intake data, in particular to measures of the severity of the drinking
problem as it then was. It must be remembered that these “life-charts” are all
comprised of people who, from the first year onwards, vary greatly in the extent
to which their alcoholism has developed. If there is any consistent relationship
between stages of development and subsequent behaviour, then we would hope to
find a measurable relationship between the measures of severity of problem at
intake and the summary scores by which we have characterised the 10 succeeding
years.
The final table (5) shows how these groups appeared at intake into the study.
This information has not been used in any way in the analysis so far, but we can
see that there is a tendency for the same pattern that existed throughout followup
to have been present at intake. Only the first two items in this table--the daily
alcohol intake (in milliliters) and the Troubles scale (0 to 10)--achieve statistical
significance (p < .05), but with such small numbers of people this is scarcely
surprising. Nonetheless, these two items suggest that both the groups
subsequently classified as high dependence groups had a worse problem to begin
with. This is supported by a crude intake dependence measure--a rating of
“severe” as opposed to “moderate,” made from case notes by an independent
clinician involved in developing the SADQ--being greatest for these two groups.
Similarly, some gradient was already present across the three low dependence
groups. In fact, the Troubles score at intake correlates .44 (p < .01) with the
subsequent SADQ score, the highest correlation that was found between intake
and followup measures.
TABLE 5
Cluster Profiles on Selected Variables
Measured at Intake into the Study
Hi/B Hi /B Lo/B L o / M  L o / G
Daily Alc. 556 388 413 311 271
Troubles 6.8 6.1 5.5 4.1 3.1
Dependence .67 .67 .64 .36 .42
Previous Trtmt. .33 .50 .64 .40 .17
Yrs of Problem 5.8 4.9 6.1 3.9 2.2
Age at Intake 34 39 40 39 40
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In the lower half of the table, the variables relating to the history of the
alcoholism problem prior to intake are shown. These show rather weak
patterning, but do suggest that the worst lower dependence group (Lo/B) might
have had a long-standing problem. It is interesting to note that this group, who
drank for almost 12 months in every year of the followup, were even previously
a long-standing problem group. As to how they have maintained this status and
an average SADQ score of 33, suggesting some of them would rate only
moderately dependent, we can only speculate. There is, of course, no reason
why everyone who drinks heavily should move from moderate into very severe
dependence in terms of the syndrome measured by the SADQ (see, for example,
Edwards et al. 1986). These individuals, who in general fare badly, are possibly
distinguished by not experiencing the high dependence levels of the Hi/B group
nor their resulting treatment and intermittent abstinence.
CONCLUSIONS
The patterns of drinking and abstinence which have been recorded vary
enormously. There is a set of “hardline” drinkers, who have drunk in a heavy or
troubled fashion more or less continuously throughout the 10 years. There are
some who have moved into abstinence at various points over the years, and who
are still abstinent; and there are others whose pattern has been to move to and
from abstinence in irregular fashion. These two latter patterns, in particular, are
more prominent in the groups showing higher levels of dependence.
Little relative change seems to have occurred amongst the majority of people in
the study, in the sense that at intake the group profiles on drinking and
associated troubles were similar to those at followup. It is not possible to say
whether they have generally improved or worsened in an absolute sense, because
of the different measuring procedures used at intake and follow-up. However,
one scale which is consistent is the “Troubles” scale, and the mean ratings are
much the same now as they were then.
The overriding and most important impression from these figures is that
behaviour throughout the followup period is at least a two-dimensional
phenomenon. Clearly, dependence is a powerful concept in separating out these
individual life courses in respect to their abstinence, drinking relapses, and
treatment, as well as their other indicator scores. Where there has been a shift
into abstinence, it has  been the highly dependent  people  who have
disproportionately experienced it. Even so, for these abstaining, highly
dependent people, their general well-being in other areas of their life does not
match that of the best lower dependence group. It is clear that the categories
developed by the cluster analysis are not just characterised by drinking
behaviour. but also by the other measures used. Whether this categorisation will
be useful or not is a question that awaits an answer, and which we will attempt
to assess when we analyse the detailed tape recordings.
The group with the worst drinking record has not experienced (nor yet acquired)
the worst levels of dependence, even though they tended to have at intake a
long-standing problem. Rather, the worst dependence levels are associated with
some of the lowest levels of well-being as measured by our indicator scores,
possibly in conjunction with a pattern of treatment and relapse. The suggestion
in these figures that this group at intake was the youngest on average and had
the highest daily alcohol consumption comes from too small a sample to be
substantiated. It should be recalled, too, that individuals in this group appear
more erratic in their drinking record; and that both the highest dependence
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groups have undertaken treatment more than any of the others. On a speculative
basis, therefore, it might be argued that the processes underlying relapse and
recovery might profitably be regarded differently amongst the highly dependent
groups than amongst moderate dependence drinking groups.
Part of the aim of this analysis, as previously stated, is to provide a framework
for our subsequent analyses of the tape-recorded material. We hope in those
analyses to be able to relate the present distinctions to the larger, unanswered
questions given at the outset. Have the right dimensions been used by which to
measure career, and has the measurement methodology been adequate? Will this
discrete, grouped structure prove more or less valuable than a continuum
approach; and what, if anything, will characterise the development processes
within these groups?
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Relapse and Recovery
Among Opioid Addicts 12 Years
After Treatment
D. Dwayne Simpson and Kerry L. Marsh
Conceptual formulations involving drug abuse and the addiction process include a
variety of physiological, psychological, social, and environmental factors. Many
of the drug abuse “theories” presented by Lettieri et al. (1980) focus attention on
separate and sometimes unique etiological factors, but more conceptual
integration is necessary to deal with the complex stages of addiction careers--
including initiation, maintenance, relapses, and termination. Longitudinal studies
of addiction designed to address these conceptual domains are an important part
of this theoretical development and refinement process.
Empirical evidence of relapse and recovery among opioid addicts over a period
of approximately 12 years after admission to community-based treatment
programs is presented in this chapter. The data include multiple episodes of
daily opioid use and abstinence over time. Several analytic strategies have been
used to explore the complex relationships involved in “relapse” and “recovery,”
terms which generally carry a medical connotation of “sick” or “well.” A broader
interpretation of these terms, however, is necessary when addiction outcomes are
studied. That is, instead of focusing only on whether or not there was a return
to drug use during a followup period, it may be more informative to examine
fluctuations in drug use over time as well as other related outcomes, such as
criminal involvement and employment. Operationally, the term relapse in the
analyses of opioid addicts presented here refers to the reoccurrence of daily
opioid use after a temporary period of abstinence from daily use. Reduction of
drug use, criminal involvement, and unemployment are considered to be general
indicators of recovery. These measures are also examined in relation to several
domains of theoretical influence as discussed in previous chapters.
The data used in this chapter--the Drug Abuse Reporting Program (DARP)--
were initiated in 1969 for the purpose of describing and assessing clients and
services in community-based drug abuse treatment programs. During 1969 to
1973, intake records were obtained on almost 44,000 admissions to 52 federally
funded agencies from across the United States. Since that time, data collection
and research have been conducted to evaluate during-treatment performance
(Sells 1974; Sells and Simpson 1976), posttreatment outcomes in the first few
years following DARP treatments (Sells and Simpson 1980; Simpson and Sells
1982), and long-term outcomes based on If-year followup studies of opioid
addicts (Simpson et al. 1986a, 1986b). This study focuses on relapse and
recovery of addicts over time. After describing the sample, the first section
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summarizes outcomes at different points in time from the DARP preadmission
baseline period to the 12-year followup interview. Since many addicts
experienced repeated cycles of abstinence and addiction over time, the second
and third sections describe relapse and recovery episodes during Years 1-6 and
during Years 7-12, respectively. Finally, the fourth section examines social
adjustment indicators associated with relapse.
DESCRIPTION OF THE SAMPLE
6-Year Followup. The first two cohorts of admissions to drug abuse treatment
programs in the DARP (June 1969 through May 1972) totaled 27,214. Using this
population, the initial wave of the 6-year DARP followup studies (Simpson and
Joe 1977) included a stratified random sample of 4,107 opioid and nonopioid
drug users from 25 different treatment agencies in the United States. Of this
sample, 87% of the cases were located, and successful interviews were completed
with 3,131 respondents (i.e., 76%). The stratification factors for the sampling
procedure included DARP treatment classification, time in treatment, race-ethnic
group, sex, age, and treatment agency. Treatments included methadone
maintenance (MM) programs, therapeutic communities (TC), outpatient drug-free
treatments (DF), and outpatient detoxification (DT); an intake only (IO) group
was also selected, comprised of persons who completed intake and admission
procedures but who did not return for treatment in DARP. (The IO group in
this study was viewed as an important comparison group but not as a control
group since the DARP treatment groups were not formed through random
assignment.)
12-Year Followup. From the completed 6-year followup interviews described
above, a sample of 697 cases was subsequently selected for the 12-year followup
study. All were daily opioid users at the time of admission, and the sample
included black and white males from all five treatment groups, as well as black
and white females from methadone maintenance treatment programs. The sample
was drawn from 18 different DARP treatment agencies, as explained by Simpson
(1984a). The fieldwork, including locating and interviewing the sample, was
carried out under contract during 1982 and 1983 by the National Opinion
Research Center (NORC). Altogether, 80% of the cases were located: 490 (70%)
were interviewed after granting informed consent, 52 (8%) were deceased, and 13
(2%) refused to be interviewed. The remaining 142 (20%) were not located
before time and resources for the fieldwork ran out. Analysis of treatment
admission and 6-year followup data revealed no evidence of sampling bias
associated with the nonlocated cases in the 12-year followup study (Simpson
1984a).
The followup interviews were conducted face-to-face by trained interviewers
using strict procedures to protect the confidentiality of information. Average
duration of the interviews was approximately 2 hours, for which the respondent
was paid $15. The interview assessed behavioral changes and outcomes over
time, as well as psychological and social factors involved throughout the
addiction career. Major criterion behaviors included illicit drug use, drug abuse
treatment, alcohol use, employment, and criminality. Checks for internal
consistency and comparisons of self-reported information with results of
urinalyses and with criminal justice records of post-DARP incarcerations
indicated a high level of reliability and validity of the data (Simpson 1984b).
The sample of 490 former opioid addicts was comprised of 18% females and 82%
males (a difference due to sampling constraints in the treatment population),
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included 51% blacks and 49% whites, and had a median age of 34 at the time of
the 12-year followup interview (with 19% over 40 years of age). However, the
findings presented in this chapter are based only on males (N = 405) since the
female sample was relatively small and several outcome measures presented below
are differentially associated with gender. For instance, a study by Marsh and
Simpson (1985) which focused on the female sample found that sex-related
differences exist on several behavioral measures (such as employment and
criminality) as well as psychological factors (such as motivations for treatment).
Sociodemographic and DARP treatment characteristics of the male sample are
described in table 1.
OUTCOMES OVER TIME
Behavioral outcomes over time, from the pre-DARP baseline throughout the 12-
year followup period. are summarized in table 2. The 6-year followup study
obtained information on a retrospective month-by-month basis for Years 1-6--
from termination of DARP treatment until the Year 6 followup interview. Thus,
it served as the basis for outcome tabulations in Years 1 to 3 immediately after
termination of DARP treatment and Year 6 subsequent to admission. The 12-
year followup study served as the basis for outcome tabulations in Year 12 after
admission. Tabulations for drug use and employment measures in each time
period were based only on “time at risk” (i.e., while persons were not confined in
jail or residential treatment facilities).
Individual measures of drug use are grouped into three different categories in
table 2, which include opioids (heroin, illegal methadone, and other opiates),
mari juana,  and other  nonopioids  (cocaine,  amphetamines/s t imulants ,
barbiturates/sedatives, and hallucinogens). Other individual measures include
time spent in jail or prison and 6 months or more each year of employment (i.e.,
at least 50% of the months at risk each year). Simpson et al. (1986a) examined
these data in detail and noted that the 12% increase in nonopioid use from Year
6 to Year 12 primarily represented cocaine use.
In order to examine different outcome measures simultaneously, the sample was
classified into six mutually exclusive categories, which are shown in table 2 and
illustrated in figure 1. These categories emphasize drug use and incarcerations
during each year. The first category includes persons who were institutionalized
for the entire year (usually in jail or prison, except for residential treatment in a
few cases). The second and third categories include daily opioid users (in 1 or
more months) in combination with and without jail. The fourth category
represents those who were in jail or prison (for 1 or more months) but who were
not daily opioid users. (This category was divided almost equally between
persons with no drug use and those who continued to use opioids less than daily
or who used other nonopioid drugs.) Finally, the last two categories had no jail
and low drug involvement; category five included less-than-daily opioid users
(defined as the use of opioid and/or nonopioid drugs in 1 or more months, but
no daily opioid use), and category six included those with no drug use (defined
as no use of any drugs during the year, with the exception of less-than-weekly
marijuana use).
These data indicate that, following substantial declines in daily opioid use and
incarcerations in the early years of the followup period, category size tended to
stabilize over time. It should be noted, however, that the pre-DARP measure for
jail and prison represented a lifetime rate since I-year preadmission baseline data
were not available. During Year 6 and Year 12, about one-fourth of the sample
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TABLE 1
Description of the Sample
at Admission to DARP Treatment (N = 405)
Male
Black
White
Under 21 years old
21-25 years old
26-30 years old
Over 30 years old
Ever arrested
Ever jailed
Employed any time last year
DARP Treatment Assignment:
Methadone maintenance
Therapeutic community
Outpatient drug-free
Outpatient detoxification
Intake only
100%
53%
47%
25%
39%
20%
16%
87%
71%
67%
22%
24%
18%
21%
15%
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TABLE 2
Outcomes Over Time for Male Addicts (N = 405)
Pre- Years During Followup
DARP 1 2 3 6 12
INDIVIDUAL MEASURES
% Daily Opioid Use
% Any Opioid Use
% Marijuana Use
% Any Nonopioid Use
% Any Jail/Prison
% Employed 6 Mos.
or More
100
100
51
55
71
36
OUTCOME CATEGORIES
(Mutually Exclusive)
% Institutionalized 3
% Daily Op + Jail 68
% Daily Op + No Jail 29
% Jail (No Daily Op) 0
% No Jail + <Daily Op 0
% No Jail + No Drug Use 0
FAVORABLE RECOVERY PROFILES
% No Drugs
+ No Jail
+ 100% Employment 0
% No Daily Drugs
+ No Jail
+ Any Employment 0
47 34 28 25 24
63 51 45 42 39
55 56 51 57 61
39 35 34 35 47
33 33 30 30 29
49 57 61 64 54
3 8 8 7 9
19 15 11 12 11
26 16 15 11 13
12 10 11 11 10
21 28 27 33 25
19 23 28 26 32
8 12 14 12 11
25 32 37 39 30
Note. For pre-DARP measures, drug use was based on the last 2 months
before admission to DARP, employment was based on the last 12 months, and
incarceration in jail or prison was a lifetime measure. Sample sizes were
adjusted in each time period so that tabulations were based only on persons who
were “at risk” (e.g., persons in jail during an entire year were omitted from drug
use and employment tabulations for that period).
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FIGURE 1
OUTCOMES OVER TIME
continued daily opioid use, and almost half of these daily users also spent time in
jail. About one-fifth of the sample continued to be incarcerated for all or part
of each year in the followup period, even though they were not using opioids
daily. Thus, 57% of the sample appeared to be making reasonable adjustments
by Year 12 since they were not jailed and did not use opioid drugs daily.
Indeed, over half of the former addicts in these two categories in Year 12
reported no drug use at all (except less-than-weekly marijuana in some cases).
Judgments about favorable recovery from addiction are value-laden and must be
made in the context of expectations and standards formed by numerous factors.
Selection of appropriate criteria, performance levels for specified criteria, and
various environmental constraints and influences are but a few of the factors that
may be involved. Needless to say, judgment standards may vary, and outcomes
considered favorable by one evaluator are not necessarily acceptable to another.
To illustrate, two examples of “favorable recovery profiles” are presented at the
bottom of table 2. The first profile extends the logic of outcome category six
(i.e., No Jail + No Drug Use) described above by adding 100% employment as a
criterion (i.e., being employed during every month). Only 8% to 14% of the
sample met these highly restrictive and demanding recovery standards in any one
year of the followup period, a reduction to only one-third to one-half of the
previously defined No Jail + No Drug category. In view of the limited
employment opportunities frequently available as well as the problems inherent in
reducing daily opioid habits to absolute abstinence, less restrictive standards
could be considered acceptable and more realistic. For example, this might
include “No Daily Drugs + No Jail + Any Employment,” as shown at the bottom
of table 2. Using this standard, 25% to 39% of the sample would qualify as
recoveries in each year of the followup.
RELAPSES TO DAILY OPIOID USE BY YEAR 6
The 6-year followup interview included month-by-month behavioral outcomes
beginning at the point of DARP treatment termination. Due to the variability in
treatment length, however, the sample varied in the number of months of data in
the 6-year followup interval: 97% of the sample had 24 months or more, 84%
had 36 months or more, and 64% had 48 months or more. Therefore, these data
were well suited to the study of relapse using survival analysis methods, as
reported by Joe et al. (1985a).
Relapse data from the 6-year followup study are summarized in table 3. Of the
total sample of 405 male addicts, 44% quit daily opioid use during DARP
treatment and reported no relapses by the Year-6 interview. Another 35%
resumed (or in some cases just continued) daily opioid use in the first month
immediately after termination from treatment; a few (1%) continued without
interruption throughout the 6-year followup period, 19% quit sometime later and
had no more relapses through Year 6, and the remaining 15% quit and relapsed
one or more times. Finally, 21% were abstinent for 1 or more months following
treatment, but later relapsed at least once. In summary, over one-third (36%) of
the sample had one or more relapses during the 6-year followup interval, when
“relapse” is defined as a return to daily opioid use after 1 or more months of
abstinence.
How is length of abstinence from daily opioid use related to subsequent relapse?
In order to examine abstinence rates over time, the first period of abstinence
from daily opioid use for 1 month or longer was selected for each person. The
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TABLE 3
Summary of Data for Relapse to Daily
Opioid Use by Year 6 Followup (N = 405)
I. Quit & No Relapse by Year 6 180
II. Immediate Daily Use After DARP 140
a. Continuous Use Thru Year 6 5 1%
b. Later Quit--No Relapse 77 19%
c. Later Quit--l Relapse 31 8%
d. Later Quit--2-3 Relapses 23 6%
e. Later Quit--Over 3 Relapses 4 1%
III. Delayed Relapse After DARP 85
a. 1 Relapse 53
b. 2-3 Relapses 27
c. Over 3 Relapses 5
Number
of Persons
Percentage
of Total
44%
35%
21%
13%
7%
1%
TABLE 4
Abstinence Rates During the First 42 Months’
After Initial Abstinence from Daily Opioids in Years 1-6
Minimum
Period of
Abstinence
3 Months
% Still Abstinent in Month Sample
6 9 12 15 18 21 24 27 30 36 42 Size
25292 86’ 80 74 71 68 67 66 63 61 59
6 Months 93 87* 80 77 74 72 71 68 66 63 233
12 Months 92 89* 85 83 82 79 76 73 202
24 Months 99 95* 91 88 168
1Only those persons who had at least 42 months of data, beginning with first
month of the designated period of abstinence, were included in these analyses.
*Identifies abstinence rates 6 months after the period of minimum abstinence.
_(Underline) Identifies abstinence rates 12 months after the period of minimum
abstinence.
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total length of this first abstinence period for each person was determined, and
abstinence rates over the following 42 months were calculated as shown in table
4. These data can be used to estimate the probability of maintaining abstinence
over time, given the initial duration of abstinence. For instance, table 4 shows
that 86% of those with a minimum abstinence period of 3 months were still
abstinent in Month 9 (i.e., 6 months later), while 95% of those with at least 24
months of abstinence were still abstinent 6 months later (in Month 30). For
abstinence at 12 months later, the rates for these two groups were 74% and 91%,
respectively. In other words, 74% of the former addicts able to maintain
abstinence from daily opioid use for at least 3 months were still abstinent a year
later, compared to 91% of those able to maintain abstinence for at least 24
months.
Although the DARP database is not comprehensive with regard to various
month-by-month events which immediately preceded and possibly influenced
relapse to daily use by Year 6, records were available on other drug use. These
data showed that about one-third (i.e., 31%) of the 143 persons in the sample
who relapsed by Year 6 used opioids less-than-daily within the last 3 months
immediately before relapse (and 27% used within the last month). The other
two-thirds therefore relapsed to daily use more abruptly and without extended
transitional use in the preceding months.
RELAPSES TO DAILY OPIOID USE BY YEAR 12
At the time of the 12-year followup, addiction careers in this sample ranged
from 1 to 35 years, with a median length of 9.5 years. Almost one-fourth of the
sample reported I or more months of daily opioid use in Year 12, down from
47% in the first year after DARP treatment.
Table 5 indicates that individuals who used opioids daily were not always the
same from one year to the next. Daily opioid use declined from 47% to 24%
between Years 1 and 12 (as indicated in column I), but the cumulative tally in
column II shows that 75% of the sample used opioid drugs daily sometime during
this followup. Finally, column III reveals that 15% had at least one relapse after
quitting during Year I, increasing to 65% those who relapsed one or more times
by Year 12. Thus, 35% of the sample never relapsed again after they eventually
quit.
Aside from describing daily opioid use trends through Year 12, the tabulations in
table 5 present several alternative drug use outcome measures using the same
database. Percentages of daily users for successive time intervals--shown in
column I--appear much more favorable than the cumulative tabulations in
columns II and III, but all are technically appropriate methods for describing
outcomes. Although not reported in table 5, another different and equally
appropriate procedure for describing daily opioid use outcomes is the length of
time since last addicted before the 12-year interview. For example, 76% of this
sample had not used opioids daily in the last year before followup, 68% in the
last 2 years, 63% in the last 3 years, 48% in the last 6 years, 35% in the last 8
years, and 29% in the last 10 years. Finally, 25% reported no daily opioid use at
all following DARP treatment.
Because of methodological and conceptual differences in the data-collection
procedures used for the 6-year and 12-year followup studies, the same relapse
analyses could not be extended directly to the 12-year data. In particular, the
12-year study did not obtain records on month-by-month drug use and other
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TABLE 5
Comparisons of Measures for Daily
Opioid Use Over Time
I II III
Current Cumulative Cumulative
% of Daily % of Daily % Who Quit
Users Users and Relapsed
Year 1 Post-DARP 47 47 15
Year 2 Post-DARF 34 50 25
Year 3 Post-DARP 28 53 31
Year 6 Followup 25 56 35
Year 12 Followup 24 75 65
Note. Figures for Year 12 (representing the years between 6 and 12) were
calculated from the 12-year followup interview using data-collection methods
different from those in the 6-year followup interview, and this may have
affected the comparative precision of the Year 6 and Year 12 cumulative data in
columns II and III. Also, it is noted that Years I, 2, and 3 Post-DARP refer to
the time immediately following DARP treatment; the followup interviews were
conducted an average of about 6 and 12 years, respectively, after DARP
treatment began, and the data for Year 6 and Year 12 are based on the 12
months immediately before each interview.
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behavioral outcomes; instead, the 12-year data focused more on interpretations
and perceptions of respondents regarding their addiction histories, the events and
reasons associated with various career phases, and their long-term outcomes on
the behavioral criteria studied in earlier DARP research. It was possible,
however, to link the 6-year and 12-year data in other ways to study relapse and
recovery. Of special interest was the comparison of periods of abstinence from
daily opioid use in Years l-6 (recorded in the 6-year followup) with outcomes in
Years 7-12 (obtained from the 12-year data). Based on the results presented
above from the 6-year data, it was expected that longer abstinence during Years
1-6 would be associated with better outcomes in Years 7-12.
To examine these relationships, the sample was first classified according to the
longest period of continuous abstinence from daily opioid use during the 6-year
followup interval. Five abstinence groups were defined--including 0-12 months
(11% of the sample), 13-24 months (18%), 25-36 months (23%), 37-48 months
(28%), and over 48 months (20%)--and then used to examine outcomes in Years
7-12.
Table 6 presents results for daily opioid use in Years 7-12, Years 10-12, and
Year 12; Year 12 data also includes Any Opioid Use, Any Jail or Arrests, and
50% Employed (i.e., employment during one-half or more of months at risk).
Daily opioid use information was obtained in the 12-year interview by asking
how long it had been since the respondent last used opioids daily, and this was
the source of data for the Years 7- 12 and Years 10- 12 analyses. More thorough
behavioral outcomes were obtained for the last year before interview, and these
data served as the basis for the Year 12 analyses.
Consistent with earlier findings, table 6 indicates that length of abstinence in
Years 1-6 was significantly related to outcomes in Years 7- 12. That is, persons
with longer abstinence had better long-range outcomes; 72% of the 0-12 month
abstainers in Years 1-6 returned to daily opioid use during Years 7-12, compared
to 33% of those who had over 48 months of abstinence. For the last 3 years of
the followup period (Years 10-12). these rates were 61% and 25%. respectively;
and for the last year (Year 12), they were 35% and 12%. These results for Year
12 also generalized to other behavioral measures, as observed at the bottom of
table 6. In particular, longer periods of abstinence were associated with better
outcomes on the criteria for Any Opioids, Any Jail or Arrests, and 50%
Employment.
FACTORS ASSOCIATED WITH RELAPSE AND RECOVERY
Several “reasons” were found to be almost universally reported as causes for
relapses--including the state of relaxation caused by opioids (91%). the rush
(85%), the need to avoid or eliminate withdrawal symptoms and drug craving
(81%), and the use of opioids to help forget troubles (80%). Similarly, the most
common reasons for quitting daily opioid use, as reported by those who were
abstinent a year or longer before the 12-year followup, included “being tired of
the hustle” (83%) and “needing to change after hitting bottom” (82%). Because
they were so common, these reasons are not very discriminating; in addition, they
appear to represent more of a background or contextual setting than explicit
causes which precipitate and sustain behavioral change.
Simpson et al. (1986a, 1986b) have described in detail the reasons given for
addiction stages, and Joe et al. (1984) have examined relationships among the
reasons associated with different stages. Using canonical correlation analysis,
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TABLE 6
Outcomes in Years 7-12, by Longest
Abstinence from Daily Opioids in Years 1-6
Longest
Abstinence
in Years 1-6
% of Grouo Revortinn
Daily Any Any Jail 50% Sample
Ovioids Opioids or Arrests
Years 7-12 (Last 6 Years)
Employed Sizes
0-12 mos. 72 - - - - - - 46
13-24 mos. 58 - - - - - - 73
25-36 mos. 43 - - - - - - 94
37-48 mos. 38 - - - - - - 111
Over 48 mos. 33 - - - - - - 81
X2(df=4) 24.8*** - - - - - -
Years 10-12 (Last 3 Years)
0-12 mos. 61 - - - - - - 46
13-24 mos. 42 - - - - - - 73
25-36 mos. 38 - - - - - - 94
37-48 mos. 32 - - - - - - 111
Over 48 mos. 25 - - - - - - 81
X2(df=4) 18.9*** - - - - - -
Years 12 (Last Year)
0-12 mos. 35 55 57 37 46
13-24 mos. 30 43 58 41 73
25-36 mos. 27 44 40 51 94
37-48 mos. 21 30 41 63 111
Over 48 mos. 12 30 38 63 81
X2(df=4) 11.6* 11.2* 10.27* 15.1**
Note. Outcome data other than daily opioid use are not available for Years
7-12 and 10-12.
*p<.05
**p<.01
***p<.001
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they found that reasons for changes across stages were related; for example, there
was a tendency for interpersonal relations at different stages to be more
consistently involved in influencing addiction processes for some individuals than
others. Further analyses of these and related factors associated with length of
addiction (Joe et al. 1985b) extended these results by finding evidence for
complex and multiple paths of addiction. For instance, one “lifestyle” associated
with length of time addicted was represented by a subgroup of employed addicts
who supported themselves during longer-than-average addiction careers (possibly
because they experienced fewer street risks than nonworking addicts). They also
found that longer addictions were reported by persons with lower educational and
socioeconomic background, higher social and criminal deviance throughout
careers, higher susceptibility to environmental and drug availability factors, and
higher responsiveness to family influences.
The most recent development in the study of these longitudinal predictors has
been to focus on relapse using event history analysis for modeling survival curves
(Joe et al. 1985a). The results have been consistent with other DARP research,
as well as with earlier literature reviewed by Platt and Labate (1976), in showing
that addicts with the lowest risk of relapse to daily opioid use typically included
those who were married, older, better educated, better employed, less (criminally)
deviant, and better adjusted psychologically than the others. In other words,
social adjustment emerges as a major predictive construct involved in relapse and
recovery. To explore this concept further, therefore, the sample was classified
with regard to social adjustment indicators based on (1) pre-DARP admission
data and (2) post-DARP followup data from Years 1-6. These groups were then
used to compare relapse and related criteria from the 12-year followup.
First, the sample was classified using intake information collected at the time of
DARP treatment admission; that is, the number of “positive” social adjustment
characteristics (i.e., married, over 27, over 12 years of education, no previous
incarcerations, and 6 months or more employment in the previous year) were
counted for each person, and the sample was divided into “high” and “low”
groups. Next, the sample was classified again (independently of the previous
classification) using post-DARP information from Years 1, 2, 3, and 6 of the 6-
year followup; for each separate year, the number of “positive” characteristics
(i.e., no jail, 6 months or more employment, and no more than 1 residential
move) were counted and then summed over the four l-year periods. Based on
these summed scores, the sample was divided into “high” and “low” groups. These
pre-DARP and post-DARP classifications were then used to form four groups
defined by social adjustment levels at DARP admission and during the 6-year
followup. These groups were labeled High-High (n = 117), High-Low (n = 110),
Low-High (n = 95), and Low-Low (n = 83).
Comparisons of 12-year outcomes for these four groups are summarized in table
7. In brief, the low-level social adjustment groups--especially those with low
adjustment during the 6-year followup period--had the poorest outcomes. Over
the entire period of Years l-12, relapse to daily opioid use was reported by 51%
to 81% of these groups, and it was highest for the two groups with low social
adjustment during the 6-year followup (i.e., Hi-Lo and Lo-Lo). Daily opioid
use during Years 7-12 was 41% for the Hi-Hi group, 38% for the Lo-Hi group,
48% for the Hi-Lo group, and 57% for the Lo-Lo group. Likewise, the same
basic pattern was observed for Years 10-12 (the last 3 years before the
interview), and they generalized to criminality and employment measures in Year
12. All were statistically significant except for daily opioid use in Year 12.
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TABLE 7
12-Year Outcomes by Social
Adjustment indicators Over Time
Outcomes
Years 1- 12:
% Ever relapsed
to daily opioids
Social Adjustment Levels, Classified at
DARP Intake and for 6-Year Followup X2
H i - H i  L o - H i  H i - L o  L o - L o (df=3)
% % % %
58 51 75 81 24.7*
Years 7- 12:
% Used opioids daily
Years 10-12:
% Used opioids daily
41 38 48 57 7.6*
35 27 39 48 8.6*
Year 12:
% Used opioid daily
% Employment 50%
or more
23 19 25 29 30.2**
62 64 41 44 15.4**
*p=.05
**p<.01
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Inspection of these data indicates that outcomes for the two groups with high
social adjustment levels during the 6-year followup (Hi-Hi and Lo-Hi) were
comparable, and they were more favorable than those for the two groups with
low levels of social adjustment in the 6-year followup (Lo-Lo and Hi-Lo).
Thus, indicators of social adjustment at treatment admission were less important
than those for the 6-year followup when predicting Years 7-12 outcomes. The
previous findings by Joe et al. (1985a) showing that admission data served as
significant predictors were based on survival curves, beginning immediately after
treatment (i.e., Year 1). Changes occurred in social adjustment levels over time
for some individuals, however, and the present data show that the most recent, or
proximate, indicators of adjustment appear to be the most pertinent for
predicting outcomes.
CONCLUSIONS
Compared to similar research based on smoking and alcohol, the study of users of
opioid and other illicit drugs in our society is complicated by several barriers to
observing and measuring these illegal behaviors. Changes over time in the legal
status and the availability (as well as quality) of drugs represent highly complex
influences on individual decisions about using drugs, That is, random
fluctuations in the quality and availability of drug supplies have moderating
effects on various social, psychological, and physiological factors involved in
illicit drug use by individuals. Environmental constraints, such as confinements
in jail or residential treatments, must also be recognized in identifying “time at
risk” for analyzing and interpreting drug use outcomes at any given time, and
especially before other factors are analyzed as influences in the relapse or
recovery process.
The longitudinal research findings presented here are helpful in establishing
“baseline” expectations for the long-term outcomes of opioid addicts. Among
male addicts admitted to the DARP in 1969-73, 53% had no daily opioid use in
the first year after treatment, and this rate increased to 66% in the second year
and to 72% in the third year. During the sixth year after admission to treatment,
75% of the sample reported no daily opioid use. This percentage remained
virtually unchanged 6 years later (at Year 12).
Significantly, 19% of the sample who used opioid drugs daily at some time
during Years 7-12 after admission to treatment did not use them daily in the
previous Years 1-6. This illustrates the long-term threat of relapse over time.
One-fourth (25%) of the sample never used opioids daily during the 12-year
followup period, but 65% quit for a month or longer and then relapsed to daily
use one or more times. By the end of Year 12, however, 63% of the sample had
not used opioid drugs daily for a period of at least 3 years.
These data show that relapse to daily opioid use is prevalent among addicts.
However, relapse is neither a random nor a certain occurrence. Multiple episodes
of the abstinence-relapse cycle occurred for many addicts, but resistance to
relapse increased as the period of abstinence became longer; and these behavioral
improvements also generalized to lower rates of arrests and incarcerations, as well
as more employment. Unfortunately, there was no apparent threshold for length
of abstinence which insured permanent recovery. Instead, there  was a
probabilistic decrease in the subsequent occurrence of relapse as abstinence
became longer.
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Indicators of social adjustment or adaptation during Years l-6 (i.e., higher
employment, less legal involvement, and fewer residential moves) likewise
predicted abstinence from daily opioid use in Years 7-12. Although similar
social adjustment criteria measured at treatment admission--including marital
status, age, educational achievement, and employment history--predict relapse
rates beginning in the first year following treatment (Joe et al. 1985a), these
particular measures are generally unrelated to long-term outcomes recorded years
later. As Lehman and Simpson (1984) and Lehman et al. (1985) have reported,
the statistical significance of most predictor variables diminishes as outcome
measures become more temporally distant.
The DARP followup studies give support to several major theoretical domains--
sociological, psychological, physiological, and environmental--as being influential
factors in the stages of opioid addiction, relapse, and recovery. For example,
major reasons cited for starting opioid use include the psychological euphoria and
sensation, easy availability, and social pressures. Psychological escapism and
euphoria were major reasons for sustaining opioid use over time, while the
relative significance of social influences during this stage diminished. “Drug
craving” emerged later as a factor in the maintenance and relapse of drug use.
Reasons for quitting addiction primarily involved personal psychological crises,
along with family and social pressures, and such environmental factors as legal
threats and drug availability (Joe et al. 1984). In addition, the role of drug abuse
treatment over time was regarded by most addicts as significant in the process of
recovery (Joe et al. 1982-83; Marsh et al. 1985; Simpson 1984c).
For treatment programs, these results emphasize the importance of aiming to
change short-term behaviors and identifying appropriate support mechanisms and
social networks to maintain improvements over time. Fortunately, from a
therapeutic point of view, client characteristics and background at intake do not
predetermine long-range outcomes. Criminal involvement and other indicators of
social adjustment are predictive of short-term outcomes, but long-term
therapeutic change is not limited by these or other factors studied in the DARP.
However, some long-term addiction careers are related to stabilized lifestyle
patterns involving family relations, criminality, or employment (Joe et al. 1985a)
which appear to enable and help sustain addiction. On the other hand, virtually
all  recovering addicts  in this  sample reported experiencing a personal
psychological crisis as part of the motivation and decision-making process to
quit.
Successful intervention may therefore begin with a crisis which has significant
personal implications for an addict, and the most appropriate role for treatment
or other intervention agents is to understand and use the crisis to guide and
affirm positive change. There also appears to be a tendency for one’s motives in
starting and stopping addiction to be similar over time. For instance, social
pressures and friends are particularly influential for some addicts. This finding
may have therapeutic utility in identifying the most effective approaches for
intervention by determining motivational forces in starting and maintaining daily
use. However, more work is needed which focuses on the systematic assessment
of these motivational factors and the “readiness to change” by addicts.
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The Process of Smoking Relapse
Thomas H. Brandon, Stephen T. Tiffany, and Timothy B.
Baker
Smoking cessation treatments now regularly produce cigarette abstinence in 90 to
100 percent of clients (e.g., Erickson et al. 1983; Hall et al. 1984; Tiffany et al.
1985). Despite nearly universal cessation, the most successful smoking
interventions tend to produce year-long abstinence in only about half of all
treated subjects (Hall et al. 1984; Lando 1977; Tiffany 1985). Such statistics
underscore the frequent urgings that smoking researchers shift their focus from
cessation treatments to treatments aimed at extending, rather than producing,
abstinence (e.g., Marlatt 1982). An initial step in the effort to extend abstinence
(prevent relapse) is the analysis and characterization of relapse as a naturally
occurring process. Such information could be beneficial to efforts to design
effective abstinence extension treatments. For instance, information on common
relapse situations might allow therapists to target their maintenance procedures at
a circumscribed set of situations. In addition, subjects may spontaneously use
strategies to deal with relapse and relapse crises (where the smoker is tempted to
smoke but does not necessarily do so) that may suggest treatments of general
benefit.
While  relat ively few studies  have been conducted that  are targeted at
characterizing the smoking relapse process, the few studies extant yield general
patterns of findings that are reassuringly consistent. Available data suggest that a
great deal of variance in relapse incidence can be associated with a limited set of
affective, behavioral, and contextual variables. For instance, smoking relapse
and relapse crises tend to occur when individuals are: experiencing a negative
affect such as anxiety. depression, anger (e.g., Cummings et al. 1980; Shiffman
1982) in the presence of other smokers smoking (Shiffman 1982); experiencing
interpersonal stress (Marlatt and Gordon 1980; Shiffman 1982); or consuming
food or beverage--especially alcohol (e.g., Shiffman 1982).
In addition to data on smoking relapse, there now exists a well-articulated theory
of the relapse process (Marlatt and George 1984; Marlatt and Gordon 1984).
Marlatt’s theory constitutes an interesting and important departure from other
approaches to the analysis of relapse. Instead of focusing on pre-existing
personal characteristics that predict relapse (e.g., level of physical dependence,
personality factors), Marlatt has focused on events surrounding initial uses of a
drug during the postcessation period. According to Marlatt’s theory, a person’s
cognitive/affective reaction to initial postcessation drug use is a potent
determinant of subsequent drug use.
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One possible response to postcessation drug use is what Marlatt has labeled the
“abstinence violation effect” (AVE), a cognitive/affective reaction comprising two
principal components: an attribution made with respect to the causes of drug use
(the “lapse”) and an affective reaction to the lapse. The attribution process is that
the individual attributes the cause of the lapse to internal, stable and global self-
features that are assumed, by the individual, to be uncontrollable, e.g., “lack of
willpower,” or addictive personality (Abramson et al. 1978; Weiner 1974). This
attributional process elicits an affective reaction characterized by conflict and
guilt. In theory, the stronger the AVE (the closer attributions are to the
prototype and the greater the negative affective reaction), the more likely a
“lapse” is to lead to relapse (regular drug use). The magnitude of the AVE is
posited to be a positive function of: the individual’s commitment to remaining
abstinent, the amount of effort previously expended to remain abstinent, and the
duration of the abstinence period.
Marlatt recognizes that relapse is affected by factors other than the AVE. For
example, he states that coping response execution will reduce the risk of relapse
(Shiffman 1982). In Marlatt’s model, coping likelihood appears to be a function
of both a subject’s confidence in his ability to cope with the relapse crisis
(Shiffman 1982) and the magnitude of any AVE effect. In addition, he believes
that relapse likelihood is also influenced by an individual’s expectations regarding
drug use, and by the initial effect of the drug once it is ingested in the
postcessation period.
Data are available that provide support for Marlatt’s model (although cf.
Shiffman 1984a). For example, Marlatt’s research has recently shown that,
among smokers who lapse, those who report responding with global, internal, and
stable attributions are more likely to relapse completely than other subjects
(Goldstein et al. 1984). In this same research there was also evidence that those
subjects who experienced a complete relapse reacted to their initial drug contact
with greater guilt feelings than did other subjects. This provides some support
for the notion that problematic lapses are associated with an affective reaction as
hypothesized by Marlatt. Goldstein et al. presented no data linking the
attributional style characteristic of the AVE with the magnitude of affective
reaction.
Most data gathered on relapse phenomena are vulnerable to diverse challenges
and conflictual interpretations. One reason for this is that relapse data typically
involve retrospective self-report, sometimes of target events distant in time from
data collection. This renders these data prey to biases such as memory errors and
self-presentation distortions. Due to the retrospective nature of much of the data
reporting, one bias may be particularly problematic; viz., reports of reactions to
relapse crises or initial drug use may be colored by the subject’s awareness of his
or her subsequent drug use. For example, Goldstein et al. found that lapsers and
relapsers were discriminated on the basis of guilt reactions to initial drug use.
One could interpret this to mean either that subjects experiencing the greatest
guilt went on to relapse, or that subjects who went on to relapse merely reported
experiencing the greatest guilt; i.e., knowledge that they had relapsed completely
distorted subjects’ recall of their affective reaction to initial drug use.
Another problem with research on relapse is that most studies involve self-
selection; i.e., the subject population is composed of individuals who voluntarily
come forward to provide data.
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In the present research we attempted to avoid some of the problems of previous
relapse studies by investigating relapse in an identified population of individuals
who had gone through a formal cessation program. This permitted us to survey
an entire population, thus eliminating one type of self-selection bias. Subjects in
our research were self-selected in the sense that they all volunteered for a formal
cessation program. Thus, our subjects may not be representative of smokers as a
whole.
We attempted to make frequent contact with subjects in order to gather
information on initial cigarette use prior to the potentially distorting effects of a
successful or unsuccessful resolution of the relapse crisis. Of course, our
procedure did not eliminate potential bias; it merely made us susceptible to a
different set of biases. Restricting the sample to smokers treated by a single
program constrains sample size. Also, data may reflect the effects of the
particular treatment used, and subjects’ reports to followup interviewers may
have been influenced by the subjects’ attitudes or feelings about the treatment
program.
With the above caveats in mind, this research was intended to characterize the
process of relapse with respect to temporal features and cognitive, affective, and
physical correlates. Specific questions addressed in this research were: (1) If
smoking occurs, what is the latency to sampling a second cigarette, or to
returning to regular smoking? That is, what is the time frame in which the overt
manifestations of relapse occur? (2) What is the likelihood that a subject will
relapse completely if he or she smokes a cigarette? (3) Once a subject relapses
completely, what is the likelihood that he or she will achieve a subsequent period
of abstinence? (4) What are the cognitive, affective, and physical precursors, and
consequences, of an initial post-cessation cigarette? (5) What are the contextual
features and activities associated with initial cigarette use? (6) What is the
incidence of coping response use after smoking an initial cigarette? (7) What was
the frequency and severity of urges prior to the initial lapse? and (8) Is there any
relationship between a smoker’s precessation characteristics and the timecourse of
the relapse process? In addition to characterizing the context of subjects* lapses
to cigarette use, we also explored whether any of our dependent measures
predicted latency to sample a second cigarette or return to regular smoking.
METHODS
Subjects
The subject pool consisted of 82 persons (47 women and 35 men) recruited from
the community to participate in a 2-week smoking cessation program (see
Tiffany 1985). All subjects were between the ages of 18 and 40, and had
smoked at least one pack of cigarettes per day for at least I year. Subjects’ mean
age was 31.1, mean years smoking was 12.9, and mean number of cigarettes per
day pretreatment was 24.4.
Of these 82 subjects, 72 reached complete abstinence by the second week of the
cessation treatment. During the 2-year posttreatment followup period, 54 of the
subjects reported smoking. Data from their first relapse episodes are reported
here.
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Procedure
Cessation Treatment. All subjects met in groups of two to six smokers for 6
evenings over a 2-week period. Each meeting consisted of approximately 60
minutes of behavioral counseling and 30 to 60 minutes of aversive smoking. The
exact nature of the counseling and the aversive smoking varied across four
treatment conditions.
Followup. Following treatment, all subjects were contacted by phone by a
research assistant blind to the particulars of the study. An attempt was made to
interview subjects at 2-week intervals through 3 months posttreatment, and then
monthly, through 12 months. Subjects also were contacted at 18 and 24 months
posttreatment. Collaterals, who could provide information about the subjects’
smoking, were contacted every 3 months. Structured interviews were used to
gather data about subjects’ smoking status and problematic situations that they
encountered and expected to encounter. If they had smoked at all, extensive
information was gathered concerning the relapse episode. Information was also
gathered concerning the frequency, severity, and nature of urges to smoke. A
relapse interview was completed each time a subject had smoked, after having
gone at least 2 weeks without smoking. This report, however, focusses on the
first relapse episode only. The interviewers recorded the subjects’ free responses
to the open-ended questions of the structured interview.
Content Analysis. After 2 years of followup on all subjects, two research
assistants were trained to perform a content analysis of subjects’ responses to the
relapse interviews. Response categories were derived by the authors after
reviewing a sample of the interviews. Each research assistant scored
approximately 70 interviews. Reliability data were gathered by having both
research assistants score 39 of the interviews, and calculating Kappa coefficients
for 7 of the interview questions that required the greatest degree of judgment by
the scorers. Kappas ranged from .587 for subjects’ thoughts following smoking,
to .859 for food or beverages consumed prior to relapsing, with a mean of .782.
RESULTS AND DISCUSSION
For the 54 subjects who smoked, the mean number of days between treatment
termination and the first relapse episode was 58.44. A second cigarette was
smoked by 94.4 percent of these subjects, an average of 13.17 (S.D. = 55.6 days)
days after the first cigarette. Approximately half of all subjects (n = 26) had a
second cigarette on the same day as their first, and many of these (n = 14) within
an hour of their first cigarette. We operationally defined return to daily smoking
as three consecutive days of smoking. During the 2-year followup period, 90.7
percent of subjects who smoked a single cigarette eventually returned to daily
smoking. The mean number of days between the first cigarette and daily
smoking was 41.83.
Of the 49 subjects who returned to daily smoking after their initial posttreatment
abstinence, 30.6 percent reported a subsequent, second, distinct period of
abstinence during the 2-year followup period. (Only one subject reported a third
abstinence period.) There was much variability in terms of the temporal
characteristics of the second abstinence period. The beginning of this period
ranged from 5 to 288 days after the return to daily smoking, with a mean of
87.53 days and a median of 39 days. The length of the abstinence period ranged
from 7 to 652 days (including 4 subjects who remained abstinent through the end
of the followup period), with a mean of 178.53 days and a median of 66 days.
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At 2 years posttreatment, only 16.6 percent of subjects who had smoked at least
one cigarette were abstinent. Of those who eventually returned to daily smoking,
8.2 percent were abstinent, while the 5 subjects who smoked but did not return
to daily smoking were all abstinent. The mean 2-year posttreatment smoking
rate for all 54 subjects was 19.31 cigarettes per day.
The number of days to first relapse was not correlated with days between the
first relapse and the onset of daily smoking, r(47) = .02. When the five subjects
who never returned to daily smoking were included in the calculations, a modest
correlation was found, r(52) = .35, p <. 05.
Characteristics of the Relapse Episodes
Table 1 shows that of the 89 percent of the relapsers who reported the location
of their first relapse, a majority of their relapses occurred either at home or at a
social event such as a party, or in a bar or restaurant. Other people were present
during 56.6 percent of the relapses. In 58.5 percent of all cases, subjects
reported that they had noticed others smoking prior to their relapse.
TABLE 1
Location of Relapse
Location (89% Response) % of Responders
Home 26.4
Work 11.3
Another’s Home 11.3
Bar/Party/Restaurant/Entertainment 26.4
In Transit (car, bus, plane, walking) 18.9
Other 5.7
Table 2 displays the self-report of consumption of subjects immediately
preceding relapse. Alcohol was associated with nearly one-half of all relapse
episodes. This figure is considerably higher than that reported by Shiffman
(1982). It is possible that this was caused by either fortuitous sample
characteristics or the fact that smokers who consumed alcohol were less likely to
call Shiffman’s hotline.
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TABLE 2
Consumption Preceding Relapse
Consumption (98.1% Response) % of Responders
None 30.2
Food 11.3
Alcohol 45.3
Caffeinated Coffee/Tea 24.5
Caffeinated Soft Drink 1.9
Recreational Drug 5.6
NOTE: Multiple coding results in totals over 100%.
In nearly all cases, subjects acquired their relapse cigarette through deliberate
action. Table 3 demonstrates that only 1.9 percent of the subjects were offered
the first cigarette smoked. Social pressure has been reported to be an important
determinant of relapse in previous studies (e.g., Marlatt 1982). If the data from
our research are representative, this suggests that there is little reason to train
subjects in cigarette-refusal skills as has been done with other substance abuse
populations. On the average, subjects smoked approximately two-thirds of their
first cigarette. Smokers rarely smoked all of the first cigarette they sampled.
TABLE 3
Origin of Cigarette
Origin (96.3% Response) % of Responders
Bought It 26.9
Asked For It 54.8
Found It 9.6
Was Offered It 1.9
Stole It 5.8
Relapses were distributed throughout the day (Table 4) with most occurring in
the afternoon and evening. This pattern of relapse mimics the diurnal pattern of
urge/craving self-report volunteered by individuals undergoing smoking
withdrawal (e.g., Gilbert and Pope 1982; Glassman et al. 1984).
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TABLE 4
Time of Relapse
Time  (100% Response) % of Responders
Morning (02:00 - 10:59) 7.4
Noon (11:00 - 12:59) 11.1
Afternoon (13:00 - 16:59) 27.8
Evening (17:00 - 19:59) 33.3
Night (20:00 - 01:59) 20.4
Subjects were asked to recall their mood and physical feelings prior to smoking.
Table 5 displays their responses. In keeping with previous studies (Marlatt 1982;
Shiffman 1982). most subjects reported that negative affect preceded smoking.
Anxiety or tension was reported by 35.3 percent of subjects who answered, while
depression/hopelessness, anger/irritation, or boredom/fatigue were reported by
most of the remaining subjects. Less than one in five subjects reported any
positive affect. Only 77.8 percent of subjects could recall their physical feelings
prior to relapse. Of these, as with affect, negative states predominated. In
addition, 9.5 percent volunteered that they felt under the influence of alcohol or
other drugs.
TABLE 5
Affect and Physical Feelings Preceding Relapse
A. Affect (94.4% Response) % of Responders
Negative Affect
Depression/Hopelessness
Anxiety/Tension
Anger/Irritation
Boredom/Fatigue
Happy/Celebratory/Confident
Relaxed
Other (e.g., neutral, nostalgic)
56.9
17.6
35.3
15.7
11.8
17.6
2.0
11.8
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TABLE 5 (Con't)
B. Physical Feelings (77.8% Response) % of Responders
Negative/Ill Feelings 31.0
Fatigue 26.2
Headache 2.4
Other Negative Feelings 4.8
Aroused/Agitated 40.5
Under the Influence 9.5
Relaxed 4.9
Neutral 16.7
Other 2.4
NOTE: Multiple coding results in totals over 100% and sums that exceed
subtotals.
Responses to Relapse
One-third of all subjects reported using coping responses after relapsing to lessen
their chances of further smoking. Overall, subjects used an average of 0.15
cognitive coping responses, and 0.28 behavioral coping responses. The
predominant behavioral coping response was to throw out all cigarettes to which
the subject had access. Common cognitive coping responses were to think of
reasons not to smoke or for the subject to remind himself or herself of how
much progress each had made.
When asked about the taste of their first cigarette, 45.3 percent described it in
negative terms, 22.6 percent described it as positive, and 32.1 percent said it
tasted neutral.
Table 6 lists the cognitive, affective, and physical responses to relapse that were
reported by subjects. Over one-third of the subjects did not report or recall any
cognitions, and nearly one-half did not report any affective response. The
majority of subjects responding reported self-blaming or self-deprecatory
cognitions (61.8 percent). Only 2.9 percent said that they admitted defeat or
gave up trying to abstain after smoking the first cigarette. Positive thoughts,
such as relief that the struggle to abstain had finally ended, were reported by
11.8 percent.
Depression was the most common affective response to smoking reported by
subjects (42.9 percent). Only 7.1 percent of subjects described their mood as
happy, celebratory, or confident, and only 10.7 percent said they felt relaxed
after smoking.
Most of the physical responses to smoking the first cigarette (table 6) appeared to
be agonist effects of nicotine (reported by 73.1 percent of the subjects). The
most common of these was a feeling of dizzyness or lightheadedness which was
reported by about 58 percent of our sample. This figure is congruent with data
collected by Gilbert and Pope, who found that slightly over half of the subjects
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in their laboratory study reported these symptoms upon having an initial
postwithdrawal cigarette. The fact that an initial cigarette is likely not to taste
good, and is likely to have unpleasant effects, may be useful information to
convey in counseling programs with smokers. Other negative physical feelings
were reported by 19.2 percent. Only 3.8 percent said that they felt physically
relaxed after smoking.
TABLE 6
Cognitive, Affective, and Physical Response to Relapse
A. Cognitions (63% Response) % of Responders
Self-Blame/Self-Deprecation 61.8
Vowed “Never Again” 5.9
Admitted Defeat/Gave Up 2.9
Neutral/Indifference 8.8
Relief/Positive Thoughts 11.8
Other Cognitions 17.6
B. Affect (51.9% Response) % of Responders
Depression/Hopelessness 42.9
Anxious/Tense 10.7
Anger/Irritation 10.7
Aroused/Excited 7.1
Boredom/Agitated 3.6
Relaxed 10.7
Happy/Celebratory/Confident 7.1
Other 14.3
C. Physical Feelings
(96.3% Response)
% of Responders
Nicotine Agonist 73.1
Dizzy/Light Headed 57.7
Nausea 17.3
“High” 13.5
Tachycardia 7.7
Shaky 1.9
Headache 1.9
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TABLE 6 (Con't)
Other Negative Feelings
Oral Cavity Irritation
Fatigue
Other
Other Physical Feelings
Aroused/Agitated
Relaxed
Neutral
Other
19.2
7.7
1.9
9.6
25.0
3.8
3.8
7.7
9.6
NOTE: Multiple coding results in totals over 100% and sums that exceed
subtotals.
Prior Urges
Subjects were questioned about the frequency, severity, and effects of urges that
they experienced prior to relapsing. Table 7 shows that nearly 80 percent of the
subjects reported experiencing one or more urges to smoke per day prior to their
relapse. When asked to rate urge severity on a five-point Likert scale where five
represented extreme severity, the mean rating was 3.29, between moderate and
severe.
Table 8 lists the subjects' responses when asked if and how urges to smoke
affected their lives. Only 44 percent of responding subjects reported any effect,
and the majority of those stated that urges disrupted their thinking or
functioning.
TABLE 7
Frequency, Severity, and Description
of Urges Prior to Relapse
Urge Frequency (96.3% Response) % of Responders
Almost Constant 9.6
Hourly 5.8
Daily 63.5
More Than 2 Per Day 38.5
1-2 Per Day 25.0
Every Other Day 7.7
Every Several Days 3.8
Less Often 9.6
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TABLE 8
Effect of Urges on Life
Effect of Urges (92.6% Response) % of Responders
Urges Didn’t Affect Life 56.0
Urges Affected Life 44.0
Annoyance/Irritation 2.1
Negative Mood 16.8
Disruption of Thinking or Functioning 31.4
NOTE: Multiple coding results in subtotal over 44.0%.
Regression Analyses
To reveal associations between characteristics of relapse and outcome measures,
exploratory regression analyses were performed. The categorical responses of
subjects on the various items were dummy coded and entered as predictor
variables in separate regression analyses. Response categories were entered in the
regression only if they were endorsed by at least 10 percent of the responding
subjects, and if they were among the four most frequently endorsed categories
for a given item. Dependent variables were length of time between treatment end
and first relapse, length of time to second cigarette, and length of time to
resumption of daily smoking. For the latter two analyses, length of time until
first cigarette was forced into the regression first as a covariate.
No item significantly predicted days until second cigarette with days until first
cigarette partialled out. Only one variable was significantly associated with
number of days between treatment end and smoking a first cigarette. The longer
a subject maintained abstinence before a lapse, the more likely it was that he or
she reported experiencing negative physical feelings (e.g., fatigue, headache)
before relapsing (pr = .34, F( 1,38) = 5.08, p <.05). Only one variable was
associated with the number of days between treatment end and return to daily
smoking; viz., subjects who reported that urges affected their life tended to
return to daily smoking more rapidly than other subjects; r = -.31, F(l,41) =
4.32.
Three variables were associated with the length of the interval between smoking
a first cigarette and a return to regular smoking. Negative physical feelings
preceding first relapse were associated with a shorter time period until the
resumption of daily smoking (pr = -.35, F(1,32) = 4.41, p<.05) as was having the
first cigarette in the presence of other smokers (pr = -.37, F(l,43) = 6.95, p
<.05). Finally, the origin of the subjects’ first cigarette significantly predicted
time to daily smoking (sR2 = .06, F(2,41) = 3.38, p <05). Subjects who bought
their cigarettes tended to return to daily smoking sooner (pr = -.30, F(l.41) =
4.15, p <.05).
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The relationships between a number of pretreatment variables and outcome were
also examined. The pretreatment smoking rate was found to be negatively
correlated with days from treatment end to daily smoking; r = -.42, F(1,44) =
9.38, p <.01. This relationship persisted when days to first cigarette were
partialled out (pr = -.46, F(1,43) = 11.62, p <.01), indicating that a higher
pretreatment smoking rate was associated with a quicker return to daily smoking
after an initial lapse.
Pretreatment confidence was measured on a five-point scale. Subjects were
asked to estimate the likelihood that they would be abstinent 1 year following
treatment. This measure was positively correlated only with days until first
relapse; r = .35, F(1,51) = 7.02, p <.05. This same measure, taken posttreatment,
was similarly predictive of days to relapse; r = .36, F(1,51) = 7.52, p <.01.
Other pretreatment smoking characteristics examined--age, sex, years smoking,
number of previous quit attempts, and smoking satisfaction--were not related to
any of the outcome measures.
CONCLUSIONS AND IMPLICATIONS
One reason for doing this research was to discover information that might be
helpful in developing relapse prevention or intervention treatments; i.e.,
treatments that are designed to reduce the likelihood of further smoking should a
“lapse” occur (see Marlatt 1982). Some data in this study may be helpful in that
regard. First, in the majority of cases, relapse to regular smoking does not occur
precipitously. In fact, over half of all subjects waited more than 24 hours before
having a second cigarette. This suggests that smokers do not rapidly lose control
once they sample a cigarette, and it also suggests that there is a substantial
temporal window during which to intervene if a lapse occurs. On the other
hand, the nearly universal return to regular smoking (91 percent) once a cigarette
was tasted suggests that there are powerful forces operative that a relapse
intervention program must overcome. It is encouraging that nearly one-third of
these relapsers achieved a subsequent period of abstinence. However, their long-
term abstinence rate of only 8.2 percent--compared to the 100 percent abstinence
rate for relapsers who did not return to regular smoking--lends support to
Marlatt’s (1982) recommendation that focused intervention occurs after a smoking
lapse but before full relapse. Moreover, the negligible correlation between days
to a first cigarette and days to full relapse suggests that different factors may
influence the maintenance of absolute abstinence versus the prevention of full
relapse following initial smoking. For example, maintenance of abstinence might
be a function of factors such as confidence/effectance estimates, coping skills, or
attributional styles (Hall et al., 1984; Marlatt 1982; Shiffman 1984a). However,
once a drug is actually sampled, readdiction may largely reflect the influence of
pharmacological motivational systems. Consistent with this is the fact that the
best predictor of the latency between a first cigarette and regular smoking was
the pretreatment smoking level.
While there are data indicating that coping response execution in the face of an
urge to smoke reduces the likelihood of smoking in the relapse crisis situation
(e.g., Shiffman 1982), we were concerned with whether coping responses, made
after a lapse had occurred, would reduce the likelihood or rate of subsequent
relapse on a long-term basis. Our results show that only a small percentage of
our subjects used coping responses after a lapse, and that coping response
execution was not associated with an increased relapsed latency. It may be that
coping responses are more effective if they are executed prior to a lapse. Also,
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our subjects used fairly primitive coping responses. It may be that more complex
or combinatorial coping responses would be more effective (Shiffman 1984b).
There was some evidence (p <.10) in our results that putting out a cigarette
quickly (having smoked little of it) was associated with an increased interval
from a first cigarette until a return to regular smoking. If putting out a cigarette
were considered a coping response, it would constitute the only evidence that
coping response execution was associated with delayed relapse.
One disappointing aspect of this research is that we were unable to obtain data
that strongly supported Marlatt’s relapse model. For example, there was no
evidence that reacting to a lapse with depression or hopelessness resulted in a
worse prognosis than did a different affective reaction. There was a tendency
for subjects who were depressed before their relapse to return to regular smoking
more rapidly than other subjects (F(1,39) = 2.88). However, this finding is
difficult to interpret. Prelapse depression might be associated with faster relapse
for a variety of reasons: e.g., it might reflect an enduring withdrawal or
heightened life stress. Moreover, we found no evidence that particular cognitive
responses to relapse (e.g., self-deprecation) were related to relapse rate. Nor was
there any evidence that relapse progressed more quickly the longer an individual
had been abstinent.
One characteristic of a lapse that is related to the progression to full relapse, is
the presence of negative physical feelings prior to the lapse. This is related to a
faster relapse progression, and is associated with the relapse of individuals who
had been abstinent the longest. The explanation for this pattern is unknown, but
it may be that individuals who are tired or ill are simply less able to cope
effectively with urges.
One final observation merits comment. Shiffman (1982) questioned the extent to
which relapse can be attributed to temporally and situationally discrete incidents,
and a person’s response to such incidents, versus the tonic factors that render the
individual susceptible to relapse. The present research reveals two tonic factors
that appear to have been relatively important in determining the rate of relapse:
i.e., the presence of chronic urges, and the precessation level of smoking. These
factors, in fact, seemed relatively more important in determining relapse rate in
our sample than did factors specific to the relapse context e.g., affective,
physical, or cognitive reactions to smoking. Of course, this conclusion, as well as
others, must be considered tentative given the constraints of this study--the small
sample size, the open-ended interview format, the different reliabilities of
response categories, etc. We are now analyzing data yielded by a systematic
replication of this research.
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Commitment to Abstinence and
Relapse to Tobacco, Alcohol,
and Opiates
Sharon M. Hall and Barbara E. Havassy
Interest in cross-drug generalities has existed for several years, but there are few
data that address such generalities. This is so even though there is a growing
body of indirect evidence suggesting that significant commonalities exist. For
example, Carroll and Meisch (1984) have demonstrated that food deprivation
increases the reinforcing efficacy of diverse drugs in laboratory animals. Falk, et
al. (1983) describe environmental features that have similar effects across drugs.
Examples are schedules of reinforcement that maintain persistent drug self-
administration and drug use as an adjunctive behavior. Kandel and Maloff
(1983) note sociocultural similarities in factors influencing use of many drugs--
for example, peer group pressure in the initiation of use--and termination of use
as a function of changes in demographic status. Similar examples can be drawn
from sociological, epidemiological, and psychological perspectives (Levison et al.
1983).
There are two investigations of cross-drug similarities in relapse, both of which
have considerable heuristic value. In the first investigation, Hunt and colleagues
(1971) compared relapse rates for graduates of treatment programs for alcohol,
opiate, and tobacco abuse. The investigators suggested that relapse curves are
similar across opiates, alcohol, and tobacco, both in the shape of the curve and in
the poor abstinence rates seen at long-term followup. This work has been
criticized on several grounds. Sutton (1979) noted that these are typical survival
curves that describe many phenomena. The phenomena can be as diverse and
unrelated as the death rates of neonates over time in some countries or the time
to burn out for individual light bulbs in large batches of bulbs. However, to
those in the field who have not seen them before, these data are compelling.
They reflect the experience of clinicians in the rapidity of relapse, and the
inevitability of it, for users of all three drugs.
A second landmark investigation was that of Marlatt and Gordon (1980), who
interviewed 137 subjects about the situations in which they relapsed after
treatment for tobacco, alcohol, or opiate dependence. These investigators noted
consistency across all three drugs. About one-half the relapse determinants for
the three drug categories fell into one of two categories: negative emotional
states and social pressure. Negative emotional states were described as relapse
determinants for 38% of the alcoholics, 43% of the smokers, and 28% of the
heroin addicts. Social pressure was a precipitant for 18% of the alcoholics, 25%
of the smokers, and 34% of the heroin addicts. These data raise several critical
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questions. The first is the extent to which the retrospective nature of the data
colored the perception of the event, Second, the extent to which these are
illusory correlations is not known. Particular events may have been labelled as
determinants of relapse because they were the most salient factors in the
situation. The causative factors may have been subtle and less easily verbalized.
An example of such a subtle factor is chronic mild withdrawal symptoms. The
last question is one of base rates. The categorical scheme used by Marlatt and
Gordon (1980) spans the range of human experience. The frequency of such
events in the lives of the subjects, independent of relapse, is not known. It is
possible that coding of events other than relapse to drugs would show similar
distributions of situations.
The goal of the present study was to determine factors related to relapse to three
abused drugs: tobacco, alcohol, and heroin. It differed from earlier studies by
its prospective nature, by the range of variables investigated, and by attempts to
control variables left uncontrolled in previous studies. It was based on a model
of relapse that emphasizes commitment, withdrawal symptoms (including negative
affect), and environmental support, as determinants of abstinence or relapse (Hall
1980).
This model, the emerging literature on relapse processes, and clinical lore suggest
factors which appear to be important in relapse to all three drugs.
Social Support
The first factor is social support, which can be defined as resources provided by
other persons (Cohen and Syme 1985). Social support is often conceptualized in
two ways. The first is “structural” support. The structural aspect of social
support refers to the existence and pattern of relationships with others, for
example, marital status, number of relationships, or number of contacts per time
period. The second aspect of social support is functional support. This is the
degree to which interpersonal relationships provide emotional, intellectual, or
material resources. When considering health outcomes, such as maintaining
abstinence, both structural and functional aspects of support may facilitate
abstinence or, conversely, encourage drug use (Cohen and Wills, in press).
Variables used to measure support differ depending on which aspect of support is
being measured. They also differ widely within investigations of specific drugs,
as well as across drugs. Most investigations of drugs assess the functional, rather
than structural, components of support. These have been shown to predict
outcome. Behaviors perceived as supportive by the quitter are consistent
predictors of abstinence in ex-smokers (e.g., Graham and Gibson 1971;
Mermelstein et al., in press). Positive family environment has been a consistent
predictor of outcome in alcoholics (Foster et al. 1972; Finney et al 1980; Moos et
al. 1979; Orford et al. 1976).
Evidence for the role of social support in relapse to heroin use is indirect.
Marlatt and Gordon (1980) found that social pressure, including direct pressure
to use the drug, and being in the presence of others using drugs, was the most
frequently reported determinant of relapse to heroin use.
Systems approaches to psychotherapy (e.g., Haley 1971; Bosormenyi-Nagy and
Sparks 1973) recognize that subtle forms of social support for drug use may come
from families. Therapies developed from these theories have been successfully
applied to reduction of drug use during treatment (Stanton et a1. 1978), but they
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have not been specifically applied to relapse. Also, family factors are considered
of importance by drug treatment programs, in that provision of family services
has been seen to be essential (Coleman 1977; Reed 1985).
Drug users may receive satisfactory general social support, but it may not include
specific support for quitting drug use or maintaining abstinence. If network
members also have problems with the drug, the support offered may reinforce
continued use. Or, if network members are unaware of the user’s problem, the
support they provide may not be a resource to help them cope with abstinence-
related difficulties. The relationship of drug-specific social support to relapse
has not received significant attention. Mermelstein et al. (1983) attempted to
differentiate global social support from support specific to quitting smoking.
Subjects were asked how many of their friends and how many of their coworkers
were smokers. The subjects also completed a global social support questionnaire.
No clear results emerged when the proportions of smokers among friends and
coworkers were compared to smoking status during treatment, at end of
treatment, and posttreatment, although differences at end-of-treatment were
suggested. Cohen and colleagues (1985) report data that suggest support from
intimates for quitting smoking is a determinant of abstinence.
Negative Life Events
A second variable is the occurrence of negative life events, and other global
variables, that have been included under the construct of “stress.” Stress is
frequently operationalized as major life events or changes, both positive and
negative. Most research has looked at the effects of stress on global health
outcomes. When stress is correlated with health outcomes, negative life events
predict poor outcome. Positive events, or scores combining both, usually do not
(Mueller et al. 1977; Vinokur and Selzer 1975). Data specific to the addictions
has also been reported. Ogbru (1976), Finney et al. (1980), and Cronkite and
Moos (1980) all found that negative life changes predicted relapse for alcoholics.
Benfari and Eaker (1984) reported similar findings for smokers. Krueger (1981)
found events  such as  recent  loss  of  a  relat ionship or  job,  depression,
interpersonal conflict, or disappointments were associated with occurrence of
heroin use by methadone maintenance clients who had been heroin-free for at
least 6 months.
The ongoing “stresses” of daily living, repeated or chronic minor events known as
“Hassles,” appear to be another useful way to characterize stress. Again, most
interest has been in the relationship between general health outcome and Hassles.
It was suggested that the strain of these daily events cumulatively affects health.
Delongis et al. (1982) investigated the relationship of both Hassles and major life
events to health outcomes. Hassles scores were more strongly associated with
health than were life events. While Hassles predicted significant proportions of
variance when the effect of life events was removed, the reverse was not true.
When the effect of life events was controlled, Hassles and health remained
significantly related. Although no studies relating Hassles to relapse to drug use
have appeared in the literature, the study of such relationships may be fruitful.
Marlatt and Gordon (1980) also noted that 13%-18% of relapse situations for all
three drugs could be classified as including interpersonal conflict, a common
“stressful” event. In their study, negative emotions were among the most common
relapse precipitants. Whether this reflects characterological factors or the
occurrence of negative life events is not known. Negative affect is known to be
a consistent factor in smoking relapse (e.g., Hall et al. 1983; Pomerleau et al.
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1977; Tunstall et al. 1985). Again, whether this affect reflects life events or is
characterological is not known.
Sex Differences
There is indication that women smokers and alcoholics relapse more rapidly than
men. The U.S. Public Health Service (1980) noted this trend in a comprehensive
review of the smoking literature that reported sex differences among treated
smokers. Similarly, poorer outcome has been reported for alcoholic women
(Davidson 1976), although others dispute the accuracy of this position (Vanicelli
1984). Those few studies that examined sex differences in heroin addicts have
not found differences in illicit drug use or treatment outcome variables (Cushman
1978; Savage and Simpson 1980).
An emerging literature suggests that the variables controlling drug use,
determinants of relapse, and optimal treatment may be different for women than
for men. Women smokers report they are more likely to smoke in response to
negative affect than men. The predominance of negative affect smoking among
women could be a factor in the higher relapse rates reported for them, since
negative affect smokers have been found to be more likely to relapse than
smokers who do not label negative affect as a primary determinant of smoking
(Pomerleau et al. 1977). The greater role of negative affect in use of alcohol and
heroin for women has also been noted (e.g., Beckman 1976; Braiker 1982; Reed
1985; Rhoads 1983; Westie et al. 1984). Others have suggested that the
treatments offered, rather than women’s characteristics, explain possible
differences in outcome. Several writers have suggested that chemical dependency
treatment services are not designed for alcoholic or addicted women and may fail
to recognize women’s key difficulties. If they do recognize these difficulties,
they perceive them as outside the scope of services they are willing or able to
provide (Reed and Beschner 1981; Carmen et al 1981; Reed 1985). The issue of
treatment suitability for women smokers has been little discussed. However,
self-quit rates for men smokers are better than for women, suggesting that
factors other than treatment structure may be involved in producing differences
observed (Pehacek et al. 1982).
Skills to Prevent Relapse
There are other intriguing factors that have been little studied. One is the
presence of skills to prevent relapse. Clinicians have long recognized that the
ability of patients to eloquently describe their responses to relapse situations is
often matched by a lack of coping behavior in actual relapse situations.
Interventions teaching such skills to alcoholics, smokers, and heroin addicts have
been evaluated. Most evaluations assessed the effects of training on behavioral
performance tests, rather than on relapse prevention (Eisler et al 1973; Foy et aI.
1974; Van Hasselt et al. 1978). However, some studies have looked directly at
relapse prevention as a function of skill training. Chaney and colleagues (1978)
found that providing skill training to alcoholics decreased the duration and
severity of relapse episodes at year follow- up. Hall and coworkers (1984) found
that smokers given relapse prevention skill training were less likely to relapse
than those participating in a discussion control condition. However, the stability
of this finding is not clear (Hall et al 1985). Negative results have been reported
by Cooney et al. (1982). These treatment studies cannot partial out the unique
contribution of skills, because they were part of multicomponent treatment
programs.
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Commitment to Abstinence
A final variable is commitment to abstinence. Both clinical lore and common
sense about the determinants of success suggest that a commitment to abstinence
is central to maintenance of abstinence. Commitment to abstinence is one
dimension of the broader term, “motivation.” We conceptualized it as an
indicator of motivation to cease drug use and remain abstinent. Janis (1983)
suggests that commitment is central in facilitating adherence to difficult
decisions. The decision to remain abstinent may be especially difficult for the
chronic drug user.
Studies of smokers who quit smoking without treatment indicate this may be a
promising variable, but that it may interact with other variables (Best 1975,
1980). Several dimensions of commitment must be considered. Among the most
predictive have been desire for abstinence (Goldstein et al 1983; Rosen and
Shipley 1983) and perceived probability of success (Best 1975; Rosen and Shipley
1983; Goldstein et al. 1983). Level of commitment may be directly linked to
other variables, such as the perceived costs and benefits of change (Hall 1980)
and the client’s self-efficacy about maintaining abstinence (Condiotte and
Lichtenstein 1981).
Many of these models can be easily adapted to alcohol and opiate abuse.
However, data relevant to such adaptations are lacking.
Our Approach
Several consistencies emerge. Despite a need, and despite some theorizing, few
data on cross-drug generalities exists. There is evidence for the importance of
social support in preventing relapse. Negative life events may increase the
probability that relapse will occur. However, it is unclear whether they are
causative or whether they are implicated by virtue of selected recall of a relapse
situation. There is indication that women relapse at higher rates across drugs.
Knowledge about processes underlying sex differences in the relapse process is
poor. Coping skills and commitment to abstinence, two variables considered to
be central in preventing relapse, have been little studied.
Hypotheses
This paper reports the results of a preliminary study which tested two hypotheses
about commitment to abstinence:
(1) Regardless of drug, the greater the commitment to abstinence, the
longer the time to relapse; and
(2) Negative mood, withdrawal symptoms, and negative life events would
interact with level of commitment to abstinence over time to relapse. We
predicted that at high levels of commitment these variables would not affect
outcome. At lower levels, the higher the level of these negative subjective
events, the shorter the time to relapse.
Differences in time to relapse between drug treatment classes were not expected.
In this preliminary study, relapse was defined as 1 week of daily use of the
problem drug.
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METHOD
Treatment Facilities
Subjects were drawn from three drug groups: opiate addicts completing 21-day
methadone-assisted detoxification or 28-day residential treatment, alcoholics
completing 28-day residential treatment, and smokers completing 28-day
cessation treatment.
The treatment facilities from which we recruited subjects were selected for four
reasons. The first was treatment goal. All the treatment programs chosen were
abstinence oriented. The similarity of goal allowed us to better assess the
common effects of central variables. The second was the nature of the treatment
episode, which lasted about 1 month, and had a well-defined ending date. This
similarity eliminated length of treatment as a confounding variable. Third, we
selected treatment modality groups in which there were enough clients to obtain
an adequate sample. The fourth was that the facilities treated subjects who were
representative enough of the populations within drug group so that the data
obtained would be meaningful, while allowing us to roughly equate drug
treatment classes on demographic characteristics.
Our research group offered a smoking treatment program at San Francisco
General Hospital, a large public hospital which serves a multiethnic, lower and
working class population. The program was offered at this location because both
a drug treatment and an alcohol program included in the study were at the
hospital, facilitating the acquisition of subjects with similar demographic
characteristics. Treatment included aversive smoking and group discussion and
support. Groups were led by one of two therapists. Although the treatment was
uniform across the groups, the therapists had different orientations, providing for
some variability in treatment delivery.
Alcoholics were recruited mostly from two residential programs. Both used
Alcoholics Anonymous extensively in treatment. Clients were primarily lower-
middle and working class and were from a variety of ethnic groups.
We recruited opiate addicts from four sources: three 21-day detoxification
clinics, and one 28-day residential facility. The outpatient clinics provided
methadone detoxification and supportive counseling. The inpatient program was
based on an adaptation of the abstinence-oriented Alcoholics Anonymous model.
Again, the programs treated lower-middle and working class clients of diverse
ethnic groups.
Subjects
Subjects were blacks and whites between 21 and 50 years of age, who had been
employed within the 6 months before the beginning of treatment and who gave
adequate data for followup contact. Subjects  were of  low to middle
socioeconomic status (SES) and were not upper-middle or upper SES, destitute,
or homeless. The primary source of income for all subjects was legal.
Here, we report data on the first 77 subjects to enter the study. Data have been
collected on 230 subjects, about equally distributed among the three drug groups.
Descriptive statistics for the first group of 77 are shown in table 1.. .
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TABLE 1
Descriptive Statistics
TOBACCO ALCOHOL OPIATES
M 18 25 11
SEX
F 12 4 7
WHITE 27 22 14
ETHNICITY
BALCK 3 7 4
NEVER MARRIED 18 8 5
MARRIED 6 9 6
MARITAL
STATUS
SEPARATED 1 4 2
DIVORCED 5 8 5
EMPLOYED 26 13 5
EMPLOYMENT
STATUS
ON LEAVE 1 2 0
UNEMFLOYED 2 11 8
STUDENT, NOT IN
JOB MARKET,OTHER 1 3 5
AGE = 35.43 38.34 34.78
SD = 7.60 5.53 7.31
AGE AT = 14.23 14.69 19.l7
FIRST USE
SD       = 4.35 2.87 5.76
AGE AT = 16.50 20.79 21.94
REGULAR USE
SD = 3.83 7.15 5.73
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Method
Study Induction. Subjects were recruited at their treatment site when in the last
third of treatment. Only clients who had acceptable attendance and were
abstinent were recruited. Abstinence was verified by two biochemically
validated self-reports at least 72 hours apart. Clients agreeing to participate
underwent a screening procedure and completed an informed consent. A study
intake assessment, which was administered just before the client completed
treatment, included an interview assessing demographic characteristics, health
status, and treatment history; and instruments measuring drug and alcohol use,
mood, withdrawal symptoms, life events, and motivation about drug use.
Followup. Followup assessments were completed once a week for 12 weeks
(beginning with the first week following treatment end) or until the subject
relapsed. Subjects’ drug and alcohol use, moods, and withdrawal symptoms were
monitored during followup. Social support data were also collected at the
followup assessment. We recognized this procedure could confound perceived
social support with early progress. That is, support by others may vary as a
function of cues from the subject about probability of continued abstinence
during treatment or very soon afterwards. However, all alcohol and some opiate
clients were recruited from inpatient facilities. They could not estimate social
support from their environment until they returned to it.
Measures. The following instruments were used in the present study:
(1) A preceded intake interview, measuring demographic variables, addiction and
treatment history, treatment goals, and physical health.
(2) A scale measuring Commitment to Abstinence was adapted from that used by
Marlatt (unpublished). The scale asked subjects to rate a) desire to be abstinent,
b) perceived chances of success, and c) perceived difficulty of abstinence, on a
1-10 point scale. Subjects were also asked to endorse one of five abstinence
goals, which are shown as goals 2 through 6 in table 2.
TABLE 2
Abstinence Goals
1. No clear goal.
2. Controlled use.
3. Total abstinence for a time, then decide about use.
4. Use occasionally, but not a habit.
5. Give up once-and for all, but realize I may slip.
6. Give up once and for all, be totally abstinent, never use again.
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(3) A scale measuring chronic withdrawal symptoms (Symptoms Questionnaire)
was adapted from existing scales measuring alcohol, tobacco, and opiate
withdrawal symptoms.
(4) The Mood Questionnaire (Ryman et al. 1974) was shortened and adapted for
our population.
(5) The “Hassles” scale (Kanner et al. 1981) was shortened for use with our
population.
For smokers, self-report of abstinence was verified by expired air carbon
monoxide readings of 9 ppm or less. Self-report of abstinence for alcoholics was
absence of alcohol in urine specimens. Report of abstinence by opiate addicts
was verified through absence of morphine in urine specimens. Urinary alcohol
and morphine were assayed by a commercial laboratory. The accuracy of the
morphine assay has been judged acceptable by the State of California as part of
its laboratory monitoring program for drug treatment programs. There was no
independent verification of the accuracy of the alcohol assays available to us.
Results
Overview. The small and incomplete sample suggests that a generous probability
level, for example, p < .10. would be appropriate. On the other hand, because of
the small sample size, conservative statistics, including hierarchical regression
analyses by sets, could not be used. Data analysis therefore required more tests
than ideal. As a compromise, we retained the p < .05 significance level.
Interpretation of the results should be considered tentative given the incomplete
sample size, and the less-than-optimal data analysis strategy required.
Commitment to Abstinence and Time to Relapse. Each of the four commitment
to abstinence ratings was entered as an independent variable in a series of
hierarchical regressions with drug group as the covariate. Time to relapse was
the dependent variable in each.
The first hypothesis was supported. Of the four dimensions of commitment to
abstinence, two of these, goal and perceived difficulty, were significant
predictors of time to relapse in this small sample.
A goal of total abstinence versus partial abstinence was a significant predictor of
time to relapse (F[1,69] = 4.16. p < .05, r2 = .0453), independent of treatment
class. As is shown in figure I, subjects who endorsed the most restrictive goal, “I
want to quit (drinking) once and for all, to be totally abstinent, and never (drink
another drink) again for the rest of my life,” had longer times to relapse than did
subjects committed to the other alternatives combined. The selection of “total
abstinence” as a goal also predicted relapse versus continued abstinence. At 12
weeks, 63% of those selecting this goal were abstinent. Less than 30% of those
choosing other goals were abstinent (Fisher’s Exact p < .008). The interaction
between treatment class and commitment to total abstinence was not significant.
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FIGURE 1
Weeks to Relapse as a Function of Choosing a Goal of Total
Abstinence Versus Choosing Other Goals
The interaction between perceived difficulty of abstinence and treatment class
was significant (F[2,65] = p < .01, r2 = .12). For smokers, perceived difficulty
and time to relapse were negatively correlated (r = .515, p < .01). For alcoholics,
there was no correlation (r = .062). For opiate addicts, greater perceived
difficulty predicted longer time to relapse (r = .570, p < .01). Regression lines of
time to relapse as a function of perceived difficulty for each treatment class are
shown in figure 2.
Desire to quit and likelihood of success were not significantly related to weeks to
relapse.
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FIGURE 2
Regression Lines for Drug Treatment Classes: Weeks to Relapse
as a Function of Perceived Difficulty of Abstinence
Sex Differences, Hassles, Withdrawal, Moods, and Abstinence. The hypothesized
interactions were not found. A series of hierarchical regressions were completed
with treatment condition, abstinence ratings, sex differences, Hassles scores, and
mood scores entered as independent variables. Interaction terms were entered last.
There were no significant interactions of abstinence scale values with sex of
subject, Hassles, withdrawal symptoms, or moods.
Drug Treatment Class, Time to Relapse, and Relationships among Independent
and Moderating Variables. Contrary to expectation, there were differences in
treatment class in time to relapse (F[2,74] = 5.91, p < .01, r2 = .13). For opiate
addicts, mean = 6.11 weeks, a = 4.14; for alcoholics mean = 8.66 weeks,
SD = 5.04. For cigarette smokers mean = 10.37 weeks, SD = 3.59. Only
differences between smokers and opiate addicts were significant (t[46] = 3.75,
p < .01).
To better understand factors that might mediate differences in time to relapse
across the three drug groups, we compared the groups on mean negative mood
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states following treatment, Hassles scores, withdrawal symptoms following
treatment, and commitment to abstinence in a series of exploratory analyses.
Significant differences were found between the three drug groups on expectation
of successful abstinence (F[2,74] = 4.71, p < .01, R2 = .11), predicted difficulty
in maintaining abstinence (F[2,74) = 3.06, p < .05, R2 = .076), goal of total
abstinence versus other goals (F[2.74] = 3.43, p < .04, r2 = .084), and withdrawal
symptoms (F[2,74] = 6.30, p < .01, R2 = .145). Differences between total Hassles
score, negative mood states, and desire to maintain abstinence were not
significant.
Most significant, F-values reflected differences between smokers and the other
two drug groups in thoughts about abstinence. Smokers were most likely to
predict they would be successful in maintaining abstinence. The difference
between smokers and opiate addicts was significant (t[25 for unequal
variances] = 2.52, p < .01, figure 3a). The paired comparisons between smokers
and alcoholics, and alcoholics and opiate addicts, were not significant. Smokers
saw maintaining abstinence as more difficult than the other two drug groups.
The difference between smokers and alcoholics was significant (t[57] = 2.59,
p < .01, figure 3b), but the other two paired comparisons were not significant.
FIGURE 3a
Probability of Successful Abstinence as Predicted by the Three
Drug Treatment Classes
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FIGURE 3b
Perceived Difficulty of Abstinence as a Function of Drug
Treatment Class
FIGURE 3c
Percent of Subjects Selecting Total Abstinence as a Goal for Each
Drug Treatment Class
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Smokers were more likely to select total abstinence as a goal than the other two
treatment classes. The difference between smokers and opiate addicts was
significant (t[46] = 2.59, p < .01, figure 3c). The remaining two paired
comparisons were not significant.
Opiate addicts reported significantly higher levels of withdrawal symptoms
(mean = 43.66, SD = 21.91) than both smokers (mean = 28.67, SD = 16.61;
t[46] = 2.69, p < .01) and alcoholics (mean = 25.36, SD = 16.06; t[45] = 3.30,
p < .01). Because time to relapse differed, the length of time over which
symptoms were measured differed among the three groups. Therefore, an
analysis of covariance was completed with time to relapse removed from the
equation. Differences in withdrawal symptoms remained significant.
DISCUSSION
The results confirm the first hypothesis. Independent of drug group, if subjects
endorsed a statement indicating that they intended to be abstinent and never use
the problem drug again, they were slower to return to daily drug use. They also
were more likely to be abstinent at the end of 3 months. On the one hand, this
is not surprising, since individuals’ prediction of their own behavior is often
good (Condiotte and Lichtenstein 1981). On the other hand, some might consider
an intention never to use a drug again to be an unrealistic one. Marlatt and
Gordon (1980) suggest such attitudes might facilitate relapse. Under their
concept of the “Abstinence Violation Effect” (AVE), if a single slip is considered
a failure, as it would be by those endorsing the most restrictive statement, it may
be the first step in the completion of a self-fulfilling prophecy. These
preliminary data do not support this model.
This result was not due to grouping the more moderate- abstinence goal with the
nonabstinence goals. In a secondary analysis, goals were divided into three
categories: (1) Those indicating either no goal or a nonabstinent goal (statements
1-4); (2) “Realistic” Abstinence (Statement 5); or (3) “Total” Abstinence
(Statement 6). Subjects endorsing Statement 5 relapsed the most rapidly, but the
differences between them and the subjects endorsing the first four categories
were small and not significant.
The pattern of these data suggest that smokers think differently about abstinence
than the other two drug groups. Smokers were more committed to complete
abstinence and more optimistic about their chances of abstinence. However, they
also saw abstinence as more difficult. The differences in time to relapse--i.e.,
the longer time to relapse for smokers--support their optimism. The source of
these differences is not clear.
It is possible that smokers’ combined optimism and realism reflect global attitudes
toward treatment. Smokers who enter treatment may have more faith in it than
do members of the other two drug treatment classes. It may be that a “smokers
subculture” is not one which devalues some forms of treatment, as may be the
case for some alcoholics and heroin addicts (Brown et al. 1972, 1975; Sutker et al.
1978). Also, the data show the smokers have tried to quit fewer times and
therefore have had fewer failure experiences. Failure may breed more failure as
confidence in one’s ability to quit is decreased by negative experiences.
The data indicate few differences between drug groups on subjective experience
during the post-treatment followup period. The classes  do not  differ
significantly on negative moods or on day-to-day life stresses (Hassles). Opiate
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addicts do report more withdrawal symptoms than do members of the other two
groups.
The interactions we expected to find between negative subjective experience
during the posttreatment period and level of commitment to abstinence are not
yet detectable. A larger sample size may be needed to detect such differences, if
they are present.
These are preliminary data. As such, interpretations of them must be regarded
with considerable caution. They do seem to indicate that commitment to
abstinence, a little studied factor, may be a fruitful variable to address. While
other variables--such as stress, affect, and life events--are perhaps more
fashionable, their potential as predictors has not yet been realized in this study.
It is of theoretical interest to know that certain ways of thinking about
abstinence may increase the probability of maintaining it. This knowledge is of
little clinical utility unless it can be translated into behaviors that prevent relapse
in risky situations or those that prevent the client from ever entering such
situations. Such specific knowledge may ultimately lead to useful therapeutic
techniques. Similarly, factors leading to the development of this way of thinking
and the therapeutic and environmental events that control it should be explored.
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INTRODUCTION
Relapse is a central aspect of the concept of opiate addiction (Lindesmith 1968;
Catalano and Hawkins 1985). The inability to stop opiate use is what most
people have in mind when they say that someone is “addicted” to opiates. During
their careers, most opiate addicts in fact seek primary drug-user treatment to
help them stop opiate use (McAuliffe 1975). Many achieve abstinence on their
own or by successfully completing some form of primary treatment, be it simple
detoxification, counseling, therapeutic community, or methadone maintenance.
Unfortunately, followup studies have found relapse rates to be around 50 percent
for methadone maintenance graduates (Brown et al. 1975; Cushman 1974;
Lowinson and Langrod 1973; Riordan et al. 1976; Stimmel and Rabin 1974),
about 66 percent for those who completed outpatient methadone detoxification
(Maddux et al. 1980), 10 percent for therapeutic community graduates (Smart
1976), and between 50 percent and 90 percent for dischargees from the Public
Health Service Hospital in Lexington, Kentucky (O’Donnell 1965; Stephens and
Cottrell 1972). Most opiate addicts relapse repeatedly over their disease course,
even after substantial periods of abstinence (McAuliffe 1975; Waldorf 1973).
Consequently, many theorists (e.g., Lindesmith 1968; Wikler 1965) now regard the
tendency to relapse as one of the defining characteristics of addiction.
Despite the conceptual importance of relapse and the great economic and human
cost of cycles of repeated treatment and re-addiction, relatively few researchers
have studied the causes of relapse as distinct from the causes of treatment
failure. Most field studies of relapse to date have focused on measuring the
frequency of relapse or its timing (e.g., O’Donnell 1965; Hunt and Bespalec
1974). A much smaller number of empirical studies have sought to discover the
predictors and causes of relapse (e.g., Alksne 1955; Ball and Snarr 1969; Brill et
al. 1972; Brown et al. 1971; Joe and Simpson 1983; Jorques 1983; Maddux and
Desmond 1981; McAuliffe 1982; Simpson et al. 1979; Stephens and Cottrell 1972;
Vaillant 1969; Waldorf 1973. 1979, 1983; Wikler and Pescor 1967; Willie 1983;
Winick 1962, 1964).
Most of these pioneering studies have been retrospective or cross-sectional in
design. Some researchers (e.g., Alksne et al. 1955; Brill et al. 1972; McAuliffe
1982; Waldorf 1973) simply asked long-term addicts why they had relapsed, and
then summarized the responses statistically or in a theory of relapse. Other
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researchers (e.g.. Winick 1962) correlated demographic variables with patient
outcomes and then speculated about the meaning of the results, e.g., interpreting
the relationship between age and relapse as a matter of maturation or burnout.
Although valuable first steps for generating hypotheses, retrospective studies are
vulnerable to after-the-fact rationalization by the subjects themselves, as well as
biases in the sampling frame (Robins 1966), and demographic correlations with
relapse are open to varying interpretations.
The studies to date have produced promising hypotheses and causal models (e.g.,
Marlatt and Gordon 1979; Catalano and Hawkins 1985; Milkman et al.
1983/1984), but few have attempted to explore these models systematically.
Many of the statistical studies have examined the relationship of one measure at
a time with relapse (e.g., Winick 1964). Other statistical studies of relapse have
used multivariate methods but have often employed exploratory or prediction-
oriented model specification methods, such as step-wise regression, that select
variables solely on statistical rather than theoretical for testing theoretical models.
The recent study by Jose and Simpson (1983) represents an important early
attempt to investigate relapse using multivariate statistical models specified
theoretically, although the authors apparently had to rely on existing measures as
indicators rather than on measures specifically designed for this purpose.
The present study sought to build upon the previous studies. Prospective in
design, it measured concepts from several leading theories of relapse at the point
of the subjects’ satisfactory completion of treatment. and then re-interviewed the
subjects at 6 months and 12 months to determine the extent of relapse to opiate
use. Since the study is not yet completed, this report describes the study’s
implementation to date and presents preliminary findings regarding conditioning
models of relapse from the baseline (at discharge from treatment) and the 6-
month followup data obtained thus far.
METHODS
Recruitment Plan and Followup
The 184 subjects for this study included four types: 1) “imminent completers”
(67 percent) or 2) recent completers (14 percent) of treatment programs for
opiate addiction; 3) completers of after care programs (12 percent); and 4) long-
term clients of open-ended drug counseling (7 percent). For the purpose of this
study, “completers” are persons discharged from treatment on recommendation of
treatment staff. Interviews were conducted within an average of 1 week before
or after discharge. Since outpatient drug-free counseling tends to be open-
ended, the research design assumed that clients who had been doing well in
counseling for 6 months or more were equivalent to other treatment completers;
clients from open-ended aftercare programs were treated similarly. Addicts in
corrections facilities were eligible only if they were completing a prison-based
drug treatment program.
Recruitment began in the spring of 1981 and included a large number of
treatment programs in the Boston and surrounding areas (47 programs in all).
Staff contacted each program frequently to determine when an opiate-addicted
client would be completing treatment. In order to insure a wide variation in the
hypothesized causes of relapses, the recruiters tried to obtain approximately equal
numbers in the eight-cell design presented in table 1. The design assumes a
rough correspondence between levels of three broad factors that are thought to
be related to recovery: time since last period of physiological dependence,
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psychological adjustment (motivation, attitude), and social adjustment (resources
and stability). Since the factors were measured only after a subject was
recruited, we assumed that the clients from particular modalities would
approximate the characteristics of particular cells. As table 1 shows, while some
cells were clearly harder to fill than others, we have obtained a sample of
subjects who have a wide range of treatment experience and therefore should
have ample variation in relapse experiences and their causes. All subjects
provided baseline data on hypothesized causes of relapse and background
characteristics during a 2-hour interview.
We have thus far achieved good results in obtaining 6-month followup data on
these 184 subjects. All  of  the subjects  have reached their  6-month
anniversaries: 94 percent have provided followup data, 2 percent refused or
could not be located, and 4 percent are overdue but still being pursued. To
obtain this response rate, the research staff employed the same persistence and
field techniques developed and used successfully by previous addict researchers
(Nurco et al. 1977; Robins 1966; Robins et al. 1974; Maddux and Desmond 1981;
Bale et al. 1984).
RESULTS
Demographic Characteristics
As one would expect for a sample of treatment graduates, including ones from
pain clinics and aftercare programs, this sample is somewhat older; better
educated; and more often employed, non-minority, and married than the typical
opiate addict sample. Of the 184 subject, 71 percent were males. The samples’
median age was 32 years old, with a range from 21 to 63. The subjects had
attended a median of 12.3 years of school, with one having attended as few as 3
years while another had attended as many as 4 years of graduate school. At the
time of the interview, 59 percent of the subjects were working, but 77 percent
had worked some of the immediately preceding year (a median of 6.6 months).
Of those 75 subjects who were unemployed, one-third were either disabled
(n=11), receiving welfare (n=1) or workmen’s compensation (n=3), in school full
time (n=6), supported by spouses (n=2), receiving prolonged severance pay (n=1),
or had a job waiting for them on discharge (n=1). The sample’s median
occupational prestige score for the current or last job held was 32.8, which is
approximately the score for a truck driver (Featherman et al. 1975). Whites
comprised 79 percent of the sample, blacks 18 percent, and Hispanics 3 percent.
Forty-nine percent of the sample were single, 22 percent married, 28 percent
separated or divorced, and 1 percent widowed.
Drug Addiction History
The sample members were all primary opiate addicts. They had first been
opiate-addicted a median of 9.3 years prior to the baseline interview (range = 0.3
to 25.3 years). Of course, many had intervening periods of abstinence--
voluntary or involuntary--and periods of intermittent drug use. When these
periods are excluded, the average “net” length of addiction was 4.5 years, with a
range from 2 months to 16 years. During the year prior to the baseline
interview, the subjects used illicit opiates a median of 98 days. Seventy-five
percent of the subjects began opiate drug use for the reasons usually cited for
recreational addiction (to get high, curiosity, to go along with others); the rest
cited medical reasons.
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TABLE 1
Recruitment Design: Programs, Sample Size,
and Percent of Entire Sample
Time Since Dependence
Short
(less than 3 months)
Long
(3 months or more)
Psychological
Adjustment
Social Adjustment Social Adjustment TOTAL
Low High Low High
HIGH
Methadone Pain Therapeutic
Maintenance Clinic Community
12 (6%) 24 (13%) 42 (23%)
Low
Pubilc In-
patient
Detox [30]/
Out-patient
Short-term
Methadone
Detox [3]
33 (18%)
Private, Corrections
Inpatient Drug Coun-
Detox in seling
Psychiatric
Hospital
31 (17%) 5 (3%)
Aftercare
27 (15%) 105
outpatient
Drug Free
10 (5%) 79
TOTAL 45 55 47 37 184
Note: Cell entries are 1) the modality of treatment, 2) the number of subjects
recruited from that modality, and 3) the percentage of the entire sample
recruited from that modality.
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Extent of Relapse at 6 Months
As reflected by differences in definitions across studies in this volume, the
precise meaning of “relapse” may vary widely. This chapter assumes that,
theoretically, relapse during the followup period is a continuous variable ranging
from complete abstinence to daily use. Although abstinence and relapse are
categorical concepts in layman’s terms and in some of the early scientific
literature (e.g., Ray 1961), recent research (e.g., Zinberg and Jacobson 1976;
Kurland et al. 1969; McAuliffe et al. 1985a) has shown that drug use by addicts
following treatment may assume a variety of patterns covering the entire
continuum of use. Moreover, the operant and respondent conditioning model of
opiate use that guides this research (McAuliffe and Gordon 1980; McAuliffe and
Ch’ien 1986) views addiction as a quantitative variable reflecting the strength of
the drug-taking response. A continuous concept of relapse has the advantage of
including the entire range of opiate use outcomes. The present authors hold that
it makes little sense to consider any recurrence of a chronic disease as a complete
failure to treatment: a more realistic approach is to view amelioration rather
than cure as the goal of drug treatment. If so, extent of opiate use during
followup reflects the degree of relapse.
Consistent with this theoretical view, this chapter employs two operational
definitions of relapse: 1) the number of days of opiate use during 6 months
following completion of a treatment program, and 2) a series of ordered
categories summarizing the amount of opiate use during the 6 months as shown
in table 2. While both measures are based on the same data, the first measure
describes the central tendency of the responses, whereas the second describes
their overall distribution. The validity of these “behavioral” measures was
demonstrated in our previous research (McAuliffe et al. 1985a), and in
methodological research by others (Amsel et al. 1976; Bale 1979; Maddux and
Desmond 1975; Pompi and Shreiner 1979; Stephens 1972). In the present study,
however, we tested the measures further by correlating them with seven-point
semantic differential items indicating the extent of being “addicted” versus “non-
addicted” and the extend “on opiates” and “off opiates” at followup. (For baseline
versions of these measures, see items 3 and 4 in table 3 below.) The correlations
were .56 and .71 respectively, indicating a statistically significant degree of
convergent validity (Campbell and Fiske 1959) between the behavioral measures
and the semantic differential measures of relapse at followup.
Inspection of table 2 reveals a wide range of relapse experience over the
modalities of treatment. At one end of the continuum, a majority of the clients
completing publicly funded short-term detoxification program (PDX) had periods
of daily opiate use, whereas at the other end almost all of the clients in aftercare
(AFT) and outpatient drug-free programs (OPDF) were entirely abstinent or had
only rare slips during the 6-month followup period. The mean days of opiate
use was 31 for the entire sample, and ranged from 4 to 83 across modalities,
reflecting statistically significant variation in opiate use during followup over
modalities of treatment. It is also notable that the relapse experiences of the
clients treated in particular modalities coincided reasonably well with our
sampling design based on the time since detoxification and our judgment about
the social and psychological characteristics of clients the different programs
graduated.
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TABLE 2
Outcome of Followup at 6 Months by Modality
Time Since Dependence
Short Long
(less thatn 3 months) (3 months or more)
Outcome
Abstinant or
Pam Slips
% % % % % % % %
(less than
6 days 26 50 46 70 80 82 90 89
Occasional
Use (6 to
25 days
Regular Use
(26 to 104
days)
3 9 7
7 6 18
4 0 3 0 3
17 0 0 0 4
Daily or Near
Daily (105 to
182 days or min.
2 wks daily), 62 33 29 9 20 15 10 4
Refused.
100 100 100 100 100 100 100 100
Mean Days of
Opiate Use 83 57 47 23 37 21 6 4*
n 29 12 28 23 5 39 10 27
In process 4 0 3 1 0 3 0 0
33 12 3 1 4 5 42 10 27
* Differences across all modalities is significant at the .001 level
141
TABLE 3
Correlations Among Measures of
Psychological Addiction at Baseline
Correlations
Measure (coding) 1 2 3 4
1.
2.
3.
4.
5.
How often do you feel
a craving or need for
opiates? (5 = several
times a day; 0 = never) 
Are you currenetly psy-
chologically addicted
to or dependent on
opiates? (l = yes, 0 = no) .64
Myself as I am today:
(7 = addicted, 1 = non-
addicted) .49 .56
Myself as I am today:
(1 = off opiates; 7 = on
opiates) .45 .47 .44
Number of days of
illlicit opiate use
during the year prior
to interview .45 .32 .35 .27
Note: n = 143 for all correlations, due to individual item non-response. All
of the correlations are significant at the .001 level.
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Conditioning Theories of Relapse
Conditioning theories provide a common background for several major models of
relapse (Lindesmith 1968; McAuliffe and Gordon 1980; Vaillant 1969; Wikler
1965), but these models differ in the emphasis they place on particular
reinforcing stimuli. This chapter will examine data that are relevant to this issue.
Craving at Discharge
Before considering the question of which reinforcing and conditioned stimuli are
most important in the relapse process, the analysis will first estimate the common
causal assumption of these models--that the extent of relapse is a function of the
degree of addiction. Addiction in these analyses is assumed to be reflected by
the extent of craving, which the questionnaire measured by asking, “Right now,
how often do you feel a craving or need for opiates.” The questionnaire format
allowed answers ranging from “never” (scored 0) to “more than once a day”
(scored 5). The mean craving response at baseline (discharge) was 2.2, which
represents slightly more than once per week. However, 31 percent of the
subjects said they never craved, while another 31 percent said they craved
opiates more than once a day.
The validity of the craving measure was tested by correlating it with several
other questionnaire items measuring addition at baseline (table 3). A variety of
items measuring the same concept was included in the questionnaire to insure
reliability and to measure the extent to which the scores vary depending on
differing response formats. As table 3 shows, the craving measures, two of
which (2 and 3) ask about addiction directly and two of which (4 and 5) ask
about the cause of addiction (opiate use). The overall consistency between the
different measures indicates that they appear to focus on the same underlying
concept.
A goal of any treatment for opiate addiction, regardless of its theoretical
underpinning, is to reduce craving. (“Addiction” in this chapter is defined as a
psychological rather than a physiological state.) Table 4 reveals that modalities
differ significantly in the extent to which they have eliminated their clients’
craving and psychological addiction by discharge (see item 2 in table 3 for
description of psychological addiction). Those discharged from short-term
programs, including public and private inpatient detoxification programs and
pain clinics, had high craving rates. The relatively low percentage of pain
patients admitting to psychological “addiction” may be a reflection of pain clinics’
ideology, which denies that their patients are “addicts” while allowing that the
patients are “drug dependent.” Despite long periods in treatment, subject from
methadone maintenance programs were usually detoxified immediately before the
baseline interview and consequently were experiencing craving as often as the
short-term patients. By contract, clients from the long-term drug free programs
(OPDF, AFT, TC), even programs located in prisons (CORR), reported much
lower levels of craving and psychological addition than did clients from short-
term programs. It is noteworthy that all long-term clients were either
outpatients, halfway house, or re-entry facility residents. By contract, all the
recently detoxified clients, except methadone maintenance graduates, were
inpatients. Thus, the recently detoxified clients reported more craving than did
the long-term clients, even though at the same time of the interview the recently
detoxified group was much less exposed to environmental cues that might cause
craving than was the long-term group.
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TABLE 4
Craving by Type of Program
Mean Frequency % Psychologi-
Type of Program of Cravinga ca1ly Addicted n
Public Detoxification 3.4 66 29
Methadone Maintenance 3.3 73 12
Private Pychiatric 3.2 61 28
Pain Clinic 2.3 29 24
Corrections 2.0 60 4
Outpatient Drug Free 1.7 44 10
Aftercare 1.0 26 27
Therapeutic Community 1.0 13 39
TOTAL 2.2 41 173
Significant p<.01 p<.01
aCraving scale: 0 = never, 1 = less than once a week , 2 = once per week,
3 = several times a day, 4 = once a day, 5 = more than
once per day.
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The obvious correspondence between the rates of craving in table 4 and relapse
rates across modalities in table 2 suggested the need to examine the relationship
between craving and relapse directly. Bivariate regression analysis found that the
extent of craving explained a significant amount of the variation in relapse (the
standardized regression coefficient was .30, p < .001), and the relationship
remained significant when the effects of the individual modalities of treatment
were controlled statistically (standardized b = .16, p < .05).
The Causes of Craving
Since craving at discharge and the extent of relapse at followup appear to be
related, as conditioning theories suggest that they would be, one naturally turns
to consideration of what the precise cause of craving is. Conditioning theory
itself is neutral on this point, since a response such as drug taking may be
reinforced in a variety of ways (Carr 1984; McAuliffe and Gordon 1980;
McAuliffe et al. 1985b). Consequently, a variety of conditioned cues may
stimulate craving, and theorists differ on which cues are most important. On the
one hand, some authors (Lindesmith 1968; Wikler 1965; O’Brien et al. 1981) view
relief and avoidance of withdrawal sickness as the most important source of
reinforcement for chronic opiate use. They have emphasized conditioned
withdrawal and cues similar to withdrawal as factors in causing relapse.
Lindesmith (1968), for example, speculated that avoidance of withdrawal distress
by opiates generalizes to avoidance of any distress, and that long after
detoxification, addicts may return to opiate use in response to distress of various
kinds.
On the other hand, McAuliffe (1982) and McAuliffe and Gordon (1980) place
greater emphasis on a wide range of conditioned stimuli, such as those associated
with euphoria seeking, pain relief, and anxiety reduction. These stimuli are
present in the addict’s environment, independent of withdrawal and the level of
physiological dependence, and are not systematically extinguished during the
course of most primary drug treatment (McAuliffe and Ch’ien 1986).
The present study took two approaches to the question of which cues are most
important. The first was to ask subjects what was currently causing them to
crave; and describing to them certain verbal pictures associated with different
reinforcers, in order to determine how much the cues would cause them to crave
during the interview. Tables 5 and 6 present the results of these efforts. The
second approach employed causal modeling and is described below.
For table 5, subjects who had reported some current craving were told, “I want
to know what are the things that cause you to crave (desire or need to use)
opiates. I'll read the reason, and you tell me how important it is for you.” The
response categories were “very,” “somewhat,” slightly,” and “not at all important.”"
Table 5 shows that the reasons with the highest overall ratings reflect craving
caused by anxiety, depression, and euphoric effects. Least important in the
addicts’ own judgment were both unconditioned and conditioned withdrawal
sickness, socializing, and need for sexual facilitation.
However, the importance of some of these causes varied significantly from
modality to modality, primarily reflecting differences in the time since the last
detoxification. As a group, clients from short-term detoxification programs and
methadone maintenance gave highest importance to unconditioned withdrawal
sickness and euphoria seeking. By contrast, clients from long-term drug-free
programs hardly mentioned withdrawal but did emphasize the negative effective
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TABLE 5
Mean Importance of Reasons for Current Craving
Time Since Physiological Dependence
Short Long
(less than 3 months (3 months or more)
Reasons for PDX MM Psy  Pain COFR TC OPDF AFT
Craving (n= (n= (n= (n= (n= (n= (n= (n=
26) 10) 22) 16) 3) 20) 17) 121)
You are anxious and know
that the drug will give
you relief 2.5 2.6
You just want to take it
because it feels good 2.1 2.0
You're feeling depressed 2.1 1.9
You are urder pressure
and you want to relax 2.0 1.7
You are having trouble
handling thing and you
know that you would fun-
tion better if you took
an opiate drug 1.7 1.9
You're angry with some-
one or about something 1.4 1.0
You don't feel quite
right" off drugs 1.6 2.1
You remember going
through withdrawal and 
the memory makes you
feel uncomfortable or
drug sick 1.5 1.9
You feel sick from the
lack of drugs (withdrawal) 1.8 2.3
You're getting ready to
socialize with friends 1.0 1.4
You want to enjoy sex
or find a sex partnew 0.6 0.6
2.4 1.3
1.9 0.9
1.6 0.6
1.2 0.9
1.4 0.6
1.1 0.6
1.8 0.8
1.2 0.6
2.1 0.4
1.1 0.6
0.5 0.5
2.7 1.4 2.7 1.7*
3.0 1.6 1.9 1.4*
1.7 2.0 2.0 1.7*
2.5 1.6 2.0 1.8*
1.7 1.2 1.6 1.4
1.5 1.6 1.3 0.9
2.0 0.9 1.1 0.7'
1.0 0.8 1.1 1.1
0.0 0.3 0.7 0.2*
0.7 1.1 0.6 1.2
1.5 0.6 0.3 0.5
2.0
1.7
1.7
1.6
1.4
1.2
1.3
1.2
1.2
1.0
0.6
* Statistically significant differences across modalities
Note: Importance ratings: 3 = very, 2 = samewhat, 1 = slightly, 0 = not at all
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TABLE 6
Craving Cures: Response to Hypothetical Situations
Presented as Stimuli During Interview
Cues PDX  MM  PhysPAIN C O P R TC  OPDF  AFT  TOTAL
(n=26) (n=10) (n=22) (n=16) (n=3) (n=20) (n=17) (n=121)
You are in a situ-
ation in which
you otfen used
opiates before 2.3 2.1 2.3
You remember
really enjoying
how good the feel-
ing of being under
the influence of
opiates was 2.3 2.1 2.3
You open the medi-
cine cabinet at a
friend's house end
there is a bottle
of opiates on the
shelf 1.6 2.1 2.2
Your dentist offers
to give you a pres-
cription of opiates
for a toothache 1.9
You hurt your back
and the pain is
keeping you awake 1.6
2.4 2.5
2.3 2.5
You see someone
else taking a drug 2.1
You win on the
state lottery and
suddenly you have
some extra cash
to spend 2.4
You're really bored
with nothing to do 1.9
You are going out
with a close friend
and really want to
celebrate 1.5
1.9
1.8
1.2
1.7
2.0
1.9
1.5
1.5
1.1
0.6
0.7
1.1
1.5
0.5
0.2
0.4
0.4
2.6 1.9 2.1 1.9* 2.0
2.6 1.7 1.7 1.9
2.2 2.0 2.0 1.6
2.2 1.4 1.9 1.6
2.4 1.3
2.4 1.6
2.4 1.6
1.6
0.6
1.3
0.9
1.4
1.7
1.9
1.3
0.7
2.1*
1.8*
1.8*
1.5*
2.0*
1.1*
1.3*
0.8*
1.7
1.7
1.6
1.3
1.1
* Statistically significant differences accross modalities
Ratings: 3 = a lot, 2 = some, 1 = a little, 0 = not at all
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TABLE 6 (Continued)
Cues PDX MM Psy PAIN CORR TC OPDF AFT TOTAL
(n=26) (n=10) (n=22) (n=16) (n=3) (n=20) (n=7) (n=17) (n=121)
You are watching a
movie or a TV show
depicting the story
of a person who is
about to use opi-
ates after being
in a cold sweat
and yawning 1.0
There is an empty
bottle of druqs on
the table and you
start to think that
you'll soon be
feeling drug sick 1.2
You catch a cold.
you're nose is run-
ning and you're
feeling really bad 1.2
Talking about drugs
in an interivew
like this one 0.8
You need a book or
magazine article
about someone goinq
through severe
witdrawal 0.6
1.0
1.4
1.5
0.8
0.9
1.3
1.4
1.3
1.0
0.2
0.2
0.3
0.3
0.4
0.1
2.2
2.0
1.4
1.6
0.4
0.9
0.8
0.7
0.7
0.2
1.2 1.2* 1.0
1.1 0.9* 1.0
0.7 0.8* 0.9
1.3 0.9 0.6
0.5 0.4* 0.4
* Statistically significant differences across modalitities
Ratings: 3 = a lot, 2 = some, 1 = a little, 0 = not at all
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state of being under pressure. Even though they were recently detoxified, pain
patients did not rate withdrawal items as important, most likely because they
typically took opiates in small regular doses and therefore key discriminative
stimuli for them were the clock and pain rather than withdrawal distress
(McAuliffe et al. 1985b). The reasonableness of these findings suggests that the
addicts may well have insight into the causes of their craving.
Table 6 presents the results of a slightly different question, one that attempts to
elicit craving during the interview by presenting verbal stimuli (vignettes) to the
respondents. All subjects, including those not currently bothered by craving,
were told, "I’m going to describe situations that could happen to you. Take a
minute or two to picture each situation in your mind. Then, tell me how much
it makes you feel an urge for opiates, even if you would NOT give in to the
urge.” The situations were specifically designed to distinguish conditioned
withdrawal from euphoria seeking and other motives.
The results in table 6 indicate that situations previously associated with drug use
(item l), euphoric effects (2), having ample supplies of opiates available (3 and
4). and pain (4 and 5) caused the most craving, whereas situations associated with
withdrawal sickness and relief of withdrawal (items 10, 11, 12 and 14) caused the
least. As in the previous set of items, pain patients responded differently from
most of the other clients: they experienced urges only in response to pain--back
and dental. Only subjects in corrections programs responded to the withdrawal-
associated stimuli. With occasional exceptions, clients from the remaining
modalities responded similarly to each other over the various stimuli. Thus, the
combined results of these two sets of items suggest that stimuli associated with
euphoric effects and high availability (which often translates into euphoria) and
with relief of negative feeling states (anxiety and depression) were most likely to
cause craving in persons graduating from drug treatment.
Causal Model of Relapse
To test these same hypotheses using statistical causal modeling, we estimated a
preliminary model of the relapse process at 6 months following discharge (figure
1). The model included a composite index of anxiety and depression items from
the Hopkins Symptom Checklist (DeRogatis et al. 1974); euphoria seeking (item 2
from table 6 plus the subject’s response to a question on his/her willingness to
take a constant, lifelong euphoria pill); a measure of current physical pain,
degree of current physiological dependence (one item); responsiveness to
conditioned withdrawal stimuli (items 10 and 11 from table 6); time since
detoxification; amount of opiate use during the year prior to the baseline
interview; number of “extinction trials” (times when drugs were available but not
used since detoxification); and opiate availability at baseline. The zero-order
correlations of the independent variables with relapse at 6 months are presented
in table 7. They show that relapse had a number of significant predictors, pain
being the weakest in this set of variables and availability at baseline having a
small negative zero-order correlation with opiate use during followup.
The results of the causal modeling in figure 1 showed that the effects on relapse
of most variables, except physical dependence, were felt through craving. When
craving and physiological dependence were included in a regressing analysis of
relapse, none of the other factors had significant direct path coefficients to
relapse. Craving itself was a significant function of the amount of opiate use in
the past year (which may be thought of as roughly reflecting the number of
reinforced trials) and several stimuli, including anxiety and depression,
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FIGURE 1
Conditioning Model of Relapse
TABLE 7
Zero-order Correlations of Independent Variables with
Days of Opiate Use During the 6-Month Followup Period
Independent correlation with
Variable Days of Opiate Use P value
During Followup
Months since detoxification
at baseline
Craving
Physical Dependence
Number or Extinction
Trials
Euphoria Seeking
Depression and Anxiety
Conditioned Withdrawal
Availability
Pain
-.31 .01
.30 .01
.25 .01
-.25 .01
.20 .01
.16 .02
.14 .08
-.10 .09
-.01 .47
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unconditioned and conditioned withdrawal sickness, and euphoria-seeking. The
sizes of these latter path coefficients were all roughly equivalent to each other.
One surprising result was the lack of a significant effect of availability on
craving. This effect was previously demonstrated experimentally by Meyer and
Mirin (1978) and, therefore, was left in the present model despite its lack of
statistical significance. Since the availability at baseline also did not affect
relapse directly, in our subsequent work on these data we will have to examine
this measure more closely. The most likely explanation of this result is that
availability may change rapidly soon after discharge; therefore, availability just
before discharge may not be a good long-term predictor of relapse. Also, the
pain measure had a negative effect on craving, a result which will require closer
investigation. The most likely explanation is that pain clinic patients had the
highest scores on the pain measure, but only moderate scores on craving.
Overall, however, the fit of the data to theoretical expectations is good.
DISCUSSION
We must emphasize first of all that these are preliminary results from a study
still in the field collecting and processing data. As the project proceeds, the
results will almost certainly change to some degree, although the conclusions
should remain basically the same.
The results of our field effort are encouraging. The research team has recruited
subjects in similar situations from a wide range of modalities, despite the fact
that treatment graduates for modalities, such as methadone maintenance, are a
comparatively rare species. Interviewers have succeeded in obtaining 6-month
followup interviews with 94 percent of the sample. Almost as many 12-month
followup interviews have been completed. Moreover, a validity check of key
variables indicates that the data are clean.
Several substantive findings stand out. As expected, the modalities varied widely
in outcomes during the first 6 months. We were also able to predict these
outcomes rather  well  with a  sampling design based on the t ime s ince
detoxification and the kinds of clients who were admitted. The findings also
confirm the theoretical importance of craving at discharge as a factor in
understanding relapse, even after the type of drug treatment program a subject
graduated from is controlled. Except for physical dependence, other major
hypothesized causes of relapse appeared to affect relapse primarily through their
ability to cause craving. The most important factors in this regard were the
amount of recent drug use, physiological dependence, anxiety and depression,
conditioned withdrawal sickness, and euphoria seeking. Again, we must
emphasize the preliminary nature of these analyses.
Although a part of the evidence suggested that some of these factors may be
slightly more important than others, the safest conclusion at this point in the
study is that the evidence as a whole favors an important role for each. The
differences in importance of withdrawal from one analysis to the next probably
reflect differences in what is being addressed in each analysis. The data in table
6 and figure I reflect the ability of stimuli to elicit craving when those stimuli
do occur in the vignette. However, since powerful stimuli may actually occur
infrequently during followup, they may play a relatively insignificant role in
predicting relapse during followup (table 7). In a previous study, McAuliffe
(1982) found that conditioned withdrawal symptoms occurred in many subjects,
but only in a few of those cases did those symptoms cause relapse.
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Clinical Implications
Research on relapse should have important clinical implications. Clients in
treatment and aftercare programs should be educated regarding the course of
their disease and the prospects for recovery when certain events, such as a “slip”
or “lapse” occur. Recovering addicts benefit from knowing what the major
causes of craving and relapse are and how they can be avoided (McAuliffe and
Ch’ien 1986). Studies of addict careers--as well as studies of the causes of
relapse--can, therefore, be quite useful in treatment if the findings are
communicated effectively to drug counselors and their clients, and systematically
incorporated into relapse prevention programs (e.g., Zackon et al. 1985; Marlatt
and Gordon 1979).
Evidence in the present study on relapse rates and craving across modality
suggests a change in clinical emphasis. Completers of long-term drug-free
programs and aftercare report less craving and were less likely to relapse. Highly
motivated clients from short-term programs and methadone maintenance should
be channeled into these drug-free modalities in order to reduce craving, with the
promise that satisfactory completion of the program offers the best chance of
recovery.
Finally, the discussion of the meaning and measurement of relapse has
implications for treatment policy. The present research and the author’s previous
work (McAuliffe et al. 1985a) indicates that a single episode of opiate use does
not necessarily imply a high degree of relapse long-term. studies which define
relapse as any use of the drug of abuse produce the highest possible relapse rates,
and thereby can create an atmosphere of therapeutic pessimism for clinicians and
policymakers. Research presented in this volume clearly demonstrates that
addiction is a chronic disease. A chronic disease model of addiction would take
amelioration rather than absolute cure as a realistic treatment goal; the
measurement of relapse should ideally be consistent with this goal.
REFERENCES
Alksne, H.; Trussell, R.E.; Elinson, J.; and Patrick, P. A Follow-up Study of
Treated Adolescent Narcotics Users. New York: Columbia University School
of Public Health and Administrative Medicine, 1955.
Amsel, Z.; Mandell, W.; Matthias, L.; Mason, C.; and Hocherman, I. Reliability
and validity of self-reported illegal activities and drug use collected from
narcotic addicts. Int J Addict 11(2):325-36, 1976.
Bale, R.N. The validity and reliability of self-reported data from heroin
addicts: Mailed questionnaires compared to face-to-face interviews. Int J
Addict 14(7):993-1000, 1979.
Bale, R.N.; Arnoldussen, B.H.; and Quittner, A.M. Follow-up difficulty with
substance abusers: Predictors of time to locate and relationship to outcome.
Int J Addict 19(8):885-902, 1984.
Ball, J.C., and Snarr, R.W. A test of the maturation hypothesis with respect to
opiate addiction. Bulletin on Narcotics 21:9-13, 1969.
Brill, L.; Nash, G.; and Langrod, J. The dynamics of de-addiction: A pilot
study. In: Brill, L., and Lieberman, L., eds. Major Modalities in the
Treatment of Drug Abuse. New York: Behavioral Publications, 1972. pp.
287-307.
Brown, B.S.; Gauvey, S.K.; Meyers, M.B.; and Stark, S.D. In their own
words: Addict’s reasons for initiating and withdrawing from heroin. In: Int
J Addict 6(December):635-645, 1971.
153
Brown, B.S.; Benante, J.; Greenberg, M.; and MacArthur, M. Study of
methadone terminations. Br J Addict 70(1):83-88, 1975.
Campbell, D.T.; and Fiske, D.W. Convergent and discriminant validation by the
multitrait-multimethod matrix. Psych Bull 56:81-105, 1953.
Catalano, R.F., and Hawkins, J.D. Project skills: Preliminary results from a
theoretically based aftercare experiment. In: Sherry, R.A., ed. Progress in
the Development of Cost-Effective Treatment for Drug Abusers. National
Institute on Drug Abuse Research Monograph 58, 1985. pp. 157-8.
Carr, K.D. The physiology of opiate hedonic effects and the role of opioids in
motivated behavior. Adv Alc Subst Abuse 3(5):51-18, 1984.
Cushman, P. Detoxification of rehabilitated methadone patients: Frequency and
predictors of long-term success. Am J Drug Alc Abuse 1(3):393-408, 1974.
Featherman, D.L.; Sobel, M.; and Dickens, D. A manual for coding occupations
and industries into detailed 1970 categories and a listing of 1970-basis
Duncan socioeconomic and NORC prestige scores, University of Wisconsin-
Madison: Center for Demography and Ecology, Working Paper 75-1, 1975.
Hunt, W.A., and Bespalec, D.A. Relapse rates after treatment for heroin
addiction. J Commun Psychol 2(1):85-87, 1974.
Joe, G.W., and Simpson, D.D. Social factors related to the follow-up status of
opioid addicts. J Psychoactive Drugs 15(3):207-17, 1983.
Jorques, J.S. The retirement phase of heroin using careers. J Drug Issues
13(3)343-65, 1983.
Kurland, A.A.; Kerman, F.; Wurmser, L.; and Kokoski, R. Intermittent patterns
of narcotic usage. In: Cole, J.O., and Wittenborn, J.R., eds. Drug Abuse;
Social and Psychopharmacological Aspects. Springfield, IL: Charles C.
Thomas, 1069. pp. 129-45.
Lindesmith, A.R. Addiction and Opiates Chicago: Aldine, 1968.
Lowinson, J., and Langrod, J. Detoxification of long-term methadone patients.
Proceedings of the 5th National Conference on Methadone, 1973. pp. 256-
261.
Maddux, J.F., and Desmond, D.P. Reliability and validity of information from
chronic heroin users. J Psychiat Res 12:87-95, 1975.
Maddux, J.F., and Desmond, D.P. Careers of Opioid Users. New
York: Praeger, 1981.
Maddux, J.F.; Desmond, D.P.; and Esquivel, M. Outpatient methadone
withdrawal for heroin dependence. An J Drug Alc Abuse 7(3&4):323-333,
1980.
Marlatt, G.A., and Gordon, J.R. Determinants of relapse: Implications for the
maintenance of behavior change. In: Davidson, P., ed. Behavioral Medicine;
Charming Health Lifestyles. New York: Bruner-Mazel, 1979. pp. 410-450.
McAuliffe, W.E. Beyond secondary deviance: Negative labeling and its effects
on the heroin addict. In: Gove, W.R., ed. Labeling Approach to Deviant
Behavior; The Evaluation of a Perspective. New York: Halsted/Sage, 1975.
pp. 205-242.
McAuliffe, W.E. A test of Wikler’s theory of relapse: The frequency of relapse
due to conditioned withdrawal sickness. Int J Addict 17(10:19-33, 1982.
McAuliffe, W.E., and Gordon, R.A. Reinforcement and the combination of
effects: Summary of a theory of opiate addiction. In: Lettieri, D.J.; Sayers,
M.; and Pearson, H.W, eds. Theories on Drug Abuse: Selected Contemporary
Perspectives. National Institute of Drug Abuse Research Monograph 30,
1980.
154
McAuliffe, W.E.; Ch’ien, J.M.; Zackon, F.; Tang, W.C.Y.; Friedman, R.; Sun,
F.K.C.; Layner, E.; and Lo, P.C. A cross-cultural randomized trial of
aftercare for treated addicts. In: Stumpf, K.L.; Ch’ien, J.M.N.; MacQuarrie,
O.W.; Lam, I.; and Lam, E., eds. Towards a Coordinated Approach; Current
Issues and Future Directions, Proceedings of the 2nd Pan Pacific Conference
on Drugs and Alcohol, Hong Kong, 1985a.
M c A u l i f f e ,  W . E . ,  a n d  C h ’ i e n ,  J . M . N .  R e c o v e r y  t r a i n i n g  a n d  s e l f -
help: Description of an aftercare program for treated opiate addicts. J Subst
Abuse Treat 1986. Vol. III (1) pp. 9-20.
McAuliffe, W.E.; Rohman, M.; Feldman, B.; and Launer, E. The role of
euphoric effects in the opiate addictions of heroin addicts, medical patients
and impaired health professionals. J Drug Issues 15(2):203-224, 1985b.
Meyer, R.E., and Mirin, S.M. The Heroin Stimulus; Implications For a Theory
of Addiction. New York: Plenum, 1978.
Milkman, H.; Weiner, S.; and Sunderwirth, S. Addiction relapse. Adv Alc Subst
Abuse 3(171):119-134, 1983/1984.
Nurco, D.N.; Robins, L.N.; and O’Donnell, J.A. Locating Respondents.
In: Johnston, L.D.; Nurco, D.N.; and Robins, L.N., eds. Conducting
Followup Research on Drug Treatment Programs. National Institute on Drug
Abuse Research Monograph, 1977. pp. 71-84.
O’Brien, C.P.; Testa, T.; O’Brien, T.J.; Brady, J.P.; and Wells, B. Conditioned
narcotic withdrawal in humans. Science 195 (March 11):1000-1002, 19772.
O’Brien, C.P.; Ternes, J.W.; Grabowski, J.; and Ehram, R. Classically
conditioned phenomena in human opiate addiction. In: T. Thompson, and
C.E. Jhanson, eds. Behavioral Pharmacology of Human Drug Dependence.
National Institute of Drug Abuse Research Monograph 37, 1981.
O’Donnell, J.A. The relapse rate in narcotic addiction: A critique of followup
studies. In: Wilner, D.M., and Kassebaum, C.G., eds. Narcotics. New
York: McGraw-Hill, 1965. pp. 226-246
Pompi, K.F., and Shreiner, S.C. The reliability of biographical information
obtained from court-stipulated clients newly admitted to treatment. Am J
Drug Alc Abuse 5(1):79-95, 1979.
Ray, M.B. The cycle of abstinence and relapse among heroin addicts. Social
Problems 9:132-140, 1961.
Riordan, C.E.; Mezritz, M.; Slobitz, F.; and Kleber, H.D. Successful
detoxification from methadone maintenance: Follow-up study of 38 patients.
JAMA 235(24):2604-07, 1976.
Robins, L.N.; Daves, D.H.; and Goodwin, D.W. Drug use by U.S. Army enlisted
men in Vietnam: A follow-up on their return home. Am J  Epidem
99(4)235-49, 1974.
Robins, L. Deviant Children Grown-Up. Baltimore, MD.: Williams and
Wilkins, 1966.
Simpson, D.D., and Lloyd, M.R. Client evaluations of drug abuse treatment in
relation to followup outcomes. Am J Drug Alc Abuse 6(4):397-411, 1979.
Simpson, D.D.; Savage, J.; and Lloyd, M.R. Follow-up evaluation of treatment
of drug abuse during 1969 to 1972. Arch Gen Psychiatry 36(7):772-80, 1979.
Smart, R.G. Outcome studies of therapeutic community and halfway house
treatment for addicts. Int J Addict 11(1):143-159, 1976.
Stephens, R. The truthfulness of addict respondents in research projects. Int J
Addict 7(3):549-558, 1972.
Stephens, R., and Cottrell, E. A followup study of 200 narcotic addicts
committed for treatment under the Narcotic Addict Rehabilitation Act
(NARA). Br J Addict 67:45-53, 1972.
155
Stimmel, B., and Rabin, J. The ability to remain abstinent upon leaving
methadone maintenance: A prospective study. Am J Drug Alc Abuse
1(3):379-391, 1974.
Vaillant, G.E. The natural history of urban narcotic drug addiction -- some
determinants. In: Steinberg, H, ed. Scientific Bases of Drug Dependence.
New York: Grune and Stratton, 1969. pp. 341-361.
Waldorf, D. Careers in Dope. Engelwood Cliffs, N.J.: Prentice-Hall, 1973.
Waldorf, D. Natural recovery from opiate addiction: A progress report.
Presented at the National Drug Abuse Conference, New Orleans, Louisiana,
August 29, 1979.
Waldorf, D. Natural recovery from opiate addiction: Some social-psychological
processes of untreated recovery. J Drug Issues 13(2):237-280, 1983.
Wikler, A. Conditioning factors in opiate addiction and relapse. In: Wilner,
D.M., and Kassebaum, G.G., eds. Narcotics. New York: McGraw-Hill,
1965.
Wikler, A., and Pescor, F.T. Classical conditioning of a morphine abstinence
phenomenon, reinforcement of opioid drinking behavior and “relapse” in
morphine-addicted rate. Psychopharmacologia 10:255-284, 1967.
Willie, R. Processes of recovery from heroin dependence: Relationship to
treatment, social changes and drug use. J Drug Issues 13(3):333-342, 1983.
Winick, C. Maturing out of narcotic addiction. Bulletin on Narcotics 14(1):1-7,
1962.
Winick, C. Maturing out of narcotic addiction, Bulletin on Narcotics 16(1):1-11,
1964.
Zackon, F.; McAuliffe, W.E.; and Ch’ien, J.M.N. Addict Aftercare: Recovery
Training and Self Help, Rockville, M.D., National Institute on Drug Abuse.
DHHS. Pub. No. (ADM) 85-1341. Washington, D.C.: Supt. of Docs., U.S.
Govt. Print. Off., 1985.
Zinberg, N.E., and Jacobsen, R.E. The natural history of chipping. Am J
Psychiatry 133(1):37-40, 1976.
ACKNOWLEDGMENT
National Institute on Drug Abuse Grant Number DA-02798 supported this
research.
AUTHORS
William E. McAuliffe. Ph.D.
Barry Feldman, B.A.
Rob Friedman, M.A.
Elaine Launer, B.A.
Elizabeth Magnuson, B.A.
Carl Mahoney, B.A.
Susan Santangelo, B.A.
William Ward, B.A.
Robert Weiss, M.D.
Harvard Medical School
Department of Psychiatry
MC Lean Hospital
Belmont, Massachusetts
Harvard School of Public Health
Department of Behavioral Sciences
677 Huntington Avenue
Boston, Massachusetts 02115
156
Relapse to Use of Heroin, Cocaine,
and Other Drugs in the First Year
After Treatment
Robert L. Hubbard and Mary Ellen Marsden
INTRODUCTION
Previous research documents that the major drug abuse treatment modalities
substantially reduce drug use during and after treatment from pretreatment levels
(Craddock et al. 1985; Hubbard et al. 1984; Tims 1981; Simpson et al. 1978;
Simpson and Lloyd 1978). Many clients, however, relapse to drug use after
treatment. Little is known about the process and timing of relapse, particularly
when multiple drugs are used before and after treatment. Better understanding
of the nature and causes of relapse should contribute to the design of more
effective treatment and aftercare approaches. Modified treatment approaches
could reduce relapse rates for particular types of drugs, extend the time until
relapse, and lessen the severity of posttreatment drug use. This brief paper
describes the complex nature of relapse and examines the timing of relapse to use
of specific drugs and the change from pretreatment periods in overall drug use
patterns for a sample of 2,280 drug abuse treatment clients participating in the
Treatment Outcome Prospective Study (TOPS).
MULTIDIMENSIONAL NATURE OF RELAPSE
Abuse or dependence is usually characterized in terms of the use of a single
substance such as heroin, alcohol, or tobacco. The understanding of relapse to
drug abuse, however, is complicated by current drug abuse patterns that involve
multiple use of a wide range of types of licit and illicit drugs (Craddock et al.
1985) and many patterns of abuse. A common pattern is the weekly or more
frequent use of marijuana, cocaine, alcohol, and heroin (Hubbard et al. 1985).
Heroin abusers commonly substitute other drugs for heroin. Descriptions of drug
abuse and relapse that consider only single drugs are inadequate. Definitions of
relapse must take into account the patterns of use of multiple drugs and alcohol.
A multidimensional definition of relapse should also include consideration of the
type, extent, and timing of relapse.
A basic type of relapse is the posttreatment return to use of a specific drug (e.g.,
cocaine) that was used before treatment. A second type of relapse is the
nonmedical use of a drug to substitute for a principal pretreatment drug (e.g.,
other narcotics as a substitute for heroin). A more comprehensive definition of
relapse is the posttreatment resumption of the pretreatment pattern of drug use
(e.g., multiple use of heroin, cocaine, marijuana, and alcohol) or the development
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of new patterns of use. Relapse, then, may be use after treatment of a specific
pretreatment drug, nonmedical use of its substitute, or it may refer to an overall
use pattern.
The likelihood of relapse after a particular mode of treatment can be measured in
various ways. The four methods of measurement below consider two key
dimensions: frequency of use and pretreatment drug use patterns.
Any Posttreatment
Use Among All Clients
Any Posttreatment Use
Among Pretreatment
Weekly Users
Any Posttreatment Use
Among Pretreatment
Monthly Users or
Nonusers
- Percentage of all clients reporting any use
in the year after treatment.
- Percentage of clients who used weekly or
more frequently before treatment and
reported any use in the year after treatment.
- Percentage of clients who used in the year
after treatment among clients who did not
not use weekly in the year before treatment.
Posttreatment Users Who
Report Daily Use
- Percentage of clients who reported using
their posttreatment primary drug daily for
at least 30 days in the year after treatment
among all clients who used that drug in the
year after treatment.
Each measure is useful but only partially describes relapse. The first definition
does not consider posttreatment or pretreatment use levels. The second and third
definitions consider pretreatment use levels but not posttreatment use levels. The
fourth definition focuses on the most severe relapse. A complete exploration of
posttreatment use should include relapse to weekly use as well as relapse to the
pretreatment frequency. Relapse measures should be developed that consider
resumption of any use as well as use that is less severe or frequent than
pretreatment patterns of use.
Within each of these types of relapse, indicators of the extent of relapse, such as
frequency and severity, add an important dimension to the description of drug
use patterns and use of specific drugs. The timing dimension considers the
latency, duration, and episodic nature of relapse (Mann et al. 1984). Drug abuse
treatment clients may continue drug use throughout treatment or may cease use
during treatment, only to resume use before leaving treatment or at various times
after treatment. The first posttreatment use may be brief and have little clinical
significance, or use may continue for weeks, months, or years, The lengths of
periods of use and abstinence after treatment are variable and the periods are
cyclical (see Maddux and Desmond 1974).
To appropriately study relapse, the pretreatment pattern of drug use and the
overall posttreatment pattern should be considered. Posttreatment marijuana use
by a client who used heroin daily before treatment and by another who used only
marijuana are not equivalent. Shifts to less serious drug use patterns can be
viewed as indicators of improvement rather than relapse.
A brief episode of infrequent use may not indicate serious relapse. On the other
hand, brief episodes of heavy use, even those separated by long intervals of
abstention, may be predictive of serious relapse in the future. Relapse needs to
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be defined by level and severity and within the context of overall use patterns.
Indices of multiple drug use patterns have been developed and used in major
national studies (Bray et al. 1982; Savage and Simpson 1976).
METHODS
The Treatment Outcome Prospective Study (TOPS) used personal interviews to
obtain detailed drug use histories of 11,750 clients entering 41 detoxification,
outpatient methadone, residential, and outpatient drug-free (OPDF) treatment
programs in 10 cities from 1979 to 1981 (Hubbard et al. 1984). Three different
samples totaling 5,000 of these clients were reinterviewed at 3 months, 12
months, 2 years, and 4 years after treatment.
Most of the analyses reported in this paper are based on the pretreatment and
posttreatment drug-use patterns of 2,280 clients from the 1979 and 1980
admission cohorts who were interviewed at intake and approximately 1 year after
they left treatment in one of the four modalities.
The drug-use measures developed for this paper are based on the comprehensive
assessments of nonmedical use of 12 different drug types. These assessments
were obtained in interviews covering the year before admission and the first year
after termination. Quantity and frequency of alcohol use and frequency of use
of all types of drugs for nonmedical purposes during the 12-month periods
before and after treatment were obtained. Clients were asked to report their
frequency of use on a 9-point scale from nonuse to use four or more times per
day. At the followup, clients were asked how much time elapsed before use of
specific drugs was resumed after leaving treatment. For heroin and for the
clients’ primary drug of abuse at the time of followup, questions were asked
about the time until daily use was resumed.
NATURE AND EXTENT OF RELAPSE FOR FOUR SPECIFIC DRUGS
Drug use in the first year after treatment was common. About one in five
reported weekly or more frequent heroin use, and about one in four reported
weekly or more frequent use of other nonnarcotics (amphetamines, sedatives,
barbiturates, minor tranquilizers) (Hubbard et al. 1986.) While such simple
frequency data on posttreatment use are informative, relapse can be described
more appropriately in the context of pretreatment use. Marijuana use, while of
interest, was not considered in the present analysis, and is excluded from the
“other nonnarcotics” category.
Types of Relapse
The magnitude of the relapse rates for each of the four types of drugs shown in
table 1 differs by drug and definition of relapse. The relapse rates among
pretreatment weekly users were similar for all drugs. Posttreatment use rates for
cocaine and other nonnarcotics for pretreatment nonusers and those who used
monthly or less frequently before treatment were twice the rates for heroin and
other narcotics. This posttreatment use by pretreatment nonusers or low-level
users may mean that cocaine and other nonnarcotics were being used in lieu of
heroin and/or other narcotics used before treatment. The probability of relapse
to daily use of a primary drug among all posttreatment users was highest for
heroin (54 percent). Twenty-five percent or fewer users of other narcotics,
cocaine, and other nonnarcotics relapsed to daily use of these drugs.
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TABLE 1
Types of Relapse Rates in the Year After
Treatment for Four Drug Types
Types of
Relapse Heroin
Drug Used Posttreatment
Other Other
Narcotics Cocaine Nonnarcotics
% % % %
Any Posttreatment Use
Among All Clients
31.9 28.3 44.0 45.3
Any Posttreatment Use
Among Pretreatment
Weekly Users
58.6 57.0 65.0 60.2
Any Posttreatment Use
Among Pretreatment
Monthly Users or
Nonusers
16.8 19.7 36.2 35.3
Posttreatment Daily
Use Among Post-
treatment Users
53.6 25.1 20.1 16.7
Time Until Relapse
Former clients were asked when they first used each drug after treatment.
Clients also identified their primary problem drug and reported when they first
used that drug daily for at least 1 week.
In table 2, the distributions of the periods between termination from treatment
and first use of four types of drugs are presented for all former clients who
reported any use in the first year after treatment. About 15 percent of clients
who used drugs other than marijuana in the year after treatment were using the
drug at treatment termination, and another 25 percent resumed use within the
first week after discharge. A month after leaving treatment, about 60 percent of
those who would relapse in the year after treatment had resumed use. About
half the remaining 40 percent relapsed 1 to 3 months after termination. The
timing of relapse appears to be similar for the four types of drugs. The length
of time until relapse may be critical for long-term rehabilitation outcomes.
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TABLE 2
Time Until First Use in the First Year After Treatment
Among Clients Who Reported Posttreatment Use
of Each of Four Drug Types
Drug Used Posttreatment
Weeks After
Termination Heroin
Other Other
Narcotics Cocaine Nonnarcotics
% % % %
Used at termination 15.3 14.4 10.7 15.2
Within I week 28.9 22.8 21.6 24.3
2-4 weeks 21.4 24.1 24.6 24.5
5-13 weeks 15.8 13.9 17.6 16.0
14 or more weeks 18.6 24.8 25.5 20.0
Total
Number of Post-
treatment Users
100.0 100.0 100.0 100.0
720 626 984 1,026
Mean Days to Relapse
Among Those Who
Used Posttreatment
55.0 68.3 71.9 58.8
Table 3 shows the time until first relapse to daily use for the four types of drugs.
One-third of posttreatment daily heroin, cocaine, and other nonnarcotics users
and half of the other narcotics users who were to become daily users in the year
after treatment were using daily at treatment termination. On the other extreme,
about one in five had been out of treatment at least 3 months before beginning
daily use. Extending the period between treatment termination and daily use
would seem to be important to establishing long-lasting abstinence. The
variations in the timing of the relapse to daily use for narcotics other than heroin
compared to the other three types of drugs suggest that the course of relapse to
daily use may differ by drug.
The timing of relapse to daily use appears to be different from the timing of
relapse to first use. Those who were to become daily users were most likely to
relapse immediately following termination. First daily use for those who did not
immediately start using heroin daily after treatment was more evenly spread over
the 3-month time span than was first use of the same drug.
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TABLE 3
Time Until Daily Use in the Year After Treatment
Among Clients Who Reported Posttreatment Use
of Each of Four Drugs Types
Drug Used Daily Posttreatment
Weeks After
Termination
Other Other
Heroin Narcotics Cocaine Nonnarcotics
% % % %
Used at termination 32.1 49.0 34.9 37.4
Within 1 week 13.5 9.6 7.1 11.7
2-4 weeks 20.7 15.9 19.1 16.4
5-13 weeks 15.5 14.0 19.8 15.8
14 or more weeks 18.1 11.5 19.1 18.7
Total
Number of Post-
treatment
Daily Users
100.0 100.0 100.0 100.0
386 157 126 171
CHANGE IN PATTERNS BETWEEN PRETREATMENT AND POST-
TREATMENT YEARS
Describing posttreatment use of a specific type of drug does not provide a
complete picture of relapse. Here the concept of relapse to drug use is
broadened to  consider  differences  between pretreatment  pat terns  and
posttreatment patterns.
Multiple drug use by TOPS respondents before treatment was common.
Comparisons of the use patterns of clients in the TOPS and Drug Abuse
Reporting Program (DARP) research provides evidence of the increasing
prevalence of multiple drug use over the past decade (Hubbard et al. 1985). The
focus on daily use of heroin and other narcotics alone in many studies of
treatment clients in the 1970s (Savage and Simpson 1977) may no longer be fully
descriptive of the extent of drug use or be appropriate indicators of relapse.
Several approaches were used in TOPS analyses (Bray et al. 1982; Hubbard et al.
1985) to examine patterns of multiple drug use including a set of drug use
patterns adapted from the DARP classification scheme (Simpson 1974). The
extensive variety of combinations of weekly use of eight drug types used by
TOPS clients suggested that broad rather than specific categories were required to
describe clinically useful patterns.
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Patterns were defined by hierarchical rules that required weekly or greater use of
key drugs or drug types. First, two types of heroin users were defined: heroin
users who used other narcotics and heroin users who did not use other narcotics.
Next, among the remaining clients, users of narcotics other than heroin and users
of nonnarcotics (excluding marijuana and alcohol) were then identified. Finally,
alcohol/marijuana users and minimal users (clients who did not report weekly use
of any drug or alcohol) were the residual group. The resulting five categories
are hierarchical; clients were included in the less serious patterns only if they did
not meet the criteria for the more serious patterns. The defining characteristics
of the patterns do not identify all drugs used by the clients. Rather, they
indicate the key drugs and their use levels. In table 4, the five hierarchical
patterns are shown. The alcohol and marijuana patterns were included with
nonweekly users of any drug. This analysis does not consider any level of use of
alcohol, marijuana, or infrequent drug use as relapse.
From table 4 it is clear that the patterns shift between pretreatment and
posttreatment periods, particularly to the cells to the right of the diagonal,
indicating a movement to less serious use patterns after treatment. More than 40
percent of each of the three types of narcotic users move to the
alcohol/marijuana/minimal pattern. However, 20 percent of heroin-other-
narcotic users, 39 percent of heroin users, and 24 percent of other narcotic users
resume their pretreatment use pattern. Between 10 percent and 20 percent of the
users of heroin and/or narcotics reduced their use to nonnarcotics in the year
after treatment. About 16 percent of heroin-other-narcotic users eliminated
heroin use but resumed other narcotics use.
Because drug abuse is a multidimensional phenomenon best described by multiple
drug patterns rather than single drugs, additional analyses should be conducted to
examine in more detail the transitions among drug abuse patterns from
pretreatment to posttreatment periods. The patterns in table 4 provide a
structure for more detailed analyses of relapse.
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TABLE 4
Relapse Rates to Different Drug Use Patterns
in the Year After Treatment for Clients
with Five Pretreatment Use Patterns
Posttreatment Drug Use Pattern
Pretreatment Heroin-
Drug Use Other
Pattern Narcotics Heroin
Other Non- Non-
Narcotics narcotics relapsers*
% % % % %
Heroin-Other
Narcotics
(n = 225)
20.4 7.6 16.4 12.7 44.9
Heroin
(n = 643)
Other Narcotics
(n = 295)
Nonnarcotics
(n = 508)
Alcohol/Marijuana
Minimal
(n = 609)
5.1 38.7 2.8
8.1 2.0
4.7
3 . 8
24.4
2.4 6.1
10.6 42.8
18.3 47.1
27.8 59.0
12.8 75.72 . 8 4 . 9
*Includes all clients not classified as relapsing during the year of postreatment.
Some of these may have had alcohol, marijuana, or infrequent other drug use.
SUMMARY AND RECOMMENDATIONS
This paper briefly assessed the multidimensional nature of relapse to drug use,
the length of posttreatment abstinence periods for four types of drugs, and
resumption of drug use patterns.
Rates of relapse defined in various ways showed important differences among the
drugs. Relapse to daily heroin use, for example, was very high compared to the
relapse to use of the other three types of drugs. The timing of relapse was quite
similar for all 4 drugs. Approximately two-thirds of clients who relapsed did so
within the first 3 months after leaving treatment. Between 10 percent and 15
percent were using at treatment termination. More emphasis on aftercare and
postdischarge counseling that focuses on prevention of relapse might help reduce
relapse rates and increase periods of remission for relapsing clients.
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Consideration of the complementary concept of reduction in overall use patterns
(in addition to reduction in use of individual drugs) could help researchers and
clinicians better understand posttreatment use. Because of the complexity of
drug abuse, different conceptualizations of relapse and reduction in drug use
need to be examined. The drug abuse pattern measure used here is one way to
describe the shift among patterns.
The preliminary analyses presented in this paper indicate the complex nature of
relapse among former drug abuse treatment program clients. Survival analysis or
failure rate analysis could also be used to examine the timing of relapse in more
detail. In order to learn how treatment can minimize the risk of relapse and
lengthen abstention periods, studies are needed to:
describe the multidimensional nature of relapse (type, extent, timing, and
the overall drug use pattern) and the relapse to use of specific drugs
within the context of multiple drug use patterns;
identify the correlates of relapse, particularly behavior, during treatment
and in the first 3 months after leaving treatment; and
assess the effects of relapse prevention efforts such as discharge
evaluations and aftercare services in the first months following
termination.
Relapse is a complex. dynamic process that must be examined more carefully by
researchers and clinicians. The extensive treatment histories of many clients
entering and re-entering programs suggest that recovery from drug use is long
term, and episodic relapses are experienced. The process of recovery occurs
throughout the drug use and treatment career. A better understanding of this
process should lead to improved treatment and aftercare services that will reduce
verall relapse rates, extend remission periods, and reduce the duration of relapse
episodes.
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Smoking Cessation and Relapse
Among Cardiac Patients
George E. Bigelow, Cynthia S. Rand, Janet Gross,
Thomas A. Burling, and Sheldon H. Gottlieb
Most clinical research concerning smoking cessation has been conducted with
participants in organized smoking cessation treatment programs. Such
individuals, and their experiences with smoking cessation, may not be
representative of the larger population of smokers. Participants in organized
cessation programs certainly represent a self-selected subsample of smokers, and
little is known about the dimensions in which this self-selected group might
differ from other smokers. However, since the vast majority of smoking
cessation occurs outside of such structured treatment contexts, we can see that, at
least in a statistical sense, these treatment participants are an “unusual” subsample.
Perhaps further useful information concerning smoking cessation and relapse
might be gained by studying these processes in situations in which they
spontaneously occur, rather than in organized treatment settings.
Among the populations most likely to spontaneously discontinue their smoking
habits are individuals who have recently experienced an adverse cardiac health
event. In particular, it is estimated that approximately one-third to one-half of
smokers who suffer a myocardial infarction (MI) either discontinue or
dramatically reduce their smoking habit immediately following the event
(Burlington et al. 1984). In this chapter, we will summarize recent work we have
been conducting, examining cigarette smoking cessation, and relapse among
myocardial infarction patients.
POPULATION
Participants in these studies were hospitalized surviving myocardial infarction
patients who reported being cigarette smokers at the time of their heart attack.
SETTING
This work was undertaken because the naturally occurring epidemiology of
smoking in this population--with smokers rapidly dichotomizing themselves into
long-term quitters versus resumers of smoking--appeared to offer a convenient
context within which to examine factors associated with these differential
smoking outcomes. Other features of the cardiac care setting also made it
attractive as a context for studies of smoking behavior. The fact that surviving
myocardial infarction patients routinely received several days of intensive care in
the Coronary Care Unit where smoking was not possible, meant that all patients
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would be beginning their ambulatory recovery period in a tobacco-abstinent
status. The fact that patients routinely remained in the hospital for several days
of ambulatory recovery following intensive care made it convenient to collect
data from patients and made it possible to assess their smoking during this
ambulatory period when smoking relapse became possible. In addition, medical
charts provided valuable supplemental sources of data, and routine medical
aftercare provided a convenient opportunity for assessing smoking status
outcomes post-hospitalization.
IN-HOSPITAL RELAPSE
When we first proposed to study smoking relapse in myocardial infarction
patients, the hospital’s cardiologists indicated that this was not practical since
these patients were not permitted to smoke. However, in our initial study we
found that these medical rules did not reliably control patient behavior.
In this first study (Baile et al. 1982) we conducted single predischarge interviews
with 66 patients concerning their smoking. These interviews covered smoking
history, heal th bel iefs ,  and craving and smoking experiences during
hospitalization; these results were considered in relation to one another, in
relation to demographics, and in relation to medical chart information concerning
the severity of disease.
The most dramatic finding was the rapidity and prevalence of in-hospital
smoking relapse among these myocardial infarction patients. Patients had been
on the ambulatory recovery unit on average for less than 5 days, but during this
time fully 38 percent of the patients had resumed smoking. Among relapsers, the
mean latency to smoke following transfer from intensive care was 2.25 days.
Smoking relapse did not typically occur in full-blown intensity during
hospitalization; patients reported smoking an average of 5.14 cigarettes per day
when they smoked. Despite the relatively moderate level of this smoking, it was
considered a likely precursor of more intensive smoking upon hospital discharge.
Examination of the data to identify factors associated with, or predictive of,
smoking relapse revealed that the only significant relationships were with
indicators of myocardial infarction severity. Peak blood levels of the enzyme
creatine kinase (CK) were used as the primary objective biological index of
infarction severity. CK is released when tissue is damaged, and peak CK levels
can be used both diagnostically and prognostically in evaluating myocardial
infarctions. Higher CK levels are generally reflective of greater tissue damage.
Patients who relapsed to smoking during their hospitalization had average peak
CK levels that were significantly lower than those of patients who abstained
from smoking throughout their hospitalization. Thus, smoking abstinence
appeared most likely among patients who had suffered more severe infarctions,
and smoking relapse appeared most likely among patients with the least cardiac
damage.
The likelihood of smoking relapse bore a graded negative relationship to the peak
CK level, as illustrated in figure 1. This graded relationship was statistically
significant, with p < 0.005, according to Bartholomew’s chi-square test for
ordered samples.
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FIGURE 1
From Burling et al. 1984. Copyright 1984, Lawrence Erlbaum Associates, Inc.
There were no significant differences between patients relapsing and abstaining
during their hospitalization on demographic characteristics, smoking histories,
health beliefs, or reported craving for cigarettes. Thus, severity of smoking-
related adverse health effects was a more powerful predictor of early smoking
abstinence versus relapse than were these psychosocial variables.
POST-HOSPITALIZATION SMOKING OUTCOMES
A major limitation of the previous study was that it examined smoking only
during the brief period of hospitalization immediately following myocardial
infarct ion.  In  a  subsequent  second s tudy we fol lowed pat ients’  post-
hospitalization to assess long-term smoking outcomes, and we used expired breath
carbon monoxide assessment to provide an objective biological index of smoking
status (Bigelow et al. 1984). Patients were contacted approximately 5 times per
week during their hospitalization, and were followed post-hospitalization for an
average of 12 months.
During the in-hospital period, some of the relationships observed in the previous
study were replicated. Again, a high rate of in-hospital smoking relapse was
observed--36 percent. Also, again, peak CK level was significantly lower in
those patients who resumed smoking during hospitalization.
In examining long-term smoking outcomes, peak CK was no longer a significant
predictor. However, another index of MI severity did indicate the same
relationship of smoking outcome to severity as was noted during the in-hospital
phase. Assessment of left ventricular ejection fraction by radionuclide
ventriculography was introduced into the cardiology service as a new diagnostic
and prognostic procedure part way through our study, so these data were
available only for 68 patients. Ejection fraction is a dynamic measure of cardiac
pump performance, providing a measure of the proportion of left ventricular
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blood volume that is ejected when the heart contracts; it is generally accepted as
the best overall measure of cardiac performance and one of the best prognostic
indices of cardiac health. We found these biological measures of cardiac
function, collected in-hospital at the time of the infarction, to be predictive of
long-term smoking status outcomes during followup. Ejection fraction measures
showed that patients who relapsed to smoking during the followup period had
suffered less cardiac pump damage (i.e., they had higher ejection fractions) than
patients who abstained from smoking throughout the followup period. Thus,
once again, smoking cessation tended to occur in individuals with greater health
impairment, and smoking relapse tended to occur in individuals with lesser health
impairment. The differences in mean ejection fractions for the abstaining versus
relapsing groups was statistically significant, with p < 0.004.
ANTI-SMOKING INTERVENTION
A consistent finding in the first two studies was that smoking abstinence was
more likely in patients who had experienced a more severe infarction or suffered
greater cardiac impairment. These studies did not permit us to identify the
mechanism by which health status influenced behavior change; however, we
suspected that the mechanisms might be that the greater health threat served
more effectively to motivate behavior change.
In a subsequent study, we sought to increase the prevalence of post-MI smoking
abstinence by taking advantage of the motivational potential of the inpatient
cardiac treatment setting to encourage smoking cessation (Rand et al. 1985). One
hundred inpatients were randomized to receive either usual cardiology care and
education or to receive usual care plus a supplemental directive anti-smoking
message from a member of the research team. All patients received daily
interviewing about their smoking behavior, experience, and plans, as well as
daily breath carbon monoxide sampling to assess their smoking status.
As it turns outs, our randomization was irrelevant to outcome; rather it appears
that the attention we brought to bear on smoking for all subjects had an across-
the-board effect of reducing in-hospital smoking relapse. The evidence for this
effect comes from examining the rates of in-hospital smoking relapse during this
study in comparison to the periods immediately preceding and immediately
following it. Prior to the start of this study, the incidence of in-hospital
smoking relapse was 39 percent. During this study, the incidence of in-hospital
smoking relapse fell, in successive time periods, first to 18 percent and then to 9
percent. Upon termination of this study and the contacts with patients and staff
concerning smoking, the incidence of in-hospital smoking relapse rose once
again--to 22 percent. Analysis of this final study is still underway, and its
results can only be considered preliminary. However, it appears that a procedure
of intensive data-gathering concerning smoking--a procedure that was intended
to be only neutral data-gathering and not an intervention--actually functioned as
an effective anti-smoking intervention and reduced the incidence of in-hospital
smoking relapse among post-MI cardiac patients. These data, though
preliminary, are encouraging of the possibility of developing and implementing
intervention programs for delivery in medical care settings that might effectively
reduce the prevalence of smoking inpatient populations.
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DISCUSSION
These data implicate patients’ health status and health concerns as important
determinants of smoking cessation and relapse. The preliminary results of our
intervention study suggest that it may be possible to develop intervention
procedures for incorporation into medical care settings that will significantly
reduce patients’ smoking. However, much work must yet be done to demonstrate
the practical feasibility of this approach. Survey data generally indicate that
concerns about health are the most common reason given by smokers for quitting
or for wanting to quit smoking. The present data suggest that smoking cessation
is enhanced to the degree that patients have experienced adverse health
consequences from their smoking. We would suggest that, for all the substance
abuse disorders, the probability of discontinuing substance use may depend, in
part, upon the extent to which the individual user has experienced adverse
consequences from that use.
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Clinical Implications of
Relapse Research
Bruce J. Rounsaville
Relapse and relapse prevention define the major clinical problems to be faced by
clinicians and researchers who work with substance abusers. Unlike other mental
disorders, substance abuse disorders have a necessary, if not sufficient, cause--
the abused drugs themselves. For all classes of abused substances, procedures are
highly developed for temporarily separating substance abusers from their abused
substances and keeping withdrawal symptoms at safe and comparatively
comfortable levels (Lowinsohn and Ruiz 1981). It is not necessary for any
detoxification procedures to last longer than 1 month and some can be
accomplished in less than 1 week (Riordan and Kleber 1980). Hence, if relapse
were not a major issue, substance abuse treatment could be limited to a small
subspecialty of medicine that concentrates on detoxification handled in medical
wards, emergency rooms, and outpatient medical clinics.
However, relapse (defined as resumption of substance abuse following a period of
abstinence) is the rule and not the exception in substance abusers entering or
completing treatment. Presentations in this volume and a large literature suggest
that a majority of those leaving a treatment program will relapse at least once
with greatest vulnerability to relapse in the first three months following
treatment (Hall, Hubbard, Maddux and Desmond, Simpson and Marsh, this
volume). Although successful efforts to curtail substance abuse may be more
frequent in untreated populations, as shown by the Viet Nam experience and
other reports (Robins 1980; Robins et al. 1974), clinicians are most concerned
with the comparatively poorer prognosis group who seek treatment.
In this chapter, the author will discuss material presented in previous chapters as
it relates to four issues: 1. commonalities and differences in relapse to different
substances of abuse; 2. promising directions for discriminating among groups of
patients to allow for better patient/program matching; 3. the need for more
research on the efficacy of different treatment strategies for relapse prevention;
and 4. relapse prevention strategies which are practicable within the kinds of
substance abuse treatment programs currently in place. The current state of
knowledge on factors related to relapse and its prevention raises more questions
than it answers. Hence, this chapter will be more heavily focused on possible
directions for future research than on immediate treatment implications.
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COMMONALITIES AND DIFFERENCES ACROSS DIFFERENT CLASSES OF
DRUGS
A theme across most chapters in this volume is the shared features of different
types of substance abuse. Regarding relapse, the most important shared feature
is the rate and speed of relapse to different substances. This is best illustrated
by the widely cited and reproduced graph by Hunt, Barnett and Branch (1971),
of relapse rates over 12 months following treatment, showing that smokers,
alcoholics, and heroin addicts are alike in having relapse rates of greater than 60
percent in the first year posttreatment and relapse rates of greater than 50
percent in the first three months. Most theories of drug abuse, including those
reviewed by Drs. Babor, Wesson and Grabowski (this volume), assume
commonalities in addiction and relapse to different substances, especially those
for which tolerance and withdrawal are prominent features. In addition, the data
presented by Dr. Hubbard from multiple substance abuse treatment programs
suggest that abuse of multiple drugs is the norm in those seeking treatment, and
relapse may take the form of resumption of abuse of the same substance or of
another substance, a finding which is consistent with much previous literature
(Green and Jaffe 1977; Simpson et al. 1979). Hence, in practice, substance
abusers appear to act as if there are important similarities in addiction and
relapse to different drugs.
Despite these widely recognized similarities across abused drugs, clinicians and
even self-help groups persist in physically and conceptually segregating the
treatment of those who abuse different classes of drugs. Thus, even if cross drug
similarities are important and recognized, many clinicians appear to believe that
dissimilarities across drugs are of sufficient importance to warrant the
development of independent treatment approaches. To translate theories of
relapse and research findings into improved treatment strategies, several
important cross-drug differences may need to be considered.
First, there are vast differences across drugs in the legality, social desirability,
availability, f inancial  cost ,  medical  consequences,  and interact ion of
pharmacological properties with ability to carry out productive work and family
life. Thus, for example, while smoking cigarettes and self-injecting heroin may
share underlying reinforcement principals and the propensity for relapse
following treatment. the “psychosocial” differences in the two addictions
profoundly affect the populations at risk and the circumstances leading to
treatment seeking. Cigarettes are comparatively inexpensive, legally obtained, do
not cause impairment in mental functioning during an intoxicated state, and
seldom lead to adverse social and occupational consequences, although the
medical consequences are profound. Conversely, heroin is illegal, expensive,
characterized in its effects by major fluctuations in mental state and mood
related to intoxication and withdrawal effects, and likely to be associated with
major legal, social, occupational, and medical consequences. Hence, cigarette
smokers seeking treatment come from all socioeconomic strata and are motivated
to curtail use by the desire to prevent or reduce physical consequences of their
habit. In contrast, heroin users are more frequently from disadvantaged segments
of the population, involved in illegal activities to support and obtain drugs, and
motivated to seek treatment because of serious social, occupational, or legal
pressure. These kinds of differences reduce the extent to which abusers of
different substances recognize a commonality with abusers of other substances.
Likewise, the treatment interventions aimed at maintaining abstinence and
preventing relapse for the different classes of drugs are likely to be greatly
affected by the differences in the populations involved. For example, the
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occupational and legal counseling needed by many treatment-seeking heroin
addicts is clearly irrelevant to the vast majority of those who need help with
stopping cigarette smoking. As another example, while a general cross-drug
principle in relapse prevention may be avoiding the situations in which use of
drugs is likely, these will be vastly different for heroin addicts, alcoholics, and
cigarette smokers.
The types of pharmacological strategies available for maintaining abstinence are
also greatly different across abused drugs. These include (a) maintenance on a
drug with similar agonist effects but pharmacological properties that reduce the
dysfunctional aspects of substance use, such as methadone maintenance or use of
nicotine chewing gum, (b) use of antagonists which reduce the positive
reinforcing properties of the substance if it is used after a period of abstinence,
and (c) use of substances, such as disulfiram, which lead to profound negative
reinforcement if the abused substance is used after a period of abstinence. While
the latter two types of pharmacological aids to maintaining abstinence have
appealed to only a relatively small minority of abusers of the relevant classes of
drugs (Green and Jaffe 1977), the maintenance approach has been the dominant
one for treatment of opioid addiction (Kosten and Kleber 1984). For no other
class of drugs has maintenance been a major treatment strategy, and this
difference results in major cross-drug dissimilarities in (a) the way that relapse is
defined, (b) the goals of treatment, and (c) the major parameters of treatment
such as its length, counseling strategies, etc. Thus, the definition of relapse is
fairly straightforward for drugs such as cocaine or cigarettes for which
abstinence appears to be the only acceptable outcome. In contrast, for opioid
addicts, continuation of powerful opioid use in the form of methadone is not
considered relapse as long as the client refrains from using illicit opioids. Hence,
the comparability of findings regarding predictors of relapse, efficacy of
treatment strategies, etc., is greatly limited when opioid addicts are considered.
To make cross-drug findings comparable, only those who are not maintained on
methadone can be utilized. To illustrate why this is necessary, one can consider
the issue of the impact of degree of dependence (Babor et al., this volume;
Edwards et al., in press) on relapse to different classes of drugs following a
period of abstinence while in treatment. While it may be predicted that those
with greater prior dependence might take a shorter time to relapse, this
prediction may not hold in a mixed group of heroin addicts who had entered
methadone maintenance or a drug-free program. For methadone maintenance,
those who were more severely dependent may be those most likely to stay in
treatment and thus to avoid relapse, while the converse would be most likely for
a drug-free program. Likewise, the option of drug maintenance as an approach
to treatment has profound effects on the goal of treatment and its desirable
duration. For opiate addicts, the ultimate goal of treatment may be abstinence
from all opiates. However, an intermediate goal for several years would be
maintenance on methadone while improving psychosocial functioning. For many
addicts, the goal of successfully curtailing methadone maintenance at any time is
believed to be unrealistic (Dole and Nyswander 1967). Alternatively, the goal of
treatment for other classes of drugs is either abstinence or, more controversially,
controlled use (Orford et al. 1976; Sobell and Sobell 1978). These fundamental
differences in goals of treatment necessitate great differences in the way that
abusers of different classes of drugs are encouraged to think about resolving their
drug use problem.
To sum up, while many underlying similarities can be noted across theories and
patterns of relapse to different classes of drugs, translating basic knowledge into
effective treatment strategies may need to be done separately for different classes
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of drugs. In some instances, the patterns of use are so similar across drugs that a
successful strategy for curtailing, for example alcoholism, can be readily
translated to cocaine abuse with minor modifications. However, whenever the
goal of treatment is not abstinence, relapse prevention strategies need to differ
greatly and comparison of followup research findings across drugs cannot be
made directly.
SOME ISSUES FOR CROSS-SUBSTANCE RESEARCH
Several of the chapters in this volume suggest the need for cross-drug research in
order to determine similarities and differences as they relate to potential
treatment strategies. For example, a major issue for the dependence construct
presented by Dr. Babor (this volume) is the degree to which behaviors
hypothesized as making up the dependence syndrome are found in drugs other
than alcohol. The dependence syndrome has important implications for the goals
and strategies  of  t reatment  because of  i ts  relat ionship to the issue of
multidimensionality of functioning and of controlled substance use as a goal of
treatment. According to the dependence construct, functioning of substance
abusers is multidimensional, so that severity of dependence is at least somewhat
independent of the social and occupational consequences of substance abuse.
Hence, improvement in one area, such as achieving abstinence, will not
necessarily lead to improvement in other areas. Conversely, failure to achieve
abstinence will not necessarily prevent attainment of treatment goals in other
areas. This emphasis goes against the strategies of medical model programs and
others, such as Alcoholics Anonymous, which emphasize abstinence as the major
goal which must be achieved before other issues are considered (Wesson et al.,
this volume). Another corollary of the dependence construct is that controlled
substance use may be an acceptable goal for those whose degree of dependence is
not high (Orford et al. 1976). This proposition has been highly controversial in
the treatment of alcoholism. If cross-drug studies show that the characteristics of
the dependence syndrome are similar across drugs and that severity of
dependence is related to relapse, this would add impetus to efforts to translate
successful treatment strategies developed with one substance to treatment of those
who abuse other substances, and increase the utility of multidimensional
outcomes and controlled use in treatment planning.
In developing innovative treatment strategies for preventing relapse to different
substances it would be desirable to have a paradigmatic substance, clients who
are comparatively amenable to participating in the research, a definition of
relapse which is clear and where treatment failure can be noted after a
comparatively brief interval. The several chapters in this volume pertaining to
cigarette smoking (Bigelow et al.; Brandon et al.; Hall and Havassy; Grabowski)
suggest that this type of substance dependence has these properties which may
make it a fruitful area in which to explore the determinants of relapse and to test
rapidly different approaches for preventing relapse. Because cigarettes are legal
and inexpensive enough to not be associated with financial strain to support the
habit, subjects are likely to be more cooperative and truthful about their
cigarette use. In defining relapse, there appears to be a powerful relationship
between smoking a single cigarette and resumption of compulsive use. Also,
abstinence is the usual treatment goal. Hence, relapse can be precisely measured.
In addition, the great majority of relapses appear to occur comparatively quickly
following completion of treatment, which is also comparatively brief. Hence, the
amount of time needed to complete paradigmatic studies is comparatively brief.
Because of these considerations , those who study treatment of cigarette smoking
are in a position to obtain more rapidly research results that could suggest
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promising directions to be taken by those working with other types of substance
abusers. However, as noted above, translation of strategies across drugs may
involve substantial modifications, and separate demonstration of treatment
efficacy of a given approach across drugs is needed.
DISCRIMINATING AMONG SUBSTANCE ABUSERS FOR PATIENT/
PROGRAM MATCHING
It is a truism that substance abusers are a heterogenous group, and this is
certainly true about their ability to avoid relapse, as a significant minority appear
to succeed with any given treatment effort. To increase the efficiency of
treatment efforts, there has been an upsurge of interest in defining subgroups of
patients who are likely to derive the greatest benefit from the different types of
treatments available. To provide an empirical basis for this patient/program
matching, investigators have long attempted to discover patient characteristics
that are associated with treatment success and failure in substance abusers
(Luborsky and McLellan 1978; Maddux and Desmond 1981; McLellan 1983;
Ogborne 1978; Szapocznik and Ladner 1977; Vaillant 1983). The most commonly
assessed predictors of outcome include clients’ demographic characteristics, drug
use history, and/or legal history. Reviews of the many such studies which have
been completed suggest that the help they provide to clinicians in matching
patients to programs is limited. Two trends characterize the results. First, most
studies tend to show the “rich get richer” phenomenon, with those clients with
the least severe symptoms or problems and the greatest social or psychological
assets tend to have the best prognosis. Second, the amount of variance accounted
for by patient predictors is generally modest, with any given predictor seldom
accounting for more than 5 to 10 percent of the variance in outcome.
The lack of clinical utility of most predictor studies is based on several factors.
First, many predictors which are studied have comparatively static traits or
characteristics. In general, the safest assumption in predicting the way clients
will perform is to assume that they will continue to do as they have in the past.
This general pattern was found in the study described by Dr. Taylor and
colleagues (this volume). However, the very thing which one is trying to predict
in treatment is change from current behavior, and measurement of past traits is
not necessarily a likely strategy for defining the propensity to change. Second,
many of the characteristics which have been evaluated as predictors are not
readily translatable to treatment strategies due to the static nature of the
predictors studied. For example, determining that black males with a long
criminal history have a poor prognosis does not suggest any particular clinical
response except, perhaps, to fret more over this group.
Several directions in prognostic research show promise toward yielding findings
which will be of greater utility to clinicians. First, the assessment of engagement
in treatment has the advantage of measuring the beginning of the change process
rather than some static trait that characterized past behavior. In the general field
of psychotherapy research, this concept has been captured in research on the
therapeutic alliance (Hartley 1985) which has yielded exciting and comparatively
powerful results. In the substance abuse field, findings in smoking programs
suggest that clients at the end of treatment are strongly able to predict their own
ability to maintain abstinence (Bigelow, Brandon, Hall, this volume). This
finding is consistent with the general concept that the clients’ engagement in
treatment or assessment of its success is a comparatively powerful index of the
change process. A second promising area is the assessment of psychopathology.
Using a global measure of severity of psychiatric problems, McLellan and
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associates have demonstrated that this variable is both strongly associated with
success in treatment of alcoholics and other substance abusers and that it is
useful as a guide to patient/program matching, as those with comparatively high
severity are most likely to benefit from professional psychotherapy (McLellan et
al., in press; Woody et al. 1984). Thus, this type of assessment has the advantage
of being associated with a treatment strategy designed to address the problem.
Similarly, depression, which has been shown to be responsive to psychological
and pharmacological treatments, has also been shown to be common in substance
abusers and related to poorer treatment outcome (Rounsaville et al. 1982a and b,
1985; Rounsaville et al., submitted), A third promising area for predictor studies
is the assessment of the posttreatment environment. Characteristics of the
posttreatment environment have been shown to be comparatively strongly related
to relapse (Maddux and Desmond 1982; O’Donnell 1969; Vaillant 1973) and are
more closely associated with treatment interventions, such as family therapy, that
may be used to enhance the supportiveness of this environment.
THE NEED FOR RESEARCH ON SPECIFICITY OF RESULTS FROM
DIFFERENT APPROACHES TO RELAPSE PREVENTION
In common with the literature on treatment approaches for other types of
disorders, treatment of substance use disorders is characterized by a wide variety
of techniques based, in part, on a bewilderingly diverse set of theoretical
propositions. A crucial task for treatment research at this time is to determine
the special properties of the different treatment approaches, either in the types
of effects yielded or in the types of clients for which they are most effective
(Parloff 1980). Because different types of treatment approaches involve different
expenses, length of time required, and different professional credentials of the
practitioners, evidence for differential efficacy across approaches is needed to
justify the effort and expense involved in maintaining this diversity.
For those who espouse a particular approach to treating substance abusers, the
crucial hypothesis to be ruled out is that effects of all treatment approaches are
due to some nonspecific common elements, such as counteracting demoralization
(Frank 1974; Klein and Rabkin 1984). In the general psychotherapy field, the
evidence suggesting the importance of nonspecific elements is extensive.
Reviews of the psychotherapy efficacy literature using meta-analysis have shown
that psychotherapy is usually found to be effective in contrast with comparison
conditions but that there is little evidence to date to suggest the greater efficacy
of any given approach (Smith et al. 1980). In the field of substance abuse
treatment, large-scale treatment followup studies such as those carried out by the
Texas Christian University group have shown that, while the results of drug
treatments are generally positive and related to being in treatment at least a
minimum length of time, the treatment outcomes for those receiving such diverse
programs as methadone maintenance, outpatient drug-free treatments, and
therapeutic communities were not statistically distinguishable (Simpson and Sells
1982). In a more focused, carefully controlled clinical trial evaluating the
efficacy of two very different forms of professional therapy as treatment of
clients on methadone maintenance, Woody and colleagues (1983) found that the
results of Supportive Expressive therapy (Luborsky 1984) and Cognitive Therapy
(Beck et al. 1979) were not significantly different, although both were superior to
the control condition.
Regarding the lack of specificity of effects from therapies based on different
theories of substance abuse, or of other types of psychopathology, it should be
noted that the empirical test of a theory-based therapy has no direct relationship
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to testing the hypotheses of the theory. Therapies are always simultaneously
more and less than the theories on which they are based. All therapies include
elements, such as the therapists’ attempt to instill hope, that are not usually
specified or seen as crucial to the theory underlying more specific techniques
(Frank 1974; Klein and Rabkin 1984). In addition, most therapeutic maneuvers
can be seen as working through different mechanisms using different theoretical
conceptualizations of therapeutic change. For example, methadone maintenance
is seen as a treatment approach based on Dole and Nyswander’s substance-
induced metabolic deficit theory (Dole 1967) while it could as readily be seen by
a behavioral theorist as achieving its  effect  by blocking the posit ive
reinforcement yielded through intravenous heroin use. In addition to containing
elements which are not specified in the underlying theories, treatments never
include maneuvers which are relevant to all of the propositions suggested by the
theories. Because of these factors, evidence for the efficacy or lack of efficacy
of a theory is not relevant to supporting or refuting it. A faulty theory can
inspire an effective treatment as in the case of the development of lithium
treatment for mania (Cade 1949) and a correct theory can be translated into an
ineffective therapy. Hence, while the theories described in this volume may
inspire treatment interventions, testing the efficacy of theory-based treatment is
a separate process more directly relevant to clinical utility.
Determining the specific effects of a form of treatment is the second half of the
equation in the attempt to maximize the efficiency of patient/program matching.
The increased importance of research on patient/program matching is partially
caused by financial pressures to maximize the cost effectiveness of treatments
(Parloff 1982), but it is also related to advances in research methods to enable
investigators to assess specific effects of different treatments more precisely. In
the past 15 years, following the influential publication of guidelines suggested by
Fiske et al. (1970), research on the efficacy of psychotherapy has developed a set
of research standards which have allowed investigators to reduce the uncontrolled
variability which may have undermined previous efforts to detect specific
treatment effects  (American Psychiatr ic  Associat ion Commission on
Psychotherapy 1982, Williams and Spitzer 1984). These design features include
the following: (a) use of credible control groups, which reduce the likelihood
that treatment effects of the therapies being studied are due to nonspecific
factors; (b) use of randomized treatment assignment, which reduces the likelihood
that differences in outcomes across treatments are due to differences in the types
of patients assigned to the treatments; (c) specified, homogenous patient groups,
which allow for better matching of treatment groups, greater specificity in the
treatment techniques utilized, and greater comparability in the measurement of
treatment outcome across patients; (d) specified lengths and “dosages” of
treatments, which have allowed comparability in the timing of outcome
measurements and in the determination of the amount of treatment received; (e)
improved methods for measuring outcome including use of reliable, standardized
instruments; measurement of outcome by blind, independent raters; use of
multiple outcome measures; use of multiple informants to measure outcome; and
use of outcome measures which are designed to detect the theoretically specific
effects of the different treatments being evaluated; (f) specification of the
psychotherapeutic techniques being compared in training manuals, which reduce
the variability in the delivery of treatments and reduce the overlap in the
treatments being compared; (g) greater specification and reduced variability in
the background of the therapists and of the specific training they have received
to conduct the therapy being tested; and (h) monitoring of the therapies being
contrasted to insure that the techniques are being practiced as described in
training manuals and to detect commonalities and differences in the therapies
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being compared. While earlier psychotherapy efficacy studies have included
many of these elements, the project which utilizes all of the above features for
the first time is the NIMH Collaborative Study on the Treatment of Depression
(Elkin et al. 1985). This study compares four treatments for ambulatory patients
with Major Depression: (a) Cognitive Therapy (Beck et al. 1979); (b) Short Term
Interpersonal Psychotherapy; (c) Imipramine and Clinical Management; and (d)
Placebo and Clinical Management. This project breaks new ground in several
ways, and the results, which are due to be announced by the middle of 1986, will
be crucial for demonstrating the value of the methods listed above for detecting
specificity of different treatments for depression. If the treatments in this study
are shown to yield different types of results, this will suggest the value of
similarly designed studies of different treatments with other clinical groups, such
as substance abusers.
Carefully designed, controlled studies, with randomized assignment evaluating the
efficacy of different approaches to treatment of substance abusers are
comparatively rare (Desmond 1979; Rounsaville and Kleber 1985). Moreover, it
should be noted that most of the major modalities for treating substance abusers
today have not undergone efficacy testing of this sort. This includes such
widespread treatment packages as methadone maintenance, therapeutic
communities, and many outpatient drug-free approaches. Instead, these
treatment approaches became more widespread following promising uncontrolled
demonstration projects suggesting that the treatment had effects such as
treatment retention, which were clearly superior to those reported for other
approaches. Following the widespread use of these programs, followup studies
have suggested their efficacy (De Leon 1984; McLellan et al. 1982; Simpson and
Sells 1982). Although the research methods for evaluating efficacy of treatments
have been available for many years, there are several factors in performing
clinical trials with substance abusers which make this work difficult. First, the
urgency of the treatment needs of most substance abusers makes them and their
clinicians reluctant to participate in clinical trials, which include a theoretically
inert placebo or non-intensive control condition. Hence, as long as an active,
standard treatment is available as an alternative, recruitment is difficult. Second,
related to the treatment urgency, it has been difficult in treatment studies with
substance abusers to keep the treatment conditions distinct. In trials by Senay et
al. (1973) and Bales et al. (1980), clients who were assigned to different
treatments frequently obtained care in treatment conditions to which they were
not originally assigned. Third, because of the often heated controversy generated
by differences in treatment philosophy for proponents of different treatment
approaches (Davis 1970). clinicians espousing one or another of the established
approaches are often reluctant to allow clients to participate in studies which
include alternative methods.
Despite the difficulties described above, progress in developing and testing
improved methods for preventing relapse to substance abuse must take place
through a rational series of well-designed clinical trials using the features
described above. Once open trials and/or demonstration projects suggest the
value of new approaches, studies of two general types are needed to demonstrate
their unique properties. At one level, clinical trials are needed to suggest the
efficacy of a new treatment “package” such as a behavioral relapse prevention
approach (Marlatt and George 1984; Marlatt and Gordon 1980). At a second
level, studies are needed which aim at identifying the active ingredients of a
treatment package or conditions in which it is most effective. This can be
accomplished by offering the same general treatment approach to different
groups while varying a single crucial element such as time when the treatment is
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offered or provision of a specific method for handling situations of high relapse
risk.
Several of the chapters in this volume suggest treatment comparisons which may
be fruitful. First, in Dr. Hall’s assessment of factors related to relapse to abuse
of three substances, she found that subjects who simply predicted that they
would not relapse were most likely to fulfill this prediction. This finding seems
to contrast with the theory and treatment approach of Marlatt and colleagues
(Marlatt and George 1984; Marlatt and Gordon 1980). which aims at helping the
subject recognize that a temporary resumption of drug use is likely. Clients are
encouraged to practice positive responses to this anticipated event. A systematic
comparison of approaches which emphasize anticipation of relapse with those
which simply rule out further use would be useful to determine if the specific
relapse anticipation is valuable. Second, several of the chapters suggest that
timing and duration of relapse prevention efforts are important elements. For
Dr. Bigelow’s study of a smoking prevention approach with myocardial infarction
patients, beginning the program before the use of the first cigarette proved
crucial (Bigelow et al., this volume). From the DARP and TOPS studies, the
findings on relapse suggest that the time of greatest vulnerability is shortly after
the cessation of treatment although vulnerability remains high throughout the
first posttreatment year and never disappears even after 12 years (Hubbard,
Simpson and Marsh). Regarding the efficacy of posttreatment relapse prevention
approaches, an important issue is the maximally cost effective duration of
posttreatment followup. If, for example, posttreatment followup efforts persist
beyond the first 6 months, does this yield any detectable added improvement in
relapse rates? Third, the longitudinal findings discussed by Drs. Maddux and
Simpson (this volume) suggest the importance for relapse prevention of a
supportive social environment following completion of treatment. Studies aimed
at evaluating approaches for enhancing the social network of substance abusers
after treatment may fruitfully compare such approaches as family psychotherapy,
provision of drop-in groups or centers, or provision of specific assistance while
in treatment in getting the client involved in self-help groups like Alcoholics
Anonymous, that can continue, following discharge from treatment.
CURRENTLY PRACTICABLE RELAPSE PREVENTION STRATEGIES
While a central conclusion of this chapter is that more careful research is needed
to develop and evaluate promising new strategies for reducing relapse to drug
abuse, this will be a long-term process, while the treatment needs of substance
abusers are immediate. The longitudinal findings presented in this volume
indicate that a substantial number of substance abusers will relapse following
treatment and much of this relapse will occur within the first year. A simplistic
response to these findings would be to extend treatment by 1 year. This response
is not likely to reduce relapse dramatically because many of those who relapse
following treatment were already beginning to resume drug use at the end of
their treatment and were not genuine program completers. Other problems with
simply extending the length of treatment include the added expense (especially
for those who need no further treatment) and the fact that attrition by those with
a high probability of relapse will take place even while they are offered
continuous treatment. Unless continuous treatment is to be considered a lifelong
answer for substance abusers, they need to be prepared to manage without it.
Five steps could be considered by programs at this time suggested by findings
presented in this volume. This list of strategies is not intended to be exhaustive
and a review of aftercare approaches is provided by Hawkins and Catalano (in
press).
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A first, basic step in preventing relapse is making a recognition of its likelihood
a focus of the treatment program. At minimum this should involve explicit
policies regarding reentry into treatment when relapse occurs. Preferably, the
procedures for reentering treatment following a brief relapse should be facilitated
so that the client is encouraged to seek help early and before resumption of
substance abuse has become entrenched. These could include encouraging clients
to telephone their counselors if a slip occurs even if they are no longer on the
treatment program.
A second step which is likely to reduce relapse would be the inclusion of
interventions in treatment specifically designed to anticipate relapse. This could
include the kind of training for constructive responses described by Marlatt
(1980, 1984) and it could usefully include family members who could be trained
to recognize early signs of relapse and encouraged to place pressure on the
relapsing family member to re-enter treatment.
A third step would take the strategy of using the time in treatment to enhance
the supportiveness of the posttreatment environment. One relatively simple and
inexpensive intervention of this type would be to make efforts to encourage
clients to become engaged in self-help groups while they are also in treatment.
Counselors could accompany clients to self-help group meetings and make
explanatory literature available. Fellow clients who are farther along in
treatment could be encouraged to accompany new clients to self-help group
meetings. Spouses and family members of clients could be encouraged to get
involved in self-help spouse groups, such as Al Anon. A more staff-intensive
intervention would be to involve families or significant others of all clients in
treatment and to engage these members of the social network in relapse
prevention strategies as well as traditional family therapy.
A fourth step would be to develop aftercare programs which offer continued
contact with the client but at a much less intensive level than regular treatment.
Because the majority of relapse will occur during the first year following
treatment, this length of time would probably be optimal for these kinds of
efforts. Aftercare programs could take the form of monthly telephone calls by
counselors to check up on how the client is progressing; regular therapy meetings,
but on a much less frequent basis; or “drop-in” groups which meet weekly at a
specific time and which are open to any former clients who wish to attend. Such
aftercare efforts would necessarily involve considerable additional staff time and
this would need to be taken into account in fees collected from clients or funding
agencies while the clients are in the full treatment program.
A final step would be to make interventions while in treatment that take into
account the likelihood of drug substitution as a form of relapse. Segregation of
treatment programs for abusers of different drugs is the most common strategy,
and this may ignore drug abuse that is not seen by the client as primary but
which may increase in importance when the major type of drug abuse is
curtailed, as shown in Dr. Hubbard’s chapter (this volume). Addressing
additional drugs of abuse could take the form of engaging the client in multiple
treatment programs or forming subcomponents within a treatment program, such
as an alcoholics’ group that is run within a methadone maintenance program.
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Relapse and Recovery:
Some Directions for Research
and Practice
Carl G. Leukefeld and Frank M. Tims
The addictions treatment field is maturing. Studies can now be
cited which indicate that drug abuse treatments are effective and
produce desired behavioral change (Tims 1981). But these studies
also point to a high rate of relapse. Indeed, they tend to support
the concept of addiction as a "chronic relapsing disease." Growing
out of these studies are other findings showing that differential
prognoses appear to be a function of such variables as time in
treatment, commitment to seek change, and associated kinds (and
severity) of psychopathology. There are also abundant data showing
that drug abusers commonly experience multiple treatments. Given
these and related findings, a major problem confronting treatment
is the bringing about and maintenance of positive behavioral
change--preventing relapse. As is pointed out in several chapters
of this volume (e.g., Hubbard and Marsden; Taylor et al.),
consideration of relapse from either theoretical or clinical
practice perspectives encounters both philosophical and theoretical
dilemmas. What is the clinical significance of reverting to
"controlled" use or a shift to a substance not thought to be as
pernicious as the one(s) for which treatment was provided? At what
point is relapse considered to have occurred?
There has been more limited exploration of recovery. Recovery is a
desired end in which drug abuse and related behavior are no longer
problematic in the individual's life. In the Alcoholics Anonymous
model, an alcoholic never actually recovers, and is always at risk
for relapse. The debate over who recovers is a continuing one.
The few studies of untreated or "natural" recoveries (e.g., Waldorf
1983) suffer from major limitations, notably, unknown sampling
bias, and consequently, non-generalizability to the untreated drug
abuser. Some recent research indicates that a significant
percentage of treated addicts have relatively short addiction
careers (Simpson and Marsh, this volume). A major issue is the
definition of recovery. Some researchers and clinicians define
recovery as total abstinence, whereas others accept some limited
substance use. A similar question may be posed with regard to the
definition of relapse. Rigid criteria may be problematic to both
researcher and clinician, while a more permissive standard is
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fraught with clinical risk (i.e., that permitted use of a less
pernicious drug may undermine the client's commitment to abstinence
in any of several ways -- such as triggering craving for other
drugs, lapses in self-control, and violation of an abstinence
norm). A single use of a given substance may be the first step to
loss of control, simply a slip from the path of recovery, or it may
have another, more specialized meaning of relapse (e.g., Duckitt et
al. 1985; Marlatt and George 1984).
This volume does not resolve the specific definitional questions
relating to relapse and recovery, but rather explores issues and
approaches to conceptual refinement, research directions, and
pragmatic questions for clinicians in these areas. The principal
thrust of the meeting on which this monograph is based considered
opiates, alcohol, and tobacco as the three substances across which
commonalities in relapse to use and recovery from dependence might
be usefully studied. Indeed, examination of the arguments for the
utility of this approach (National Academy of Sciences 1981)
suggested that it might yield valuable insights, and this has been
our experience. From practice, as well as from the observations of
researchers (see Hubbard and Marsden, this volume), it is evident
that multiple, chronic dependence is not unusual. This has been a
dilemma for methadone programs which give attention to heroin
addiction in a treatment population where alcoholism, smoking, and
abuse of other drugs is widespread. Should treatment be directed
toward one drug while ignoring others, or should the clinic staff
make demands on the client that other problematic substances, some
of which may be legal (e.g., alcohol, tobacco), also be given up?
This sort of question has numerous implications for both treatment
research and practice.
Before presenting the following specific recommendations for
practice and research, it is important to indicate that there was a
high degree of agreement, based on discussions regarding both
research and practice considerations, by the participants. In
fact, general merging toward total consensus might be a more
appropriate description. The extent of that consensus was
unexpected. Clearly, the following recommendations for research
and practice will overlap, and the separation here into three
sections focused on theory, research, and practice, is not intended
to detract from, but to enhance conceptual clarity. We hope this
volume focuses additional attention on relapse and recovery.
Alcoholics Anonymous, Narcotics Anonymous, and other groups which
have been labeled as self-help groups, have provided the supports
necessary for sustaining the recovering person. However, there are
clear definitional discrepancies regarding relapse when studies are
reviewed, including those in this volume.
Relapse and recovery have been defined in many ways. There was not
an attempt made here to standardize the definition of relapse or
recovery. Rather, these concepts are viewed as related phenomena
which are important for our better understanding of addiction and
practice interventions.
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CONSIDERATIONS FOR THEORY: THEMES TO APPROACH THEORY AND THEORY
DEVELOPMENT
Numerous theoretical positions have been taken to explain relapse.
Yet, a coherent, integrated theory is lacking. Discussion related
to theory and theory development acknowledged the importance of
theory as a guide to research and practice, but the lack of
explanatory power in existing theory, and the lack of theoretical
organization, was repeatedly cited as cause for concern. For
example, it was noted that Lettieri et al. (1980) have identified
over 43 theories to explain drug abuse.
That aside, an overall theory as suggested by Edwards et al.
(1981), which combines cognitive, physiological, and behavioral
components, is important for developing a broad conceptualization
of relapse and recovery. In addition, a theory of relapse and
recovery should explain a variety of related phenomena. Specific
criteria need to be explicated so that they can be used to evaluate
theory--proven or disproven. Clearly, theories must be judged on
specific criteria which include utility and their ability to direct
research in a meaningful, parsimonious fashion. Moreover, theories
should help generate principles and techniques for clinical
practice, and should benefit from insight derived from practice.
Such interplay between theoretical formulation and clinical
experience is generally lacking.
A related question to consider when alcohol, tobacco, and drugs are
taken into account is the specificity of the behavioral disorder.
Current research and practice trends are focusing on specificity
and individual drugs, rather than the suggested focus on examining
relapse from a more general perspective.
IMPLICATIONS FOR RELAPSE AND RECOVERY RESEARCH
Overall, a great deal needs to be done in this area of research.
There are research opportunities which can lead to better
understanding of relapse and recovery. Specific discussion focused
on two broad areas: (1) Design issues related to planning relapse
and recovery studies, and (2) research implementation strategies.
As a beginning point and a carryover from discussions related to
theory, research definitions should relate to theory. It was
suggested that cognitive behavioral theories may have particular
utility for relapse and recovery. Ideally, it would be appropriate
to design prospective studies which examine relapse and recovery,
although use of available study populations may make it necessary
to approach studies retrospectively. It was suggested that
existing data bases such as TOPS and DARP might serve as a
beginning to examine relapse and recovery within retrospective
analyses. Five general types of studies were suggested to more
closely examine relapse and recovery:
1. Longitudinal studies which clarify the natural history of
addiction careers. Such studies would be designed to
allow researchers to examine more closely relapse and
recovery.
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2. Descriptive studies to pinpoint who relapses. These
studies would provide a clearer understanding of sex, age,
and drug type variables as these variables impact on
relapse. Similarly, studies of individuals in recovery
might provide a clearer picture and description of
recovery processes.
3. Laboratory studies to examine physiological factors. Such
studies would provide further insight into the nature of
factors related to the clinical aspects of relapse and
recovery. Limited information is currently available
regarding the physiological aspects of those recovering.
4. Experimental studies to assess behavioral aspects of
relapse, particularly the role of environmental stimuli,
including both treatment and non-treatment factors. Such
studies should enable understanding of the role of
treatment as well as other variables in relapse processes
for well-defined subgroups of clients.
5. Clinical studies which would clarify the role of
psychopathology as a risk factor in relapse. This would
extend already existing findings on psychopathology as a
prognostic variable, and specify how subgroups of clients
respond to treatment and to the other stimuli present in
the natural environment, as well as how changes in
psychopathology moderate risk of relapse. In this
connection, it is important to assess clients on a
continuing basis at intake. during treatment, and during
the posttreatment period. Such studies might also address
familial characterlstlcs, as well as individual
psychopathology, as predisposing factors.
It was also suggested that treatment evaluations be designed to
incorporate relapse and recovery as an a priori focus. Such
treatment evaluations should include: (1) theoretical and
operational definitions of relapse and recovery, (2) credible
control group(s), (3) random assignment of groups to treatments,
(4) well-defined patient groups, (5) standardized treatments which
are adequately described in manuals, (6) specified treatment
lengths and treatment doses as well as assurance that interventions
are delivered, (7) use of consistent, reliable and valid outcome
measures, and (8) specific therapist characteristics and training.
The second broad area of discussion focused on research
implementation strategies which address specific problems. focus
shifted to specific areas and problems which mlght have high payoff
or should receive specific attentlon for the study of relapse and
recovery. The major impression gained from thls discussion was the
limited amount of information available on recovery. In the drug
abuse area, self-help groups based upon research findings are being
initiated as aftercare services (see McAuliffe. this volume) to
prevent relapse and enhance client recovery.
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IMPLICATIONS FOR PRACTICE: RELAPSE AND RECOVERY
The overriding implication for practitioners, based on discussion
from this review, is that factors associated with relapse need to
be explicitly identified and become part of the treatment process.
That emphasis could decrease relapse and enhance recovery. A
better understanding of patient motivation and decision-making
should also be a significant part of treatment. Likewise,
understanding the timing of interventions could make an important
contribution to recovery.
Since a number of individuals start using substances immediately
following their departure from treatment, treatment could be
designed so that patients do not drift away from treatment
facilities. Formal procedures for discharging patients with
specified treatment protocols could go a long way toward decreasing
patient drift. Treatment contracts with individual patients might
form the foundation of reducing relapse.
The practitioner's role involves not only bringing about positive
behavioral change and cessation of drug use, but also maintaining
that change and preventing relapse. The development of a better
understanding on the part of practitioners and clients regarding
the risk of relapse, and the desirability of maintaining the gains
they have made, are important. Equally important is the
understanding of the relapse process itself so that appropriate
strategies and support systems may be devised and implemented.
This approach calls for skill development in self-regulation on the
part of the client while recognizing indications of increasing
risk. Thus, clinicians must explicitly deal with relapse as part
of the treatment process and treatment protocol. Perhaps the most
powerful determinant of relapse is the individual's (lack of)
commitment to abstinence. Careful consideration should be given to
formulatlng strategies for helping the client develop such a
commitment to abstinence. At the most basic level, commitment to
change should be incorporated into the treatment process from the
outset. It seems that identified and individualized factors
associated with relapse could also be incorporated with treatment
to decrease relapse. Practitioners must also realistically deal
with limited motivation or commitment by individuals to engage in
the treatment process. It was suggested that this emphasis might
also become part of treatment at the outset. Many users have a low
tolerance for stress and find it easy to return to use rather than
deal with stressors. Based on these discussions, the ability to
cope with distress was identified as an important component of
Alcoholics Anonymous and other self-help models.
Based upon information currently available, the first three months
of treatment are probably the most critical for relapse, as is the .
first year of treatment. With this in mind, clinicians should make
aftercare contacts at the:
first week after treatment
first month after treatment
third month after treatment
first year after treatment
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It was suggested that individualized contact would be most
effective and that telephone contact would be acceptable, although
outreach/aftercare workers might be a more effective approach.
Given the constraints on available resources, insight therapy
should be limited. Rather, encouragement, support, containment,
and direct intervention, as well as confrontation, should be used
in clinical settings. In fact, there may be need for external
treatment controls or coercive approaches for alcohol and drug
abusers to decrease relapse rates. Such approaches as Bigelow's
crisis intervention model (this volume) which was developed with
nicotine dependent, myocardial infarction patients, may be quite
useful in developing strategies for reducing drug use and examining
relapse. While Bigelow's study dealt with a specialized treatment
population, it underscores the utility of exploring critical life
events and concerns of clients, and making timely interventions to
crystallize whatever potential commitment to abstinence may be
present.
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